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Abstract 
Since 1945, a seaweed derivative known as carrageenan has grown in 
importance in relation to how industrial food and pharmaceutical industries 
respond to demands for preventive technologies in public health. In 
advanced liberal nations, carrageenan is particularly interesting as an actor-
network through which are exhibited anxieties about processed food and 
health, controversies over carcinogeneity, and the hopes embodied in 
technologies to prevent obesity and HIV/ AIDS. These matters are of central 
concern in the research reported here, whose main aims are to build on 
insights from critical studies of public health and to contribute to scholarly 
formulations of a new critical geography of public health. Attention is drawn 
to evidence that preventive health is deployed such that individuals and 
communities are expected to avoid conditions of ill-health by acting as 
prudent and moral citizens. Prevention and prudentialism seem to expose 
individuals and communities to novel health technologies, knowledge and 
tactics of governmentality that, in turn, appear to shape social life and 
subjectivities across various scales and locations. Risk minimisation and risk 
aversion have become paramount in the spatial and temporal threads that 
comprise the fabric of social life and identity formation and performance. In 
this light, a third and related aim is to examine how and to what effect 
various notions of risk are deployed in the constitution of preventive 
technologies for public health. Particular, attention is paid to a qualitative 
exploration of risk mitigation via carrageenan's use in fat-free and low-fat 
foods, preventive treatments for HIV/AIDS, and responses to cancer. A 
substantive part of this thesis concerns an analysis of risk minimisation and 
risk aversion in the practice of public health, and that are implicit in 
carrageenan-based technologies. Such technologies include microbicides and 
some fast food products, whilst practices associated with them cover the use 
of food labels and media coverage of all these concerns. Indebted to insights 
from governmentality and actor-network theory, I speculate that prevention 
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in public health discourses target individuals from a distance with the aim of 
encouraging them to modify their behaviours by acting on their own 
conduct. I also explore the spatial and temporal implications of this 
governing at a distance, asking if preventing risk is spatial insofar as it affects 
subjects of risk, and temporal in that the prevention of risk affects the 
present. The findings reveal deeper moral and political orderings to risk that 
are less emancipatory than they may appear, and that have demonstrable 
effects on the carrageenan industry. 
x 
Illustration: Seaweed farms at low-tide, Nusa Lembongan, Bali, Indonesia 1999 
Source: Photo by author 
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Preface 
I never intended to write a thesis about carrageenan and issues of public 
health. After completing an honours thesis at the Australian National 
University focusing on seaweed farming in Indonesia, I had thought I would 
spend my PhD resolving questions about the emergence of what had seemed 
to me, a rather perplexing and significant new form of aquaculture. I 
understood that seaweed farming was related to changes in food and other 
markets (particularly processed foods) and patterns of trade and 
consumption, and whose effects were having a surprisingly positive 
reception amongst communities in Indonesia, the Philippines and elsewhere. 
As I wrote in my honours thesis about farming on the Island of Nusa 
Lembongan in Indonesia 'almost every person interviewed commented on 
the kelaparan (hunger or famine) that was a permanent feature of living on 
the island before the 1980s prior to the introduction of seaweed farming' 
(Burges Watson 1999: 28). 
I was perplexed because of the lack of critique of such an innovative new 
development in aquaculture; it almost seemed too perfect. I wrote that there 
was little published on the environmental effects, but that seaweed farming 
was providing an important -source of income for formerly impoverished 
communities, and because of this it seemed to have few detractors. On one 
occasion in 2000 I gave a slide presentation about my findings at the annual 
meeting of the Marine and Coastal Community Network in Canberra. I was 
surprised that the members of MCCN, whom I considered to have a strong 
environmental focus, seemed particularly enthusiastic in their support for 
this important new form of income for coastal communities. I showed them a 
slide (the illustration preceding this preface) of the extensive farming 
operations in Nusa Lembongan, Bali, where seaweed covered almost all the 
inshore coastal zone in some areas. I had expected many questions about the 
environmental consequences, but there were few. Moreover there seemed 
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little interest in what was generating this rapid increase in demand for 
seaweed. Did they consider seaweed benign, or did its location make it less 
of an environmental issue than if it had been in a so-called developed 
country? 
Later, investigating the decline of seaweed harvesting in Prince Edward 
Island, Canada, where the carrageenan industry had been the mainstay of a 
number of previously impoverished communities in the west, I came across 
something that I was not expecting. Of the 32 people I interviewed, many 
similar in age to me, all had stories to tell me about cancer deaths in their 
families. I was 37 years old and I only knew one family friend who had died 
of cancer; it came as a shock to hear of cancer so often in a remote coastal 
community. It had nothing directly to do with the decline of seaweed 
farming in their community; indeed many informal suggestions were that 
the problem was related to fertilisers used on Prince Edward Island's famous 
potatoes (others suggested cigarettes were a factor). Members of the 
community harboured anger about the geographical reorganisation of the 
industry, one entailing a dramatic reduction of seaweed harvesting in the 
west and a sharp increase in farming in the east, but the high prevalence of 
cancer seemed to be accepted with a resigned fate. Amongst concerns about 
environment, health and their geographies, I began to wonder what risk 
meant and if it meant different things in different places. Then September 
11th, 2001 happened and risk and anxiety extended into another dimension 
altogether. 
In making his case on September 12th 2002 for the invasion of Iraq, President 
George W. Bush referred to what he called the grave and gathering danger to 
international security posed by Iraq's biological and chemical weapons. 
Reiterating the threat at the United Nations Security Council on February 
5th, 2004, US Secretary of State, Colin Powell, stated that the invasion was 
justified by 'facts and conclusions based on solid intelligence' (Kessler 2004: 
A01). Despite the solidity of evidence, over a year later weapon stockpiles 
had not been found in Iraq. In an about-face, Colin Powell admitted to a 
Washington Post reporter that he may not have recommended the invasion 
had he known that there were no stockpiles of banned weapons. Powell 
remarked that the 'absence of a stockpile changes the political calculus; it 
changes the answer you get' (Kessler 2004: A01). 
The political calculus changed the answer. In Powell's confession what is 
revealed is that risk was not wholly visible in the first place. Rather, risk was 
rendered visible through calculations of probabilities, not materiality of 
weapons. Only after the weapons failed to appear was the mis-calculation 
revealed. In the estimation, management and action that followed the initial 
calculus, Iraqi citizens faced the deployment of solid, material tanks, guns 
and other weapons of US risk mitigation. In a reversal of brutalising effects, 
the destruction executed by the Western military forces preceded a risk of 
weapons of mass destruction. Preventing a risk did not simply guard against 
possible future risks, but had manifold consequences in the present. 
Members in a Canadian community of seaweed farmers did not appear to 
take action against the risk of cancer, the MCCN did not seem overly 
concerned about potential environmental issues in Nusa Lembongan, and 
yet the US was prepared to invade a sovereign territory on the basis of a 
calculation of risk. I thought risk would be an interesting topic for 
investigation in relation to its temporal and spatial qualities. 
Preventive activities are increasingly common among individuals, 
organisations and institutions in relation to public health. Probiotic foods, 
mediated messages encouraging reduced intake of alcoholic beverages, 
barrier methods to diminish the risk of sexually transmitted diseases, testing 
genetic predispositions to particular health conditions; each exemplifies 
practices of preventive health. I thought, when I discovered that carrageenan 
had uses in technologies for preventive health, it might be possible to join 
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some of the dots. After my reading exposure to theories of risk, geography 
and actor-network theory, this thesis is an attempt at just that. 
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Chapter 1 
Risk in the new public 
health 
It is difficult to overemphasise the extent to which western society is 
concerned with the aversion of risk and how this informs thinking and praxis 
in public health. Ewald (1993: 221) suggests that risk has 'acquired a kind of 
ontological status'; it does not just indicate something that might happen, but 
is a factor in how people understand and respond to questions of health. 
Faced with questions about how to avoid illnesses before they happen, 
material technologies, bodies and actions are mobilised by people, 
institutions and organisations to modify the present and fight against the 
past. Actions against risk in this mode of thinking help define the new public 
health (Petersen & Lupton 1996). 
Carrageenan is a derivative of seaweed and a technology of risk 
management. Known also as a hydrocolloid, it is one in a family of 
substances with hydro (water) and colloidal (gelling) properties that include 
agar, alginates and a variety of non-seaweed substances. A chemical 
definition of hydrocolloid is a 'non-crystalline substance with very large 
molecules which dissolves in water to give a thickened (viscous) solution' 
(McHugh 2003: 2). Hydrocolloids have many uses 
pharmaceutical and other industries that may be 
conjunction with other hydrocolloids and, to 
interchangeable. Carrageenan has uses, inter aim, 
pharmaceutical industries as a common additive 
thickening and emulsifying properties. At different 
in food, chemical, 
used singly or in 
some extent, are 
within food and 
for its stabilising, 
times it has been 
investigated for active properties in pharmaceutical products. 
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In this thesis I examine carrageenan's growing importance in the responses 
of industrial food and pharmaceutical industries to the demand for 
preventive technologies in public health. Drawing upon the literature on 
governmentality inspired by Foucault, I treat the new public health as a 
particular mentality and/or regime of government and administration 
(Dean, M 1999b: 2). Using carrageenan as both an intrinsic and instrumental 
case study (Stake 1994), I explore the workings of prevention in public 
health, and specifically the constitution of carrageenan within changing and 
polyvalent rationalities of risk. My purposes are to consider the modes of 
calculation of risk; the technologies and practices through which the 
governance of risk and carrageenan has its effects; and the implications for 
individuals in the changing nature of governance and its articulation, and 
visibility, within public health. Further, I consider how individuals are 
refashioned as prudent consumers of health through the powers of freedom 
(Rose 1999). The research is intrinsic insofar as it offers insights into the 
particular case study of carrageenan, and instrumental in its concerns with 
critical geographies of public health (Brown, T & Duncan 2002) to 'provide 
insight into an issue or refinement of theory' (Stake 1994: 139). 
By bringing risk to account in the present I question the effects of preventive 
actions against risk, first in relation to carrageenan and its development, and 
second, by extension, to obligations and responsibilities that emerge for 
prudent consumers of health. I also question how particular ways of thinking 
about public health and risk affect the carrageenan industry and map the 
implications of these effects for prudent and moral subjects. Across the thesis 
prudentialism is the primary focus; explored through the case study of 
carrageenan with respect to three public health examples - carcinogenicity, 
HIV/ AIDS and obesity; and three major themes - visibility, spatiality and 
futurity - themes I relate to these empirical public health concerns. 
Furthermore, I examine the effects of risk on and through carrageenan and in 
relation to individual and collective subjectivities. My proposition is that 
there are deeper moral and political orderings to risk functioning within the 
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new public health whose effects are less emancipatory than may appear; and 
whose effects on the carrageenan industry are demonstrable. 
My work is positioned in a scholarly community whose members are 
considering the manifold effects of the increased role of preventive health 
and its relation to individual subjectivity in contemporary societies (Lupton 
1999a, 1999c; Petersen & Bunton 2002; Petersen & Lupton 1996; Webster 
2002). It is also engaged in a larger task of addressing the underlying 
geopolitics of prevention as an effect of particular political rationalities and 
techniques of government (Dean, M 1999b; O'Malley 1992, 1996; Rose 1996, 
1999). Nonetheless, this work is both original and significant in questioning • 
the rationality of preventive health by placing at the centre of analysis a material 
technology that registers with the public almost entirely through 
informational mediation, and through which the logic of public health 
strategies may be traced. It is deliberately far-reaching in scope but focused 
at a micro-scale on the empirical example of a substance that is most often 
used in minute amounts, but whose spatial reach is great. 
The new public health and prudentialism 
The term new public health draws attention to how regimes of power and 
knowledge associated with regulating .public health have, since the mid 
1970s, reoriented away from earlier models typified by closer attention to 
infectious disease and biomedical interventions against individual 
pathologies (Petersen & Lupton 1996). The new public health describes a way 
of thinking about health in which priorities are established in terms of the 
health of the public, raising the centrality of population in the measurement 
and actions regarding health, and in terms of environmental conditions and 
risks individuals are exposed to. In practical terms, the new public health 
manifests in concerns of particular kinds: measurement of the likelihood of 
illness at the scale of population; a focus on environmental conditions likely 
to produce illness; and in aspirations to enable individuals to manage their 
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own health. Taken together, these concerns provide a context in which issues 
of prevention and health promotion have taken centre stage in seeking to 
address health risks to the public and new responsibilities for individuals in 
managing such risks. The ascendancy of prevention and health promotion in 
contemporary societies thus creates a governmental environment in which 
individuals are (supposedly) active participants in the management of risk 
(Dean, M 1999a; Nettleton, Bunton & Burrows 1995; Petersen & Bunton 2002; 
Pryce 2001). The public face of government through risk is found in state and 
• privately funded health promotion and provision; in and through which 
prudent subjects are proximate to the codes and norms for their conduct in 
relation to health. 
Throughout this thesis I draw upon contributions to the study of 
governmentality and risk to describe how public health happens, and 
carrageenan's entanglements within it. The language and actions of risk and 
prevention are increasingly recognised as features of contemporary life in 
general, and together form a topic of significant and growing academic 
research and endeavour. 1 Risk literatures and studies encompass various 
perspectives and, because of the ubiquitous nature of risk in social life, cross 
a number of academic fields including geography, sociology, criminology, 
politics and anthropology (for a discussion of these and other approaches to 
risk see for example Lupton 1999a). Questions of prevention extend beyond 
issue of health to encompass all manner of concerns, including for example, 
insurance (Dean, M 1999b; Ewald 1991) and criminal law (Levi 2000; 
O'Malley 1992). 
Approaches to risk that fall within the theoretical ambit of governmentality 
extend the work of Michel Foucault in emphasising an increasing 
individualisation of risk as a modality or rationality underlying governance 
in many western societies (Brown, T & Duncan 2002; Castel 1991; Dean, M 
I Risk literature is extensive, but see for example: (Beck & Ritter 1992; Boyne 2003; Dean, M 1999b, 
1999a; Ewald 1991, 1993; Lupton 1999a, 1999c; O'Malley 1996; Petersen 1996; Petersen & Bunton 1997, 
2002; Petersen & Lupton 1996; Rose 2001). 
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1999b; O'Malley 1992, 1996; Petersen 1996; Petersen & Bunton 1997, 2002; 
Petersen & Lupton 1996; Rose 2001). Foucault first coined the term biopolitics 
to refer to the practices of governance that address the vital processes of 
human life (Foucault 1979; Rose 2001). Politics was no longer read as a 
system in which subjects were governed from above, but rather as one in 
which subjects were governed through systems for the management of life in 
more general terms. Foucault's understanding of the power over life he 
termed bio power. That involves the twin arms of an anatamo-politics of the 
human body and biopolitics of population (Foucault 1979). He suggests that 
by the nineteenth century power entailed intermixing anatamo-politics - as 
the means to integrate bodies into regulated systems and make them 
efficient, and biopolitics - as the means through which a population's 
mortality, morbidity and birth could be measured and regulated. Through 
these dual technologies the more or less rational exercise of power over life, 
and health, was enabled. 
Castel (1991) has described the mentality that has made new preventive 
forms of intervention in public health possible as a transition from a sense of 
dangerousness to one of risk. He uses the example of US interventions in 
mental health, to describe the shift in the last hundred years of so, between 
an emphasis on preventive strategies that control the dangerous patient, to 
preventive strategies directed to individuals at risk. Assessing risks related to 
the health of populations, facilitates the extension of calculations of risks 
beyond individual manifestations of illness, to national and global 
environmental concerns and to calculations of risk in already healthy spaces 
(Brown, T & Duncan 2002; Petersen & Lupton 1996). Armstrong (1995) 
suggests that from the early part of the twentieth century, the incorporation 
of spaces of health gave rise to a new form of surveillance medicine. 
Surveillance medicine, after Foucault, is typified by the strategy of health 
promotion over concerns such as diet, exercise and sex as 'vehicles for 
encouraging the community to survey itself' (Armstrong 1995: 400). From 
these perspectives, health risk occupies more expansive territories of concern 
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in human activity than was previously the case. Moreover, one difference 
between dangerousness and risk is that with risk 'one does not start from a 
conflictual situation observable in experience, rather one deduces it from a 
general definition of the dangers one wishes to prevent' (Castel 1991: 288). 
One effect of this turn in rationality is that there are then no limits on what 
can be considered a risk because it no longer depends on observable signs 
and symptoms but on calculations of probabilities. Another effect of these 
new forms of preventive intervention, is that subjects are no longer the focus 
of calculations for direct interventions; rather calculation is based on a 
combination of factors of risk that are likely to produce undesirable outcomes 
in individuals (Castel 1991; Lupton 1999a ; Petersen 1996). Moreover, from 
the 1970s onwards, biomedically-based disease models involving a medical 
cause and outcome, were no longer the only factors considered in risk 
calculation. Increasingly, disease is measured using multi-causal approaches 
which incorporate not only the biomedical concerns, but social and 
psychological factors of risk associated with different disease cOnditions 
(Brown, T 2000; Brown, T & Duncan 2002). Thus new public health is typified 
by an increased emphasis on health promotion as a technology through 
which such multi-causal and risks can be addressed, in part via the 
production of prudent individuals. O'Malley (1996) terms as new prudentialism 
the self-regulatory effect of governance through the individual. Prudent 
individuals regulate all aspects of their personal and collective 
responsibilities within family or community, through such things as a, 
concern for personal health, and managing diet and nutrition. Risk may then 
be understood as one modality through which individuals are enabled to 
manage issues of prevention in health, and through which, Castel (1991) 
argues, the desire for health has become central to the formation of 
individual subjectivities in contemporary society. 
To contextualise how such a transition became possible, in the first volume of 
the History of Sexuality, Foucault (1979) argues that government has become 
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more concerned with the conduct of conduct than with social organisation, one 
result of which is that the individual supposedly becomes increasingly self-
regulating and self-governing. In this view, government is achieved through 
strategies and tactics that direct rather than control individuals and 
populations, or through •the powers of freedom (Rose 1999). From this 
perspective a critique of governing practices involves an exploration of the 
mentalities that make the issues of government thinkable. Through critique, 
it becomes possible to view the workings of social order as effects of 
particular strategies of governance rather than assuming that risk, choice or 
freedom occur outside of these strategies (Dean, M 1999b; Rose 2001). 
Central to this new interpretation of the forms of governing the health and 
welfare of populations were scientific and expert systems of knowledge upon 
which various techniques, technologies and systems of care and 
administration were based. Proponents of the governmentality perspective 
suggest that risk is central to the ordering of disease and, by association, 
people. Risk is rendered calculable through diverse expert knowledges and lay 
understandings (Gilman 1988; O'Malley 1992, 1996, 2001; Petersen & Bunton 
2002; Petersen & Lupton 1996). The domination of scientific-institutional 
expertise in both constituting and interpreting risk is broadly accepted, even 
if risks are contested by other knowledges. For example in the area of public 
health, epidemiology is recognised as one complex assemblage of practices - 
such as laboratory experiments, statistical surveys, clinical studies and risk 
profiling - that has played a particularly significant role in the calculation 
and dissemination of health risk (Brown, T 2000; Dean, M 1999a; Nettleton, 
Bunton & Burrows 1995; Petersen 1996). The epidemiological framing of risk 
at the scale of population has particular effects, not least of which is that 
other scales may be under-explored. 
Yet as Dean (1999a) points out, while the twin focus of governmental 
strategy is population health and active participation by subjects, there are 
also situations in which subjects or groups are specifically targeted for health 
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intervention. Hence, the classification of those at risk may also be much more 
broadly encompassing than were earlier rationalities of dangerousness. Take, 
for example, Foucault's tracery of a village idiot who is construed as 
criminally dangerous and in need of incarceration (Foucault 1979). Indeed, 
one of the consequences of the language of risk is that the entire 
population can be the locus of a vulnerability that can also single out 
specific populations, in a way that the language of danger, class or 
disadvantage cannot (Dean, M 1999a: 147). 
Among other effects, the new public health expands the production and 
articulation of risk and at risk subjects, extends the spaces in which they may 
be identified, and intensifies the role of prudent subjects. Discourses that 
promote individual choice, as a manifestation of prudentialism, are then 
within the tactics of governmentality and are not outside relations of 
power/knowledge. 
Campaigns and technologies employed to direct individuals towards 
preventive self-care might include for example, the distribution of condoms 
for sexual health, or the dissemination of information on safe sex. Through 
material intermediaries, the new public health discourses have entered 
previously non-medicalised spaces such that the understanding of a division 
separating illness from health no longer exists; in epidemiological terms the 
whole population comes into 'its network of visibility' (Armstrong 1995: 
395). Everyone is at risk and what is then normal practice for individuals in 
relation to health is also transformed. Put another way, normality is 
problematised even within so-called healthy populations (Brown, T & 
Duncan 2002: 364). Through provision, promotion and prudentialism 
subjects are no longer recipients, but become consumers of a multiplying and 
expanding range of concerns about health (Brown, T & Duncan 2000; 
Henderson & Petersen 2002; Nettleton, Bunton & Burrows 1995). In this 
view, consumerism is deployed as the model upon which health systems are 
based and, as such, accord with a more general tendency towards 
consumerism as the key mode through which individuals engage with the 
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world. Prudent individuals are active consumers rather than passive 
recipients of health. 
In the case of carrageenan for example, food labels provide one source of 
information through which individuals are enabled to make (healthy) 
consumer choices, thus producing through individual actions a collectively 
healthy population. Such biopolitical and regulatory intervention in the 
public sphere is nothing particularly new. In Australia, Stratford (1998a; 
1998b) traces similar governmental technologies to new domestic sciences 
from the 1860s onward. Presently, however, the multiplication and extension 
of sites of biopolitical interventions in health is accelerating. Like war in Iraq, 
the possibility of future health events may be based on the calculus of 
probabilities, such that there become a 'potentially infinite' number of 
possibilities for intervention (Caste! 1991: 289). So how do individuals choose 
to avoid risk? 
Circumscribing freedom 
In academic discussions of risk, the idea that individuals have choice is 
contentious. Different theoretical perspectives emphasise or de-emphasise 
the reflexive ability of subjects to make choices and of the contextual 
importance of factors that influence choice. For proponents of Ulrich Beck's 
Risk Society Thesis (RST) for example, subjects are considered more reflexive 
than for those who adhere more closely to Foucauldian readings of risk. 
According to Beck, in RST the self becomes reflexive about risk, not because 
of particular practices associated with governance such as the promotion of 
health, but through the loss of traditions and advancements in technological 
culture: 
Risk society begins where tradition ends, when, in all spheres of life, we 
can no longer take traditional certainties for granted. The less we can 
rely on traditional securities, the more risks we have to negotiate. The 
more risks, the more decisions and choices we have to make (Beck 1998: 
10). 
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In this view, the individual encounters more and more occasions in which 
there are no easy answers, reflexivity becomes a necessity and, moreover, is 
more or less a rational activity in response to risks that are real. 
Foucault's (1977) approach is different, and considers the construction of the 
body as more docile than reflexive in the face of disciplinary power (although 
his views about docility are tempered in later works such as the History of 
Sexuality Vol 1.). Individual choice is a delimited and, indeed, delimiting 
range of governmentally inspired options, and subject to forms of 
surveillance to monitor deviance from normalised practices. Science and 
expert knowledge are considered key forms of understanding through which 
risk messages are mediated and constructed. Once outside the circumscribed 
range of responses, individuals are likely subjects of governmental 
intervention. 
In more recent scholarship that extends Foucault's work, the particular 
governing practices associated with a mentality of rule sometimes described 
as neo-liberal underscore a new understanding of the subject (Dean, M 
1999b). Neo-liberalism refers to a specific style of governing populations, 
distinguishable from other forms of political rationality, by its winding back 
social governance and welfare, promoting free market economics, and 
working through so-called individual rights and freedoms. Under systems 
that are neo-liberal in character, citizens are neither completely docile, nor 
completely reflexive; rather they exercise a form of regulated freedom (Dean, M 
1999b; Lupton 1999a; Petersen 1996). Under neo-liberal forms of rule, the 
relationship between the subject and society is reworked from government of 
to government through. This adjustment can be seen in Australia, the UK and 
the US for example, through differential techniques to wind back social 
institutions of health care in favour of market privatisation of services. In 
neo-liberal polities such as these, 
society is regarded less as a source of needs that are individually 
distributed and collectively borne and more as a source of energies 
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contained within individuals' exercise of freedom and responsibility 
(Dean, M 1999b: 152). 
Neo-liberalism then, implies that there are limits to the notion of freedom; it 
is not boundless, but is rather circumscribed within a 'sphere of freedom' 
(Petersen 1996). Within a sphere of freedom individuals may to some extent, 
be 'authors of their subjectivity' (Nettleton, Bunton & Burrows 1995). The 
(continual) transformations of individual subjectivities in relation to health 
are then 'neither clearly liberatory nor clearly repressive' (Cruikshank 1994: 
30). 
The calculation of risk and at risk subjects in the new public health has a 
transformative effect on individual subjectivities and the socio-spatial 
landscapes of disease and health. However while the focus on individualised 
practices of self-care in relation to health risk underscores the new centrality 
of health in contemporary society, as others have cautioned, risk and health 
are not the only factors upon which individual decisions are made (Brown, T 
& Duncan 2000). Although spaces of public health are conceived by the 
complex interweavings of political rationalities, tactics of governance and 
material technologies, health (or its provision) is experienced and situated in 
place; it is lived. 
Determining how public health and prevention work necessitates 
consideration of the limits and bounds of the sphere of freedom and the effect 
of individuals' subject positions in influencing their understanding of risk, as 
well as other factors that may be un-related to risk but that facilitate decision-
making. First, there are diverse sources of information from which 
understandings of risk may be derived and by which individuals may 
manage risks differently (Lupton & Tulloch 2002; Robertson 2000). In other 
words, the understanding of risk is contextual and based on cultural and 
interpretive characteristics that have been overlooked in much of the risk 
literature (Wynne 1996: 45; 2002). Arguably, therefore, proponents of the RST 
perspective may too readily have assumed that individual understanding of 
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risk is derived from expert knowledge, and may have failed to fully 
appreciate the contingency of scientific knowledge and its communication. 
Second, the self is a more complex project than the RST permits, involving 
the embodiment of rationalities that include an aesthetic-expressive 
dimension (Brown, T & Duncan 2002; Petersen 1996; Rose 2001) and gender 
and sexuality (Lupton 1999b; McNay 1999). Third, decisions that have a 
bearing on health are not necessarily made simply on the basis of risk 
calculations. In Brown and Duncan's (2000) account of the rise of cigar bars 
in London, for example, the health risks associated with smoking may be less 
of an influence on choice than the 'exotic' places and erotic fantasies cigars 
evoke. Cultural and hermeneutic dimensions and regulated freedom not 
only complicate the idea of risk knowledge as 'ambiguous knowledge' 
(Wynne 2002: 460) but also contest assumptions that decision-making is only 
ever premised on issues of health and/or risk. The ambiguity of risk 
knowledge, and importance of other factors of decision-making have 
implications for my interest in carrageenan because it is represented in 
popular media sources as safe or risky based on various associations that 
may include seaweed, Irish moss, Ireland, food additives, cancer and 
chemistry, and because such representations may feed other more 'desirable 
rhetorics' (Brown, T & Duncan 2000: 365) such as 'naturally' sourced 
products - discussions of which occur throughout the thesis. 
Consideration of the effect of risk then concerns how preventive health is 
enacted through regulated freedom. Thus far I have emphasised the notion 
of a prudent individual as active in self-government, but individual 
responsibility is linked to responsibility for others. Individuals are 'located in 
a variety of heterogeneous and overlapping networks of personal concern 
and investment - for oneself, one's family, one's neighbourhood, one's 
community, one's workplace' (Rose 1996: 331). On one hand, the moral 
discourse of individual responsibility is deployed through community. On 
the other, an ethics of prudent behaviour is enacted through community. In 
this view, a feature of risk as a modality of contemporary neo-liberal styles of 
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rule is that both sell-surveillance and collective surveillance of health are 
socially constructed styles of conduct (Petersen 1996). 
The significance of risk can only be considered in relation to what it is 
attached to; it does not exist without some factors be they calculations, 
statistics, epidemiology, management techniques. Rather than one mode of 
rationality, risk is polyvalent (Dean, M 1999a; O'Malley 2000). The systems of 
monitoring and calculating risk are varied, and each has its own assemblage 
of practices. One task of this thesis is to expose assemblages of risk 
calculations in the technologies that are deployed, the rationalities that 
underlie their deployment and their effects. In the measurement of 
carrageenan as a factor in cancer, developed in chapter four for example, I 
consider the different calculations of risk that are encountered between 
regulatory authorities and the views of an MD with an interest in preventive 
oncology. 
Finally, the effects of risk do not always match the results that might be 
expected by the aims of prevention. Dean (1999b: 132) has commented that 
while risk is a modality 'shaping human conduct in the service of specific 
ends' and with definite aims, the effects of this mode of rationality are not 
always predictable. Furthermore, failure to live up to the expectations of 
prudentialism may have other costs: failing the self (Brown, T & Duncan 
2002). 
Spaces of the new public health 
Whether or not individuals enact their responsibilities under the terms of the 
new public health, such enabling practices of self-care demonstrates a• 
reworking of the extracorporeal spaces of health and a focus on a geography 
that is closest in. Rose (2001: 1) has argued that 'contemporary biopolitics is 
risk politics'. In his view however, risk applies less to notions of population 
risk, more to economic risks of health and ill-heath. The market is viewed 
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within (most) accounts of neo-liberalism as a space external to the 
governmentality of the new public health discourse2. While Rose's focus is on 
an enabling state that reworks space in order that people may govern 
themselves, Armstrong (1995) describes a move away from the body as the 
site of intervention and increased focus on extracorporeal spaces. The effects 
- of spaces of health and illness are productive of social relations and not only: 
is the relationship between symptom, sign and illness redrawn but the 
very nature of illness is reconstrued. And illness begins to leave the 
three-dimensional confine of the volume of the human body to inhabit a 
novel extracorporeal space (Armstrong 1995: 395). 
Once reconstituted as extracorporeal, spaces themselves become subject to 
risk assignations in relation to health. Lifestyles and place can then become 
factors of 'un-health' and subject to strategies of mitigation. For example, 
individuals may be encouraged to walk further each day, wear a pedometer 
or change dietary practices. Built environments, too, are objects of the health 
gaze, with their different elements contributing to obesity via excessive 
access to food and limited pursuit of physical activity, and with 
environmental health research and interventions seeking to address this 
complex problem (Richardson 2004). In this view, illness is no longer 
mapped in terms of symptom, sign and disease but through issues such as 
lifestyle and the identification of certain places and spaces as indicators of the 
likelihood of illness. The inclusion of social and physical space into the health 
gaze also incorporates aesthetics such as food choices, fashion and desire 
(Brown, T & Duncan 2002). 
Both perspectives have utility in identifying spatial formations common to 
the new public health that are located in sites of consumption. The 
commodification of health care provision and the role of market forces in 
modifying the relations amongst individuals, health and health care, has 
been identified as a significant new area of study and interest. As the title of 
2 A notable exception to this is Mitchell Dean's (1999a) concept of reflexive government. For the 
purposes of this thesis however, the relationship between governmental and economic spaces is not 
viewed as critical to the overall arguments about prudent subjects and spaces of public health. 
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Henderson and Petersen's (2002) edited collection Consuming Health 
suggests, one spatialisation of new public health is through sites of 
consumption in which the prudent subject is a consumer of health. 
Campaigns and technologies employed to direct individuals towards 
preventive self-care might include for example, the distribution of condoms 
for sexual health, or the dissemination of information on safe sex. Through 
material intermediaries, the new public health discourses have entered 
previously non-medicalised spaces such that the understanding of a division 
separating illness from health no longer exists; in epidemiological terms the 
whole population comes into 'its network of visibility' (Armstrong 1995: 
395). Everyone is at risk and what is then normal practice for individuals in 
relation to health is also transformed. Put another way, normality is 
problematised even within so-called healthy populations (Brown, T & 
Duncan 2002: 364). 
In short, one important effect of the new public health discourse is that 
spatial topologies are modified and transformed. For example, divisions 
between health and illness erode; understandings of health (re)emphasise 
lifestyle factors; and, issues in the provision of public health may be 
addressed as global concerns. The incorporation of health into the general 
space of populations involves a comprehensive remapping of space. 
Moreover, by locating health and illness in spaces beyond the corporeal body 
in more generalised spaces such as community and global health provision, 
there are issues for the constitution of individual identity. As Petersen and 
Lupton (1996: 114) summarise, 'social relations and bodily practices take 
place within spaces and in places; they shape and are shaped by space and 
place'. 
Thus, discourses of public health do not simply work through centralised 
state centered apparatus, but rather, 'government is accomplished through 
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multiple actors and agencies' (Dean, M 1999b: 26) and through 
transformations of space. 
Much recent critical scholarship has addressed the discursive production of 
people and places in new public health; (Lupton 1999a, 1999c; Petersen & 
Bunton 2002; Petersen & Lupton 1996) however less attention has been given 
to such concerns within geography. Space and place, then, are crucial to the 
operation of public health and is given effect by the turn to the new public 
health. It is through this lens that I explore carrageerian. 
Critical geographic scholarship and public health 
A critical approach to the analysis of geographies of public health emerged in 
recent debates within post-medical geography, (Brown, T & Duncan 2002; 
Dyck 1999; Kearns & Moon 2002; Parr 2004) and it is with such debate that 
the theoretical underpinnings of this thesis resonate most strongly within the 
field of geography. Developing a geography of public health from the micro-
terrains of individual bodies to the macro-terrains of global politics advances 
the critique of prevention and risk towards a consideration of and focus on 
the spaces and places in and through which governance of health is lived, 
perceived and conceived (Lefebvre 1991). 
Brown and Duncan's (2002) vision for a new critical geography of public health 
builds on governmentality approaches' to risk and medical sociology and 
draws upon insights from post-medical geographies of health. They argue 
for a critical edge to health geography that scrutinises the underlying 
medico-morality of contemporary public health, and which acknowledges 
the exercise of power implicit in the focus on prevention and the active 
participation of subjects in managing their own well-being. 
Tracing elements of a genealogy of a 'social model of health', they also 
describe how (contemporarily) psychological and social factors have been 
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incorporated into medical models of public health that extend the critical 
elements of health geography, but only so far. In their view, geographers 
have tended to use medico-social models for research rather than to adopt a 
more critical approach that would deliver the insights of post-structuralist 
scholarship. The shift from a focus on disease to one on health in the research 
interests of geographers, as noted by Kearns and Moon (2002) for example, 
may be interpreted as a transition in disciplinary interests, and a 
diversification and extension of geography's interest in questions of 
philosophy. However, in my view, the transition suggests a shift in the 
political understanding of health and illness, such that the turn in geography 
mirrors discourses of the new public health. Along similar lines, Nettleton et 
al. (1995) recognise that a distinction can be made between a sociology of and 
a sociology for health promotion and prevention. In such views, criticality 
rests with the recognition that there has been a change in the mentality that 
makes the thinking of health possible and not simply a shift in approach to 
health research. Brown and Duncan (2002) contend that in health geography 
few scholars adopt such a critical perspective. In addition, criticality is often 
used as a term to imply a concern for social justice and equity, and may be 
applied to the provision of health (Kearns & Moon 2002; Parr 2004). In this 
thesis, criticality, after Brown and Duncan, is represented by a willingness to 
think critically and delimit what a Foucauldian inspired critical geography 
might involve. 
Notwithstanding Parr's (2004) hesitancy in announcing a new field within 
geography, and the fluidity of definitions of critical geography, Brown and 
Duncan (2002) suggest four themes to include in a prospective critical 
geography of public health. First, such an approach would be cognisant of 
the extensive critical new public health literature that reveals emergent 
common tropes in public health (Kearns 1997). A critical geography would 
interpret their relevance to public health practice, particularly in relation to 
issues of space and place. Second, the approach would question how space 
and place are problematised by the new public health, paying attention to the• 
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use of place-based identities such as those implicit in the term community. 
Third, it would look beyond theory to interrogate situated experiences to 
examine how the new public health works and, I add, to ask how material 
technologies enable the workings of the new public health at a distance. Last, 
it would consider the notion of responsible citizenship, and examine/explore 
how individuals respond to or resist prudentialism in relation to health. 
Critical geographies of public health incorporate elements of Foucauldian 
notions of technologies of self; and health as new and central arenas in which 
social life and multiple spaces of social life are organised. I adopt Brown and 
Duncan's (2002) methodological strategy for a critical geography of public 
health, but with one addition. I incorporate elements of a network approach 
that emphasise the importance of material actors in constituting power (and 
the new public health) at a distance. 
Public health and ANT 
Practitioners of actor-network theory (ANT) argue that it is through the 
description of heterogeneous networks of factors that an understanding of 
the workings of social order is facilitated (Callon 1999; Latour 1991; Law 
1992; Murdoch 1997, 1998). In contrast to much sociological enquiry, a 
principal concern of ANT is that domination cannot occur solely through the 
workings of social interactions, but requires more stable forms in which 
power can be assimilated and protected from the destabilising effects of 
space and time. For scholars of ANT it is through networks of human and 
non-human actors that society takes form. 
Latour's ... portrayal of social life as necessarily dependent upon non-
human resources makes space and time central to the theory of actor-
networks: any consideration of the length and breadth of heterogeneous • 
association entails shifting through space and time as we seek to 
determine how these two dimensions are bound into, and emerge from, 
the complex webs or networks which compose our socio-spatial 
landscape (Murdoch 1997: 332). 
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Murdoch's placement of space and time as central to ANT analysis 
underscores the importance of geography to the following analysis of 
carrageenan and prudentialism in the new public health. Yet as Murdoch 
(2001) points out, from within sociology critics of ANT suggest that there is 
insufficient attention to human agency in determining the course of actor-
networks. The calculation of risk, described as a mentality underlying 
practices of governance, is a useful example in demonstrating the limits of 
the ANT approach arising from its abandonment of a priori distinctions 
between the social and natural. Murdoch (2001: 128) agrees that a case may 
be made for the problem of human exemptionalism, noting that humans play a 
particularly significant role in shaping network topologies. At the same time, 
ANT is a useful methodological framework through which to map the 
heterogeneous assemblages of human and non-human factors affecting how 
the mentalities of risk and public health are operationalised. Discourses of 
public health may be understood to act at a distance via material 
technologies and through and on space and time, a discussion of which now 
follows. 
Space and distance in public health 
Prevention in the new public health works through re-territorialisations of 
the socio-spatial landscapes of disease and disorder, risk and health. The 
significance of space and distance (temporalities and proximities) in 
understanding how networks of humans and non-humans are bound 
together is a crucial element of ANT approaches, and one critical to analyses 
of carrageenan and of how public health works. 
Investigating conditions under which the new public health policies and 
practices are able to work beyond their theoretical formulations involves 
recognising how different technologies are incorporated in the functioning of 
public health. What is more, it is difficult (if not impossible) to imagine a 
place where there are no interactions between material technologies and 
humans in society. 'Technology is everywhere' and the relation of ends and 
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means is 'profoundly problematized' (Latour 2002a: 248). In one example, 
Strum and Latour (1987) show how the social organisation of life amongst a 
group of baboons must be continuously performed to last beyond the 
immediacy of the local interactions. This well-known case study of baboon 
societies has been used to demonstrate, by opposing them to human 
societies, the material workings of social life. Without material actors, society 
cannot be made durable. The significance of the material to local and 
immediate social interactions amongst humans is that human society seems 
to exist largely 'somewhere else, outside, beyond, above or below' (Murdoch 
1997: 326). 
Public health depends on interactions that implicate factors beyond the local 
and immediate space(s) of encounter, that are part of a much more complex 
web of interactions whose influence on individual actions in relation to 
health are significant. Congealments of technologies in social transactions, 
for example information accessible on Internet sites, enable the social to 
extend beyond the local and immediate such that through materials 
'interactions can be stabilized, summarized and extended through space and 
time' (Murdoch 1997: 327). One significant argument amongst ANT scholars 
is that the separation that is assumed among science, nature and artefacts is 
artifice. Latour (1993: 31) has suggested that modernity relies on the notion of 
a dualism such that there must be a 'complete separation between the natural 
world (constructed, nevertheless, by man) and the social world (sustained, 
nevertheless, by things)'. In reality, Latour suggests all technologies are 
hybrids of social and natural, and all scientific discoveries and innovations 
can be examined from this perspective (see also Whatmore 2002; Whatmore 
& Thorne 1997). A significant implication of the ANT approach is that 
material actors cross and muddy the boundaries of body, state and nation. In 
this view, the new public health is not only a western (neo-liberal) concern, 
but may have transformative effects elsewhere - for bodies, states and 
nations, to the global scale of geopolitics. 
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By definition, public health is not of itself proximate; it is only through 
medicines, texts, transport systems or mediated representations that it is 
possible to act on the health of a remote public. In ANT, proximity and 
distance are understood to be effects; in public health this means 
configurations of discourses of the new public health and various material 
actors may be associated to configurations of space/time. For example, 
telemedicine involves the treatment of patients at a distance where the use of 
Internet technologies enables the expertise of doctors to be brought into close 
proximity with patients (Mort, May & Williams 2003; Webster 2002). As 
Webster (2002: 446) observes, such technologies may be seen to 're-invent the 
boundaries of the body in space time'. Using the metaphor of the network to 
describe the workings of public health, it is possible to envisage spatial 
relations, even body geographies, as effects of complex assemblages of social 
and technological life and, moreover, to understand the role of systems of 
governance, their processes and tactics, as elements within them. 
The geographical implications of ANT are far-reaching and depend on 
relational understandings of space/ time. Proximity and distance are not 
measurements or fixed co-ordinates, but describe the relations within a 
network. If space and distance are the (relational) effect of socially complex 
interactions between material and non-material factors, discourses of the 
new public health and its assemblages may be understood as inherently 
spatial and as executing transformative effects on space. Accordingly, the 
turn to prevention is understood to have created, or mapped, new spaces of 
illness/ wellness and, in particular, to have incorporated healthy spaces as 
hitherto unmapped zones (Brown, T & Duncan 2002: 365). 
The articulation of the new public health at different scales, from the 
geography closest in to the global scale of geopolitics, may be viewed in 
terms of their heterogeneous networks and spatial topologies. Yet, ANT 
rejects the idea of scale as a pre-existing measurement in favour of an 
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approach that recognises that scale, too, is determined by networks. Thus 
community, nation, body, and the global and local are defined by the 
connections and shapes of the network (Murdoch 1998). 
A network notion is ideally suited to follow the change of scales since it 
does not require the analyst to partition her world with any [a] priori 
scale. The scale, that is, the type, number and topography of connections 
is left to the actors ,themselves (Latour 1997: 6). 
In the analysis of spatial topologies there are overlaps with theorists not 
normally recognised as traditional ANT scholars, but who acknowledge the 
importance of space to questions of governmentality and health. For 
example, Dean (1999b: 192) suggests that the scale of community no longer 
accords with traditional geographic (Euclidean) ideas but may be conceived 
more as the 'transitory, overlapping, multiple relations of affinity and 
identifications felt by self-responsible subjects'. In this vein Rose (1996) 
suggests that community has become a new spatialisation of government. 
The importance of community to how public health works is thus an effect of 
the new spatial topologies through which risk enters into new social 
formations, an example of which might be the virtual communities of health 
that can be found on the Internet (Parr 2002; Petersen & Bunton 2002). The 
emergence of community as a new space in which public health works is 
then an effect of discourses of risk aversion and minimisation. 
Changes of scale through which carrageenan is implicated in the geopolitics 
of actions at a distance in the new public health, are demonstrated by 
congealments with material actors and innovative health technologies (IHTs) 
such as the McDonald's low-fat McLean Burger for prevention of obesity; 
food labels providing a source of public information on food contents; and 
Carraguard®, a microbicide in development for the prevention of 
HIV/ AIDS. In these examples geopolitics may involve, sometimes 
simultaneously, contexts that include the micro-terrains of human bodies 
and macro-terrains of global space. Moreover, critical geopolitics studies how 
the 'geo-graphing' of global space occurs within relations of space/power 
and knowledge (Hyndman 2004; b Tuathail 1996; Roberts, Secor & Sparke 
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2003) opening interesting avenues of exploration for public health. After all, 
the emergence of global forms of health provision and mediation is premised 
upon global flows of information and technologies, and the interactions of 
material and non-material actors. 
Three themes, spatiality, visibility and futurity emerge from the discussions 
thus far: spatiality, because of the extension and transformative effect of the 
sites of the new public health; futurity, because prevention is forward 
looking and based on calculation of risks of probable events; and visibility, 
because in order that individuals may govern themselves, risks must be 
revealed. Taking this into consideration, I will consider how I advance a 
critical geography of carrageenan. But before outlining the methodological 
approach I will take, I first consider some implications of combining ANT 
• and governmentality approaches. 
Introducing elements of ANT to studies of goverrunentality raises certain 
methodological and theoretical questions about their contrasting concerns. 
Dean (1998) raises these issues in a discussion of Foucaults work on 
'questions of method'. He suggests Foucault's methods 
involved examining 'regimes of practices' as 'more or less organized or 
routinized ways of doing things that manifest an immanent logic of reason of 
their own' (185). Because of this methodological approach, Dean suggests 
that it is possible to see the links between Foucault's work and sociologies of 
science in that 'they both reject an absolutist account of knowledge' and look 
instead to understand how knowledge (and power) is dependent on 
particular regimes, practices and heterogeneous networks. The difference, 
according to Dean, is in the concern with 'what is constructed'. For 
Latour and other theorists of science and technology how 'reality' is socially 
constructed is of concern, whereas for Foucault it is what counts as true. On 
this view is not reality that is constructed, but ways of knowing the truth 
about it, what Dean (1998: 194) calls the 'realm of effectivity of the 
construction of truth'. While approaches inspired by Latour and 
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Foucault diverge on this crucial issue, there are overlaps in how they come to 
these understandings. Foucault and Latour share similar methodological 
strategies - they both seek to unpack networks/regimes/dispotifs through 
which power is assimilated. Yet Latour critiques Foucauldian styles of 
analysis for the asymmetrical focus on social science and failure to bring 
science to critical account (Crawford, TH 1993). Latour remarks, 'the test of 
his definition is to see if hard sciences can be bought into his description' 
(Crawford, TH 1993: 252). Certainly, there is greater attention to the 
everyday practices of science and technology from practitioners of ANT (see 
for eg. Callon 1999; Garrety 1997; Latour 1988; taw 1986). In my view, the 
differences in theoretical underpinnings of the method produce different foci 
and results, most significantly in what the methods get attached to. For studies 
of governmentality, the 'realm of effectivity' is approached from an analytics 
of government, addressing the discourses and multiple actors and agencies 
through which this is accomplished (Dean, M 1999b). For practitioners of 
ANT, the focus is instead on the network of actors which have the quality of 
power - government is in the network. The two approaches may therefore be 
considered reciprocal and complementary. As an example, it is possible to 
approach the analysis of carrageenan regulations from different vantage 
points. From the perspective of an analytics of government, there are various 
concrete mechanisms, such as the Food and Drug Administration (FDA), 
which operate as boundary objects between the diffuse world of discourses, 
people and things, and how public health may be enacted. Alternatively, 
using an ANT approach, everything in the network of the FDA, scientists, 
papers, technologies, have qualities of power that are the device(s) of public 
health. Combining ANT and governmentality approaches affords different 
perspectives of carrageenan and public health networks; particularly useful 
given that carrageenan is dependent on 'hard' science for its manufacture 
and representation. Moreover, as I will presently detail, a similar 
methodological strategy, critical discourse analysis, may be applied to garner 
different perspectives for a critical geography of carrageenan. 
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Towards a critical geography of carrageenan 
In what follows I use the figure of carrageenan to explore a critical 
geography of risk, prevention, expert knowledge, technological 
development, consumerism, health and the prudent individual. In exploring 
the construction of carrageenan as it is related to discourses of risk and the 
new public health, I draw on three public health examples through which 
carrageenan is an actor-network in relation to medically defined illnesses: 
cancer, obesity and HIV/AIDS. Indebted to ANT and governmentality, and 
to an emerging narrative about risk as polyvalent rationality underlying the 
new public health and its socio-spatial and temporal topologies, the thesis is 
informed first and foremost by the notion of prudentialism and questions of 
visibility, spatiality and futurity in relation to health risks. Such risks occur 
not only in issues of pre-defined illness but in issues of pre-defined health, 
and I explore also issues of public health related to carrageenan within the 
spaces of the already healthy population in the realm of food, aesthetics 
(obesity) and sexuality (HIV). The geopolitical dimensions of prudentialism 
cover the regulatory practices both internal and external to nations as a point 
of contact among risk, consumers and carrageenan. Geopolitical concerns 
also extend to the examination of issues in post-colonial health and the 
provision of innovative health technologies (IHTs) across national borders. 
The temporal dimensions of risk flow across and between all the chapters as 
the past, present and future are bought into the complex networks through 
which risks are calculated and rendered visible. 
Carrageenan lends itself to an analysis of how individuals are obliged to 
health prevention because, in various applications, and in the spaces in 
which carrageenan and public health overlap, risk minimisation and 
aversion require that risks be revealed. What is unique about this case study 
is first that carrageenan is a material technology made visible to consumers 
through mediated messages about it. Carrageenan is used in minute 
quantities for its functional properties. In the terms of ANT, carrageenan 
does not exist outside the networks in which it is constructed and enrolled. 
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Carrageenan is a hybrid form that incorporates such things as scientific 
technologies, scientists and systems of representation. 
Second, there are few people who have extensive knowledge of the 
carrageenan industry, and along with its use, experts with a broad 
knowledge of the industry have been predominantly based in the (neo-
liberal) west. The hourglass structure of the carrageenan industry is 
composed of extensive harvesting and farming of seaweed for carrageenan 3; 
manufacture dominated by a few processorst and the use of carrageenan as 
a ubiquitous item of consumption. Three companies, namely FMC 
Biopolymers, CP Kelco and Degussa, dominate the processing of 
carrageenan5. In 1996 European and American countries accounted for 63% 
of the purchases of carrageenan products (Bixler, 1996: 39), although there 
has been a growing demand for them in Asian countries. Yet beyond the 
worldwide sourcing of raw materials for carrageenan, localised processing 
and western/international focus of sales, carrageenan use has been based 
predominantly in western countries, where it has been widespread. The 
main applications are in the convenience food market, and particularly in 
dairy products, where 0.01% to 0.05% carrageenan may be sufficient to 
achieve a technical function such as thickening or emulsifying (McHugh 
2003: 69). A survey of any supermarket for the term carrageenan, E407 or 
E407a (as regulatory names) - and by extension, a survey of its locations in 
homes, workplaces and bodies - demonstrates the spatial ubiquity of 
carrageenan in the west. Thus while carrageenan has vast spatial reach and 
3 McHugh and Philipson describe the manufacturing of carrageenan as 'unusual' when compared with 
other tropical industries; even though it is common for the raw materials to be exported for value 
adding, carrageenan processing has been dominated by a very few processors located far from the 
source material (McHugh & Philipson 1989: 149). 
4 Blanchetti-Revelli describes the market relationships as one of oligopsony between seaweed 
producers and processors, and oligopoly between processors and carrageenan users (Blanchetti-Revelli 
1995b). 
5 The carrageenan-bearing seaweed industry has been subject to various acquisitions and mergers and 
sources of precise data on carrageenan production amongst companies are notoriously difficult to 
access. Amongst the interviews conducted with industry participants it was well accepted that the 
three companies are the largest and most influential in the carrageenan industry. As well as 
maintaining email contact with industry participants, one industry source from which I received 
occasional email news updates on the status of carrageenan and hydrocolloid industry developments 
included www.hydrocolloid.com (Seisun 2004). 
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complex network topologies, there is a waist to the knowledge of the industry 
amongst western-dominated processors of carrageenan. During the course of 
this research, I have been fortunate to have access to and interview key 
players in carrageenan processing, about which I will expand presently. 
Third, with carrageenan's deployment, the future . is called to account in the 
present through risk and also through the two IHTs as the central topics of 
chapters five and six: the McLean burger and Carraguard. The calculation of 
risk centres on the future health of the body politic, even as the effects are 
registered and experienced by individuals. Carrageenan offers an empirical 
example through which to explore theoretical concerns associated with 
prudentialism and individuals' responsibilities for preventing ill-health 
through the themes of visibility, spatiality and futurity. In summary, 
carrageenan is an extremely complex actor-network. Due to the intricacy of 
that actor-network, the empirical data for this thesis have necessarily been 
derived from a broad range of sources and through research in multiple 
fieldwork locations. 
Fieldwork, data collection and critical discourse analysis 
Combining the foci of carrageenan and issues in public health in this research 
was an extension of prior interest in the carrageenan-bearing seaweed 
industry. During the work for my honours thesis Farming the sea: seaweed 
cultivation in Nusa Lembongan (Burges Watson 1999) international and 
national contacts in the carrageenan processing industry were developed. 
My fieldwork was initiated with informal conversations with farmers, local 
leaders, tourist operators and officials on the island of Nusa Lembongan and 
nearby island of Bali in Indonesia, in an attempt to understand the dynamics 
of seaweed farming and to uncover local issues of particular importance. 
During the course of the research I investigated local activities concerning 
the harvesting of seaweed for carrageenan, but became increasingly 
interested in how global markets and distant cultures of food and 
pharmaceutical consumption were implicit in the local. 
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As Blanchetti-Revelli (1995a) suggests, there is • nothing unusual about 
incursions of western cultural forms or the reach of global capitalism, but the 
intensity of interconnections and their lack of visibility in the local context of 
a seaweed farming community is intriguing. For me such interconnections 
were heightened on Nusa Lembongan as it is also a popular site for 
international tourist activity. 6 In order to gain insight into the dynamics of 
the seaweed industry for the extended doctoral project, it was necessary to 
expand the horizons of the research to carrageenan-processing corporations 
and sites of carrageenan use. My concern to trace the public health related 
networks in which carrageenan is a part required that I gather situated points 
of view from multiple nodes within carrageenan networks. Therefore I 
synthesized conversational and semi-structured interviews with key 
informants in the carrageenan industry, observations of common 
consumption sites such as supermarkets, and extensive literature based 
research across global popular media and academic sources. 
Selection of industry participants was built on previous research and initially 
relied on contacts in Indonesia and Australia which snowballed to Canada, the 
US and Europe. It might be expected that access to corporate sites would be 
limited for time or other reasons, however I found a level of openness to and 
enthusiasm for my research amongst industry participants. There are at least 
three possible reasons for this. First, my honours research was circulated and 
Well received amongst some members of the seaweed industry, and may 
have been a factor in the access I had to corporate executives, the FMC 
Biopolymers extraction plant in Rockland, Maine, and various industry 
employees. Second, carrageenan-bearing seaweed farming has become a 
popular choice amongst development agencies to ameliorate poverty in low-
income coastal communities in some locations, such that there may be 
6 Tourists and seaweed farmers alike had little knowledge of the uses or market for carrageenan. 
Tourist brochures for Nusa Lembongan, Indonesia advertised seaweed farming as a traditional activity 
and suggested the seaweed was used in cosmetics and shampoo (Burges Watson 1999). Similarly, in 
farming areas in the Philippines, Blanchetti-Revelli notes the lack local knowledge about uses for 
carrageenan (Blanchetti-Revelli 1995a). 
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perceived benefits to public exposure through research publications. Third, 
seaweed is an unusual topic for many people in the west, and in general I 
found most participants in my research had a passion for the subject and 
were enthusiastic about sharing their knowledge. 
In all, face-to-face semi-structured and conversational interviews were 
conducted with 44 participants in the carrageenan industry including key 
industry players based mostly on the east coasts of Canada and the US where 
the industry first established commercial roots. In particular, Harris Bixler, 
David Myslabodski, Gordan Guist and Dimitri Stancioff, names peppered 
through this thesis, have been active in relation to the commercial 
carrageenan industry, some from its beginnings. Some interviews were 
arranged by formal letters of introduction; some lasted one hour or even less, 
and yet others were more informal conversations over hours or days. In 
Camden, Maine for example, conversations with Dimitri Stancioff lasted for 
three full days, and could generate a thesis in themselves. In Rockland, 
Maine, the home of FMC Biopolymer, I spent one week interviewing various 
current and former employees and was given a tour of the carrageenan 
processing factory. Two months of fieldwork were spent in Miminegash, 
Prince Edward Island, Canada, a place central to the carrageenan-bearing 
seaweed industry until farming seaweed became commercially viable in the 
tropics in the mid-1970s. The knowledge I gained through participant 
observation of seaweed harvesting and interviews with former and current 
harvesters of Irish moss seaweed and local company representatives in 
Miminegash, underpins this thesis. All interviews elicited participants' 
views of the changes in the market for carrageenan, and specific 
consequences related to food and pharmaceutical uses of carrageenan. 
Consistent with the ethical guidelines established by the University of 
Tasmania for fieldwork and face-to-face interviews, participation was by 
consent and recorded on audio-tape or in writing. Before all interviews 
participants were informed of their right to discontinue or withdraw from 
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the research. Where possible, I checked the data by reporting preliminary 
findings to key informants. All face-to-face interviews were audio-taped and 
transcribed for qualitative analysis. Furthermore, I could trace elements of 
the carrageenan network only so far through interviews and my physical 
relocations; thus much of my research incorporated, and included, 
communications technologies. Joanne Tobacman, protagonist in the debates 
concerning carcinogenicity and carrageenan (chapter four) was interviewed 
by telephone and email on three occasions. Data were also gathered from 
popular media sources including newspapers, magazines and the Internet. 
Details of these primary data occur in the chapters where they appear. 
Texts and interview materials were analysed for connections amongst the 
issues raised by studies of governmentality and risk and how such concerns 
may be seen to constitute dialogue; and representations of issues in public 
health. Critical discourse analysis (CDA) (Fairclough 2001, 2003; Fowler 
1991) describes a range of different approaches that share a concern with 
both the 'order of discourse', those relatively durable social and material 
structures informing the relationships between power and knowledge; and 
closer readings of texts. Such 'moving between' the social context of texts and 
the texts themselves enables sensitivity to the ways in which language and 
discourse figure in relations of power and knowledge and social processes 
(Fairclough 2001: 229). Practitioners of CDA empha.sise that social change is 
often initiated by new discourses (such as 'the new public health') and that' 
the emergence or appearance of such may be 'read' or appreciated through 
three different arenas of social practice. First as new ways of inter(acting) 
such as genres, second as new ways of being such as styles, and third in new 
kinds of practices - such as the structuring of space (Chouliaraki & 
Fairclough 1999). Thus, in the new public health may be typified by new 
forms of interaction between governments and individuals as 'consumers'; 
individuals behave as consumers (being); and lifestyle as a new spatialisation 
of government. Moreover, the analysis of such social change can be 
achieved via detailed textual or linguistic analysis. Texts reveal the broader 
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social change via the shifting articulations of genres, discourses and styles 
(Fairclough 2003). Thus the methodological strategy I adopt, traces the 
emergence of the 'new public health' discourse in association with its 
constitution and articulation in social practices - specifically those associated 
with carrageenan. Moreover, this strategy applies for both ANT and 
governmentality approaches in its concern with the relations amongst social 
practice and discourse. 
It is widely perceived that there is both crisis and opportunity in the 
increased role of individuals negotiating issues of health. While the spaces 
for citizens to access and debate issues of health have clearly expanded, there 
is a sense that the quality of information and decision-making may be 
threatened by commercial interests; access to particular types of information; 
or overly obsessive attention to potential health risks. A critical discourse 
analysis enables consideration of how changes in social and political life 
refigure discourse, social practice and new forms of social interaction. Thus 
analyses of discourses and across genres of text including expert scientific 
sources, regulatory sites and media, and via material intermediaries 
contribute to a multi-faceted 'picture' of network connections amongst 
carrageenan, individuals and public health. 
In deploying a critical geographic and network approach to the study of 
carrageenan I am mapping new territories of investigation by focusing on a 
substance whose significance is in what it is attached to. By bringing a 
theoretically-informed perspective to carrageenan as a material technology 
associated with health prevention I am able to explore the network spaces 
between and among actors, and to study in detail how actions against risk 
become durable within networks. This tactic is appropriate since, after 
Latour (1991) it is through material technologies that government is able to 
act at a distance and through which carrageenan's associations and networks 
figure in the (re)territorialisations of the spaces of contemporary governance 
of health. 
Visibility, spatiality, futurity and carrageenan 
The calculation of risk for the purposes of public health involves rendering 
visible the elements through and with which prudent consumers are 
expected to make 'rational' choices. The public surveillance of carrageenan is 
regulated by a variety of national and international institutions such as the 
US Food and Drug Administration (FDA) and the international standards 
enshrined in the Codex Alimentarius system 7. Regulatory powers such as the 
FDA calculate the risk of carrageenan consumption and codify it on food 
labels where is it listed as an ingredient. Through enticements to read the label 
consumers (may) choose to consume carrageenan. Carrageenan's visibility is 
an essential part of the tactics of prudentialism. In general, carrageenan is a 
tasteless, odourless substance that adds functional properties to food. It 
cannot be detected by human senses other than by its • effects; for example 
carrageenan may be used to give a fat-like mouth-feel to low-fat products, or 
in chocolate milk to stop the chocolate from settling to the bottom of the 
container. Because of such properties, consumers' knowledge of carrageenan 
may be experienced through physical senses of viscosity or mouth-feel, but it 
is most likely to be understood (if at all) through mediated messages about it. 
Further, that substances such as carrageenan might be invisible has been 
raised by some proponents as contributing to a heightened sense of risk 
(Adam 1999; Beck & Ritter 1992; Millstone & Zwanenberg 2002). 
Carrageenan's use in IHTs for the prevention of obesity and HIV/ AIDS is a 
critical and active component of the technologies of health prevention 
7 Created in 1963 by the Food and Agriculture Organisation of the United Nations (FAO) and World 
Health Organisation (WHO), the Codex Alimentarius Commission establishes guidelines, standards, 
and codes of practice for the food industry for internationally traded products. The Joint WHO/FAO 
expert committee on food additives (JECFA), an expert advisory body to the Codex Alimentarius 
Commission, provides expert assessments of food additives, contaminants and naturally occurring 
toxicants. The expert assessments of substances such as carrageenan provide one source of data 
through which national and international institutions regulate the safety of food (Codex Alimentarius 
2002). 
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through which choices are enabled, and not just signified. Through the 
(invisible) technological attributes of carrageenan used in the McLean burger, 
consumers are offered a low-fat alternative to a regular fat laden burger. In 
its use as an active ingredient in a preventive technology against HIV/ AIDS 
(Carraguard), carrageenan is marketed as a clear gel that is invisible to others 
in order to encourage women to use it without men's knowledge. In the 
former case invisibility is a risk: it reduces the prudent capacities of the 
individual. In the latter, it is cast as an opportunity: a stealth technology. 
The language and calculation of risk mitigation underscore the use and 
development of carrageenan as a product in food and pharmaceuticals. In 
both, carrageenan has an evidence-rich profile that is mediated across time 
and space. The extensive networks of information and evidence about it are 
enabled through the expansive reach of regulatory authorities. That profile is 
an official guarantee of safety, and has been a factor through which 
carrageenan has been authorised for use in a number of food products for 
preventive health, including low-fat foods. On the other hand, one 
outspoken MD with an interest in preventive oncology has recently gained 
widespread attention in the international press for her research that suggests 
carrageenan is a risk to human health, despite the official body of scientific 
evidence supporting its safety (Tobacman 1998, 2001). The ambiguity of 
safety claims provides food for theoretical consideration,, but also for an 
examination of the length and reach of networks in forming and stabilising 
risk. 
Questions of futurity associated with prudentialism and the development of 
IHTs is the most exploratory of the themes. Prevention, pre-emption and 
prediction (all characteristics of risk aversion in public health) have an 
orientation towards futurity, but also have different meanings and effects, 
some of which have been identified within critical health literature. For 
example, Petersen (2002: 23) suggests that prevention is primarily concerned 
with the avoidance of 'environmental, psychological, behavioural and 
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lifestyle risk factors', while predictive medicine is more generally recognised 
as related to developments in genetic testing and the ability to predict the 
future before it happens. My own thinking in pre-emptive 8 action is greatly 
influenced by Crina Archer (2004). Drawing on the Work of the political 
theorist Hanna Arendt, Archer suggests that a new logic underscores 
practices of pre-emption that have manifested in .particular in US politics in 
over the last decade, but have become more pronounced during the George 
W. Bush presidency. She posits that 'the idea that drives the logic of pre-
emption is, quite simply, the claim that our theories can predict the future 
with a degree of certainty that eradicates the need to wait for events in the 
world to confirm or disrupt them' (Archer 2004: 3). In her view, unlike 
preventive or predictive medicine, the accuracy of claims is not the primary 
motivation for actions against risk, but the imputation that dangerousness is 
imminent. Indeed she suggests that invisible threats such as the missing 
weapons in Iraq, unfound cave dwelling terrorists, undiscovered chemical 
laboratories, are sufficient evidence upon which to calculate future 
dangerousness (Archer 2004). Indebted to such insights, I start to speculate 
about the applicability of pre-emption of invisibly calculated risks and its 
overlaps with carrageenan in my final comments on Carraguard. 
The themes of visibility, spatiality and futurity are drawn together by an 
exploration of the possibilities, limits and extent of prudentialism and the 
rise of informational resources and technologies produced towards enabling 
prudent consumers of health. 
Contemporary concerns about health 
A broader social concern underlying my choice of topic is human health. As 
it stands, rather than diminishing in contemporary society the numbers of 
people suffering the effects of HIV/AIDS, cancers and obesity are widely 
8 But note that the use of the terminology pre-emption and prevention is not always consistent. 
'Prevention' in some contexts, is closer in meaning to what I term pre-emption. See for example 
Kegley & Raymond (2003). 
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regarded as worsening. Estimates from UNAIDS in 2004 indicate that 
globally, 36.4 million people are living HIV/AIDS and in regions such as 
Sub-Saharan Africa the numbers of newly infected people is continuing to 
rise (UNAIDS 2004). The World Health Organisation (WHO) estimates that 
since 1980, the numbers of individuals who are obese or overweight have 
tripled in some areas of North America, the United Kingdom, Eastern 
Europe, the Middle East, the Pacific Islands, Australasia and China (World 
Health Organization 2003c). The WHO (2003a) predicts that increasing 
cancer rates worldwide may double between 2003-2020 to affect 15 million 
people. Despite the range of technologies available to mitigate these pressing 
health issues, it appears from such statistics that individuals are not being 
prudent enough about prevention to turn the tide of progression of any of 
the three conditions. Any light that I might shed on why this might be so I 
consider worthwhile. I am concerned to present an argument in which risk is 
a motivator of social, spatial and temporal processes and to consider the 
status of carrageenan as a food additive and active pharmaceutical 
ingredient (in development). As Parr (2004: 249) has suggested, by adopting 
a critical approach to public health, the possibility exists that new ideas may 
be generated that 'hold the potential for better understanding of social 
processes and spaces; as well as facilitating different pathways to praxis'. 
I also explore public understanding(s) of illness and health. How individuals 
negotiate their responsibilities as subjects of risk, and how information is 
understood and acted upon is critical to the outcome of public health 
initiatives. My in-depth interviews with key informants working within the 
carrageenan-processing industry in various positions around the world, 
revealed strong beliefs that there are no safety issues with carrageenan as a 
food additive. Based on the quantity and quality of scientific measurement 
such a position is not difficult to defend. However, if the issue of carrageenan 
safety is (re)framed as one of risk, the discussion broadens to encompass 
governmental rationalities in which risk renders carrageenan calculable. 
There are implications for human beings in these questions and in the 
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empirical chapters on cancer, the McLean burger and Carraguard these 
issues are explored in some depth. 
Chapter synopsis 
The following chapter begins with a close-in view of carrageenan and its 
risky assemblages, and the narrative proceeds to the final chapter, with a 
speculative discussion about a technology through which HIV/ AIDS is being 
addressed at the global scale of geopolitics in which carrageenan is one 
ingredient. Intervening chapters focus more specifically on carrageenan, the 
calculations of risk associated with its use and how risk produces 
carrageenan, and subjects. 
In chapter two I provide a geopolitico-history of carrageenan that is both 
background to the industry and its development, and that also contextualises 
developments in the industry within changing rationalities of governance 
and risk. Carrageenan's use as a common food additive from the 1930s to the 
present provides a historical context alongside which it is also possible to 
view the changing and polyvalent rationalities of risk and their effects. 
Within the histories of carrageenan, I discuss the importance of dairy as a 
foodstuff in which carrageenan occurs, which is itself a category with 
particular links to a politics of risk. I also explore the regulatory history of 
carrageenan and argue carrageenan is rendered visible and incorporated into 
the diverse strategies of governing health. It is little known by most people 
yet it is partly through the contribution of technologies such as carrageenan 
and food labels, that the accomplishment of the self-managing subject 
becomes possible. 
However in chapter three, the limits of regulatory representations are 
revealed as carrageenan is explored through the spaces in and through 
which it is defined and manufactured. Through an examination of the 
science, and natural and manufactured products that reveal carrageenan, I 
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consider how the calculation of risk is a factor in contested representations of 
carrageenan. In particular the chapter brings to the fore the case study of a 
substance defined as 'degraded' carrageenan (also referred to as poligeenan) 
because of its chemical formulation and documentation and research 
suggesting negative effects on health. I explore how degraded carrageenan 
has become an object of risk surveillance and anxiety, and the contest 
amongst epistemic communities of interest who attempt to assert their 
understandings of carrageenan and risk. 
Degraded carrageenan also features in chapter four, in which I examine a 
widely reported controversy over the status of carrageenan as a potential 
carcinogen and its implications for prudentialism in public health. Using the 
metaphor of the network and network lengthening, I consider first how 
networks are extended through the scientific calculation of risk, and second 
how risks are mediated and extended by prudent subjects. 
Similarly, chapter five refers to the calculation of risk through a case study of 
obesity in discourses of population health. In my case study of the McLean 
burger, a low-fat burger developed by the McDonald's company in 1991, I 
explore the failure of the technology to capture the public imagination as a 
failure of prudentialism. Media articles that appeared at least 4 years after 
the McLean had been withdrawn from the market provide the raw data to 
examine the popular representation of individual choice and responsibility in 
the face of failure. 
Then, in chapter six I explore some contemporary priorities in post-colonial 
health. Specifically, I consider a case study of an HP// AIDS prevention 
technology in development - Carraguard. Preventive actions on the part of 
post-colonial states to guard against diseases such as HIV/AIDS are tied to 
debates about security (King 2002). In the new public health, the location of 
risks to the body politic are no longer viewed as contained by boundaries of 
territory, but by the 'deterritorialized networks of information collection, 
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management, assemblage and disssemination' (Burges Watson & Stratford 
forthcoming). The development of Carraguard as a technology of risk 
containment is developed and considered as it is associated with post-
colonial priorities in global health. 
In my analysis I do not examine the question of the safety of carrageenan. 
Rather it is the calculation and inculcation of risk in relation to carrageenan 
that principally concerns me. If risk has become a mode through which we 
govern society and those within it, then any product might be studied from a 
risk perspective. Carrageenan has been chosen to exemplify how ubiquitous 
risk is in contemporary society, not to isolate carrageenan for an 
interrogation of safety. However I must state a personal interest in the 
outcome. During the past five years I have witnessed first-hand the growth 
of the carrageenan-bearing seaweed industry around the world. I have been 
privileged, to live amongst some of the many thousands of seaweed 
harvesters and farmers who have greatly benefited from the growth of the 
industry in providing a new source of income for many formerly 
impoverished coastal communities. I have encountered the anxieties of 
Canadian and Indonesian harvesters and farmers to risks of industry decline. 
In these And other locations seaweed harvesters' livelihood rests in part with 
the perception of risk associated with carrageenan amongst us, the self-
regulating consumers. 
The thesis is a progression and gradual expansion of a network of sorts. 
Through each successive chapter, the informative scope of carrageenan's 
entanglements is extended. It is in the politics of partial perspectives 'that 
sustained, rational, objective enquiry rests' (Haraway 1991: 287). This 
proposition is central to my thinking and greatly informs the spirit in which 
this dissertation is written. The gradual accumulations of information 
represented in this thesis are, then, my contribution to a partial perspective. 
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Illustration: Blanc-mange pudding, 1976 
Source: Courtesy Salt Institute for Documentary Photography, Portland, Maine, US 
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Chapter2 
Regulating the risk of 
carrageenan 
Carrageenan is the name given to a family of different polysaccharides 
extracted from various species of red seaweed found in numerous locations 
around the world, and in commercial quantities in countries including 
France, Canada, Chile, Philippines, Indonesia and Tanzania. 9 Commerce in 
seaweed extracts has a long history; Chinese and Japanese traders and 
doctors were reported to have shared information on seaweed extracts as 
early as 970 AD (Hansen, Packard & Doyle 1981: 7). During the nineteenth 
century, the gelling properties of seaweeds containing carrageenan were 
utilised for desserts such as blanc-mangelo, but it was not until the 1840s that 
the particular qualities of carrageenan extracts were recognised. It was to be a 
further century before a commercial industry based on carrageenan extracts 
developed. By 2003, annual global production of carrageenan was estimated 
to be worth US$240 million (McHugh 2003: 2). 
From the late 1930s carrageenan industry processors sought raw material 
primarily from wild harvested populations of Chondrus cris pus. Prince 
Edward Island, Canada, was the primary source of that raw material until 
the early 1970s (Anderson, Frenette & Webster 1977; Blanchetti-Revelli 1995b; 
Chopin 1998; Pringle & Mathieson 1986; Women in Support of Fishing 1987). 
Although Chondrus cris pus remained the major source of carrageenan, in the 
1950s tropical seaweed species of the Eucheuma variety were found to be 
9 In the taxonomic definitions of seaweed, three divisions - red, green and brown - produce extracts 
that are used in a wide variety of applications. There is much crossover among the divisions, however; 
in general green algae have been used for human and animal feeds, browns for algin extracts and reds 
for food, agar and carrageenan (Burges Watson 1999). 
10 The use of whole plants of Chondrus crispus as a food ingredient used in jellies and puddings has 
been documented in Ireland, dating as far back as the 14th Century. The origin of the term 
'carrageenan' is suspected to derive from Carrigeen Head in County Donegal in Northern Island, as a 
colloquial name given to Chondus cris pus (carrageen) (Indergaard & Ostgaard 1991; Mitchell & Guiry 
1983). 
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another valuable source of carrageenan. Wishing to expand the source of raw 
materials, Marine Colloids Inc. of Rockport Maine (now FMC Biopolymer) 
initially experimented with the aquaculture of Chondrus cris pus in Canada. 
However, it was not found to be economically viable when compared with 
the cheaper tropical sources of seaweed (Chopin 1998; Pringle & Mathieson 
1986). Aquaculture of the tropical carrageenophytes was developed from the 
1970s in countries including the Philippines and Indonesia (Ask 1999; Doty 
1981, 1987; Luxton 1993; McHugh 2003). Species such as Kappa phycus alverezii 
(common name 'cottonii') and. Eucheuma denticulatum (common name 
'spinosum'), and not Chondrus cris pus, became key to industry development. 
For over a decade now, species of Eucheuma and Kappaphycus have been the 
primary sources of raw material for carrageenan (Ask & Azanza 2002; Bixler 
1996). 
As Blanchetti-Revelli (1995b) suggests, the cultivation of tropical seaweed for 
carrageenan represented a major geographical reorganisation of production. 
Moreover, because of perceived benefits flowing to villagers in numerous 
coastal communities in countries as far apart as Kiribati, Indonesia, 
Madagascar, Tanzania and the Philippines (Bergschmidt 1997; Blanchetti-
Revelli 1995b; Doty 1981; Firdausy 1993; Firdausy & Tisdell 1991; Pettersson-
Lofquist 1995 ) interest in the carrageenan industry led to the participation of 
aid agencies, scientists and governments. Although deserving more attention 
than I am able to give it here given the parameters of my study, carrageenan 
became linked to concerns about sustainable development, environment and 
economic and social risks faced by coastal communities: 
Starting from zero in 1970, when FMC BioPolymeril [then Marine 
Colloids Inc.] invented the cultivation of cottonii and spinosum along 
with the University of Hawaii, there are now more than 50,000 families 
producing over 150,000mt/year of cottonii and spinosum. This is a very 
successful livelihood project that meets numerous development needs 
such as: poverty alleviation, women in development, coastal resource 
management, protection and conservation of coral reefs, sustainable 
il Marine Colloids Inc. supported research at the University of Hawaii on cultivation in the early 1960s 
and 1970s. FMC Corporation acquired Marine Colloids Inc in 1978/1979 thus FMC Biopolymers did 
not in fact, 'invent' cultivation. 
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livelihood! development, land reform, entrepreneurial and small 
business management skills development and establishment of marine 
parks (FMC Biopolymer 2004). 
Thus seaweed farming forms one small strand of the development discourse 
that characterises so many post-colonial societies; with all the attendant 
enthusiasm of development agencies, governments and the industry itself. 
For the processing companies, the development of seaweed farming reduced 
the uncertainties associated with wild harvesting operations 12. Farming 
represented a fundamental shift in the quality, cost and reliability of raw 
material, generating new opportunities for companies to grow and plan their 
business strategies. Cultivation of seaweed in the tropics increased from 1000 
mt in 1971 to 100,000 mt in 2002 (Ask & Azanza 2002: 257). However, in this 
chapter I consider a different story about risk, one more closely associated 
with the consumption of carrageenan and the new public health. 
Risk has an increased salience in contemporary society through which issues 
of health are increasingly preventively calculated and bought under control. 
As a result, risk discourses produce new socio-spatial relations and spur the 
development of technologies and systems of management. Carrageenan, too, 
is the subject of the governmental rationality of risk. Thus, to begin with I 
contextualise how carrageenan appears as a manifestation of risk in relation 
to the prudent consumer, on, in and through food and pharmaceuticals. I trace 
these concerns back to the middle of the twentieth century when carrageenan 
first began to be used in food products, highlighting both the extent of its use 
within dairy products and factors contributing to the increasing importance 
of dairy as a category of food. 
Castel's (1991) typology of a shift from dangerousness to risk in the 
governmentality of health provides a backdrop to the development of 
12 While not developed here, one area for further study might be to consider the different categories of 
risk that are applied to coastal communities and the communities in developing countries, as opposed 
to the western countries, displaced by the development of farming. In Prince Edward Island and other 
western locations whose populations lost incomes because of the aquaculture in tropical countries, is 
risk status measured in similar terms? 
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carrageenan as an industrial additive, however I also explore the limits of 
this typology in the context of markets in which uncertainty enables 
entrepreneurship. Thus I explore the constitution of carrageenan within 
'changing and polyvalent rationalities of risk and uncertainty. 
Rendering carrageenan visible 
Through declarative statements on food labels, the term carrageenan becomes 
visible, solid and a material text or a matter of fact. Such statements lend 
legitimacy and durability to carrageenan. Van Loon (2003: 49) suggests that a 
matter of fact is not like a claim; rather it is written, circulated and (relatively) 
durable, and thus the label becomes part of a 'network of visibility' through 
which - in this instance - the white or off-white powder derivative from 
seaweed is stabilised as carrageenan. However legislation about label content 
and naming procedures varies across nations and so carrageenan does not 
always appear directly as itself; sometimes it is disguised in numeric codes. 
For example, throughout the US, carrageenan is listed on food labels under 
ingredients (Imeson 2000) while in the EU and Australia, carrageenan may be 
represented either by official E numbers, E407 or E407a and/or official 
standard names such as carrageenan (FSANZ 2004; JECFA 2001) 13 . Were they 
to consult food-additive guide books, EU publications or any number of 
official documents that specifically mention it, prudent consumers would 
discover that E407 is an official synonym for carrageenan (for example 
JECFA 2001; Lewis, Stanley & Guist 1988). However, if consumers do not 
decode the E number one consequence becomes the production of different 
knowledges of carrageenan. An FMC Biopolymers statement about labelling 
suggests that E numbers market negative ideas about carrageenan to the 
consumer: 
13 Different extraction methods produce different 'quality' carrageenans. One method produces a 
product with fewer impurities and is the product described as food grade or labeled as 407 according 
to UN standards. The lower grade 407a has been marketed as ARC or Alternatively Refined 
Carrageenan, PNG or Philippines Natural Grade and SRC or Semi Refined Carrageenan. The lower 
grades were originally produced because of pressures in the 1970s for a cheaper grade that could be 
used for pet food (Bixler 1996). 
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the 'sad' fact is that in Europe, all additives were assigned E numbers 
rather than being called by their original names, as is the practice in the 
USA. In today's Europe, it is possible to choose between being listed by 
name or by E number. For completely natural substances such as 
alginate or carrageenan, it is important to write out the name in full to 
distinguish it from synthetic additives (FMC Biopolymer 1999: no page). 
In this instance the synthetic/natural distinction, as it applies to carrageenan, 
seems to have a bearing on the perception of safety. Clearly naturalness does 
not always equate with safety, but representations of naturalness have 
currency in marketing - an issue that is explored again in subsequent 
chapters. Nonetheless, even in the EU carrageenan is widely used as a 
preferred term. Lawrence's (2004: 203) survey of labels in the UK found that 
since E numbers were introduced in 1983, they have been used less and less. 
In my own limited survey 14 of labels in the UK, I found many examples 
where carrageenan was used in preference to the E number equivalents. A 
Marks and Spencer raspberry jelly label, for example, lists carrageenan 
alongside E508 15, Locust Bean Gum and natural flavouring. On the jelly label 
the preference for particular names is demonstrated; carrageenan over E407, 
and E508 over its common (regulatory/chemical) name potassium chloride. 
The key point is that food labels reveal carrageenan in particular ways and 
these modify public perceptions of the risks to which carrageenan becomes 
attached. 
In summary, the declaration of carrageenan or E407 on food labels is simply 
that, a declaration of the existence of a substance that might otherwise go 
unrecognised - after all, carrageenan is tasteless and odourless and generally 
used in minute quantities beyond sensory perception. In dairy products for 
example, carrageenan is added at levels of around 0.05 - 0.1% (Bixler 1996: 
43). Labels both reveal and represent a substance whose form may, for 
consumers, be understood differently; E407 and carrageenan may not be 
regarded as being quite the same. Moreover, labels are truth claims, part of a 
14 The survey was undertaken in one Marks and Spencer supermarket in Newcastle Upon Tyne, UK, 
over one day, 26th March 2004. Samples of one to three brands of 15 common carrageenan containing 
products were noted and label details recorded. 
15 Potassium chloride. 
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range of discourses associated with denominative technologies of 
governance in regulating public health. Truth is not outside society or the 
exercise of power; it exists via restraints and mechanisms through which 
certain types of discourses come to be true (Foucault 1984: 72-73). A food label 
bearing carrageenan enables and sanctions a particular set of truths about it, 
appealing to prudent consumers for whom it counts as true. The label does 
more than impart information; it (re)produces a certain truth and, as such, 
places carrageenan in particular contexts within contemporary and historical 
discourses of risk. 
Recognising the significance of mechanisms that enable the new public 
health in the present necessitates some consideration of the historical 
developments that have preceded them (Brown, T & Duncan 2002: 362). 
Taking history and discourse as the starting points from which to consider 
the regulatory environment • in which carrageenan is made visible, 
carrageenan and/or food (or pharmaceutical) labels are metonymous. Both 
stand in the place of a declaration of an individualisation of responsibility for 
consumption and risk. That is, labels provide information directly to the 
consumer and thereby enable the possibility of choice about all the products 
on the label, including carrageenan. These choices are reinforced by 
consumer education campaigns to encourage label literacy (Hadden 1986). 
Thus labels presuppose and produce a certain kind of subjectivity in which 
prudent subjects are rational and morally committed to responsible self-
behaviour. Individuals are positioned as rational consumers of health (Irvine 
2002). One effect of labelling is the reproduction of subjects of regulated 
freedom; that is, the expectation that freedom comes with responsibility. In 
this view, consuming carrageenan is a (responsible) choice. 
However, in the last few decades there have been significant changes in how 
food regulation and labelling constitute the subjects of regulated freedom. 
Indeed, transitions to particular systems of labelling mirror transformations 
from a government of subjects to neo-liberal forms of rule through regulated 
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freedom - with particular effects on the use, containment and risky profiling 
of carrageenan. In the following section I consider the example of US 
regulatory policy on carrageenan to exemplify these transitions. 
Regulating carrageenan 
Over time the US Food and Drug Administration 16 has developed and 
increased requirements for specific forms of information to be placed on 
food and pharmaceuticals. Detailed in Table 2.1, the passage of food 
regulation can be seen to transfer more and more responsibility from the 
state (as an institution of consumer protection to one that provides 
information) to consumers in order that they may govern themselves - 
such provision ranging from listing food ingredients to prevent 
adulteration, to outlining detailed nutritional information to promote so-
called healthy food choices (Committee on Nutrition Components of 
Food Labeling 1990). 
Over time, food regulations have, among other things 17, refocused attention 
from the state as enforcer of honesty and fairness in food labelling, to a 
biopolitics of preventive health. The FDA approach to food regulation has 
changed enforcement of legal measures on producers (after the fact) to
•preventive controls that supposedly enable individuals through the 
provision of information. 
If there is one dominating theme [about Food and Drug history] it is the 
change from a law that was primarily a criminal statute, protecting 
consumers through the deterrent effect of court proceedings to a law 
that is now dominantly preventive through informative regulations and 
premarket controls (Food and Drug Administration 1981: no page). 
Dean (1999a: 146) broadly defines two types of governmental technologies 
intertwined with rationalities of risk; those 'deployed from above' (such as 
16 In the US two bodies are involved in the regulation of carrageenan and related products; namely the 
Food and Drug Administration (FDA) and the US Department of Agriculture's (USDA) Food Safety 
and Inspection Service (FSIS). The FDA initially evaluates products for safety in food, and the FSIS is 
responsible for the safety and labelling of meat, poultry, and egg products. The listing of carrageenan 
under FDA and FSIS guidelines is an official evaluation of safety which can apply to general use or in 
some cases, such as processed meat products, sets guidelines and/or 'official recipes' for specific uses. 
17 Other concerns in relation to labelling, that include among others the economic aspects, are not 
developed here. An overview of economic and other factors underlying labelling is given by Hadden, 
who suggest that early labelling laws may also be traced to concerns about minimization of economic 
risks to buyers, and the regulation of competition amongst food companies (Hadden 1986). 
47 
premarket controls) and those 'invoked from below' (such as encouraging 
the use of labels as information about health). 
Table 2.1 Major food regulatory reforms, US 
Year Event Stated aims Status of carrageenan 
1906 Federal Pure Food and 
Drugs Act and Federal 
Meat Inspection Act 
Regulates safety and quality of 
food. Defines and prohibits food 
'adulteration'. 
Not commonly used as 
an ingredient or food. 
1938 Federal Food, Drug 
and Cosmetics Act 
Replaces Pure Food Act. Among 
provisions, labelling requirements 
were increased to include some 
'truthful' listing of ingredients 
and additives on some products. 
Full ingredient listing not 
required on 'standardised 
products'. 
1937, Krim-ko 
company, Chicago 
used ground Chondrus 
as ingredient for 
chocolate milk 
suspension. 
1958 Food Additives 
Amendment and 
Delaney clause18 
Provides for a pre-market 
approval system for ingredients 
'added to food'. Delaney clause 
gives FDA powers to ban food 
additives found to induce cancer 
in 'people or animals'. Classifies 
over 10,000 substances as food 
additives. 
21CFR182.7255 
1961 Carrageenin 
(Chondrus extract) 
classified 'Generally 
Recognised as Safe' 
due to long history of 
use in foods. 
1960 MCInc. petition FDA to 
expand GRAS list. 
Carrageenan listed as a 
food additive under 
21CFR172.620 . 
1969 White House 
Conference on Food, 
Nutrition and Health 
Recommends a review of GRAS 
substances following FDA's ban 
of the artificial sweetener 
cyclamate as a potential 
carcinogen under the Delaney 
clause. 
1973 FDA regulations for 
nutritional labelling of 
food introduced 
Voluntary for most foods, 
required for foods with added 
nutrients. 
1990 Nutrition Labeling and 
Education Act 
Requires the mandatory labelling 
of all processed foods in relation 
to nutrition. Plus increased 
'clarity' of ingredients labelling. 
Sources: Food and Drug Administration, Code of Federal Regulations, 2004; Hadden 1986; Neusheul 
1987; Schmidt 2000. 
Thus, in the 1970s the FDA began to allow, and then require, more and more 
detailed information on the nutritional components of food. From below, the 
development of increasingly informative food regulation expanded the 
18 See also chapter four on the Delaney clause 
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complexity of information on labels and multiplied the issues of concern for 
the prudent consumer. 
One other effect of the discourse of the new public health and prudentialism 
with respect to food was a burgeoning consumer movement. Crawford 
(1980) understood the rise of such health-based movements in the 1960s and 
1970s in the US as an effect of the changing nature of health governance and 
the turn to 'healthism'. Healthism he described as the focus on personal 
health and lifestyle modification (Brown, T & Duncan 2000; Crawford, R 
1980). Healthism was then not only an objective for individuals, but also for 
organisations and communities whose members also became active in 
monitoring and promoting prevention (Brown, T 2000; Brown, T & Duncan 
2000, 2002; Petersen 1996; Rose 2001). Large consumer organisations such as 
the American Cancer Society and American Heart Association (prudently) 
funded increased research and advertised the results of links between 
chronic diseases and diet (Levenstein 1999: 526). 
Indeed consumer groups' promotion of prevention and lifestyle change can 
be seen to have amplified governmental technologies from above and below. 
According to the taskforce established to develop voluntary labelling laws, 
the impetus for nutritional labelling in 1973 had been 'to enable consumers to 
select a diet adequate in vitamins, minerals and protein' (Committee on 
Nutrition Components of Food Labeling 1990: 5). However between 1973 
and 1990, public concern about voluntary labelling laws increased with 
growing numbers of consumer organisations linking concerns about chronic 
illness and diet - particularly because of increased attention to, and visibility 
of, connections between heart disease and the consumption of cholesterol 
and saturated fats (Hadden 1986: 149). Consumer pressure groups, such as 
the Centre for Science in the Public Interest (CSPI) and Ralph Nader's 
advocacy group Public Citizen, campaigned for greater and more reliable 
information for individuals to enable wise choices (Hadden 1986; Hilts 2003). 
Hilts (2003: 261) argues the CSPI played a key role in turning the focus of 
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labelling from honesty and fairness to the idea that 'good, detailed labelling 
could reduce disease' - with a particular focus on fat. 
Through new scientific understandings of the relationships between 
nutrition and disease, and via the amplification of governmental 
technologies of prudentialism by consumer groups, food is now incessantly 
broken down into constituent parts and reconstituted within a particular 
medico-morality of health-based risk assessment - thereby expanding the 
visibility of risk, and the requirements of self-governance. 
One manifestation of this atomisation of food is the 1990 US Nutrition 
Labeling and Education Act (NLEA) that required all pre-packaged and 
processed food to contain nutritional labelling of proteins, carbohydrates, 
total fat, saturated fat, total calories as well as other nutrients. The Act gave 
the FDA and USDA until 1994 to standardise food labelling and, in 
particular, to develop standard rules for labels with nutritional claims such 
as fat-free, light, and low cholesterol (Buchholz 2003; Hilts 2003). The 
introduction of labelling was supported by official state recognition that 
'food labeling - broadly defined - can materially aid wise dietary choices' 
and that these choices can 'affect chronic disease and risk' (Committee on 
Nutrition Components of Food Labeling 1990: 4). Labelling also enabled 
comparisons of competing food products, such that many manufacturers 
modified products to have more 'label friendly' images than competitors 
(Schwenk & Guthrie 1997) 19. The passage of the NLEA fuelled a sudden 
increase in the availability of fat-modified foods (Calorie Control Council 
2001; Golan et al. 2001; Schwenk & Guthrie 1997). Within twelve months of 
the passage of the NLEA, the Calorie Control Counci120 estimated that 
around 1,439 new products with reduced- or low-fat claims appeared on the 
19 Schwenk and Guthrie note that the increase in fat-modified foods raised concerns about the potential 
for negative effects on health of the increased consumption of food additives. They suggest there was 
insufficient evidence that the products resulted in any meaningful weight reduction (Schwenk & 
Guthrie 1997). 
20 The Calorie Control Council (CCC) is an industry body of low-calorie and reduced-fat food product 
manufacturers. 
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US market, 70% more than in the previous year (Calorie Control Council 
2001: no page). Between 1995 and 1998, during which time many new fat-
replacement technologies had received regulatory approval, an estimated 
6,500 fat-modified foods were reportedly introduced onto the market (Golan 
et al. 2001: 36). One consequence of labelling was the widespread 
modification of food to appeal to prudent consumers of health. 
Moreover, the battle against the bulge presented opportunities in the market 
for carrageenan as a technology used in fat-replacement, in items such as the 
McLean burger (chapter five). Despite its functionality in modifying the 
qualities of food for fat reduction, carrageenan rarely appears in the 
nutritional section of food labels in the US. Following the NLEA carrageenan 
was still listed as an ingredient in food products. Nutritional labelling did not 
directly change the profile of carrageenan as a risk-related concern for 
consumers. Rather, nutritional labelling provided opportunities for the 
development of new prevention technologies incorporating carrageenan. 
Indirectly though; nutritional labelling enhanced the discourse of 
prudentialism and elevated the status of the label by requiring that 
consumers should monitor it for a whole range of health concerns; this 
enhancement was reinforced by various public health education campaigns 
to 'read the label'. Having said all that, carrageenan has not always been 
listed, even as an ingredient and I wish briefly to trace its history as a food 
and pharmaceutical additive to exemplify the polyvalence of risk. 
Generally Recognised As Safe (GRAS) 
Until the late 1930s, what is now recognised as carragednan was not widely 
used as a substance added to food and the term carrageenan (or 
carrageenin) 21 did not exist in a regulatory environment for food or 
pharmaceuticals. Initially, the extract of seaweed now . recognised as 
carrageenan, was termed Chondrus extract within the FDA system. First used 
as ground Chondrus cris pus to stabilise chocolate milk in 1937, and then 
21 Stanford (1862) coined the term "carrageenin" for Chondrus crispus extract. The term carrageenan 
was adopted by the American Chemical Society to reflect the use of -an as an affix denoting the 
presence of a polysaccharide. 
51 
developed as an extract and given expanded uses in other , food products, 
carrageenan was not regulated as a food additive until the late 1960s, but was 
defined as a substance generally recognised as safe or GRAS following the 
1958 Miller amendment to the US Food and Drug Act of 1938 (Table 2.1). 
Under the Miller amendment the FDA divided substances added to food into 
regulated food additives 22 and substances that were GRA5 23 either due to 
their history of use in food prior to the 1st January 1958 (the so-called 
grandfather clause) or on the basis of a consensus of expert opinion. It is 
worth detailing the framing of carrageenan between the GRAS and regulated 
categories for two reasons. First, as better developed in later chapters, GRAS 
is deployed within contemporary narratives of risk, and not only in the US 
where the category is applied in the official regulatory environment. Second, 
the development of regulated food additives can be identified within a 
changing politics of risk in which GRAS stands in for an earlier political 
conception of risk as dangerousness as advanced by Castel (1991). 
The Miller amendment prohibited the use of any food additives considered 
inadequately tested for safety. Prohibition was significant in that 'the burden 
of proof shifted from the US federal government showing an additive to be 
harmful to the manufacturer showing it to be safe' (Hadden 1986: 131). The 
amendment represented a fundamental transition to a new conception of • 
risk, and a new spatialisation of governance and responsibility in relation to 
food. According to Castel (1991), classical prevention was based on an 
understanding of danger, typically involving a relationship between a 
22 The US Food and Drug Act (section 201 S) defines the term food additive as 'any substance the 
intended use of which results or may reasonably be expected to result, directly or indirectly, in its 
becoming a component or otherwise affecting the characteristics of any food (including any substance 
intended for use in producing, manufacturing, packing, processing, preparing, treating, packaging, 
transporting, or holding food; and including any source of radiation intended for any such use), if such 
substance is not generally recognized, among experts qualified by scientific training and experience to 
evaluate its safety, as having been adequately shown through scientific procedures (or, in the case as a 
substance used in food prior to January 1, 1958, through either scientific procedures or experience 
based on common use in food) to be safe under the conditions of its intended use' (Food and Drug 
Administration 1958). 
23 Substances such as spices, caramel and ascorbic acid are permitted in food without food additive 
approval under the GRAS system; however not all substances recognised as safe have a GRAS listing. 
The nomination of GRAS is 'additional' to those items regarded as commonly added to foods that are 
considered safe such as salt, pepper and baking powder (s.182.1 Code of Federal Regulations). 
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known event and a probable outcome. Similarly, though in obverse form, the 
category GRAS may be applied to a substance if the product had been used 
without evidence of demonstrated harm, on which basis it is considered 
`safe'; a relationship to risk is not inevitable. In contrast, regulated food 
additives involve a calculation of risk because they must be proven safe (Food 
and Drug Administration 2004). 
In 1958 Chondrus extract was grandfathered to the GRAS status through its 
previous uses. In general the GRAS definition exempts ingredients that are 
identical or similar to traditional food ingredients because they are 
considered safe. Chondrus extract was already used in milk products and 
Chondrus cris pus had a long history as a traditional food in Ireland. These 
traditions were imported to the US with Irish immigration (Burges Watson 
2005; Burges Watson & Stratford forthcoming; Chapman, VJ 1980) 24 . Thus 
under the GRAS listing Chondrus extract (carrageenin) was permitted for 
use in food under section 21CFR182.7255 of the US Code of Federal 
Regulations as harmless under prescribed conditions of use (Appendix 2.1). 
However, for Marine Colloids Inc., the regulation of Chondrus extract 
limited production capability. The wording of the GRAS legislation 
circumscribed just one species from which the extract could be derived: the 
cold-water Chondrus crispus. During the early part of the 1950s a rapid 
increase in demand, and limited supply of Chondrus crispus, led industry 
24 Chapman (1980 :111) suggests that the industry based on Chondnis crispus harvesting 'originated in 
Ireland and was introduced into the US in 1835'. In Chapman's account, the Irish born mayor of 
Boston, JV Smith, alerted the local inhabitants, immigrants associated with the Irish potato famine, to 
the presence of Chondrus cris pus around the coast of Massachusetts as an alternative to the imported 
'Irish moss' from Ireland and France (Chapman, VJ 1970; Lewis, Stanley & Guist 1988). From the mid 
1800s until prohibition in the 1920s, Chondrus crispus was principally used in the pharmacopoeia and as 
an agent in beer clarification. The history of Irish Mossing in Massachusetts is also recounted at the 
Scituate Maritime and Irish Mossing Museum. The accompanying text to the museum is based primarily 
on the book by Barbara Murphy (1980) Irish Mossers and the Scituate Harbour Village (Ball, D., Scituate 
Historical Society Director, pers comm., 15 December 2003). In Murphy's book, as in the museum, 
Daniel Ward is credited with the introduction of mossing to Scituate, which became central to the 
prosperity of that community, and the Irish moss industry at the time. Ward's early history is not 
known, though it is suggested he originated from County Derry in Northern Ireland and arrived in 
Boston in around 1829. In Scituate, the industry is understood to have helped the region become more 
prosperous than surrounding areas, gradually drawing wealthier Irish from Boston to the region 
(Murphy 1980). 
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members to explore other seaweed species as a source of the extract that, by 
this time, was recognised by its chemical name carrageenan (Blanchetti-
Revelli 1995b; Chopin 1998). In 1960 Marine Colloids Inc. petitioned the FDA 
to alter the GRAS listing to enable a wider sourcing of raw materials; both of 
species and by implication, source locations (Stancioff, 2002, pers.comm., 15 
June). The FDA moved instead to list carrageenan as a regulated food additive 
under section 21CFR172.620, with an expanded but limited list of seaweed 
species from which it could be derived. The list included carrageenan from 
Chondrus crispus (Appendix 2.2). 25 Thus Chondrus extract was listed as 
GRAS, and the extract of Chondrus cris pus - 'carrageenan' - was listed as a 
regulated food-additive. The GRAS definition remained but, for the purposes 
of food regulation, scarrageenan' became and (as it stands) is the official 
standard for carrageenan used in food products. In short, GRAS and 
regulated categories do not distinguish different levels of safety regarding 
carrageenan; rather they involve different calculations of risk. 
What prompted the FDA to change the status of the seaweed extracts to 
regulated food additive is unclear. However the timing coincided with an 
increased attention to the status of substances added to food and to public 
concerns about health risk associated with some particularly high profile 
food ingredients - amongst them saccharin and cyclamate (Hilts 2003: 202- 
206). Various public scandals ensued, in 1969 culminating in the Nixon-
initiated White House Conference on Food, Nutrition and Health that 
demanded a review of all the substances in the GRAS category. One 
explanation for the review is that the category. GRAS no longer satisfied the 
25 Under 21CFR172.620 carrageenan is defined explicitly as an extract derived from a list of eight 
species of seaweed, which includes Chondnis crispus (Appendix 2.2). According to Stancioff (2002, 
pers.comm., 13-15 June), who was involved with drafting the 1960 petition for Marine Colloids Inc., the 
species-specific regulation came as a surprise to industry. Industry members were expecting that the 
FDA would recognise the need for a more general definition of carrageenan not based on specific raw 
material sources. 'We gave these species of seaweed as examples and we didn't expect them [the FDA] 
to specify species. I think if we hadn't petitioned the FDA for the use of these other seaweeds, then 
carrageenan would still be carrageenan from any source' (Stancioff, 2002, pers.comm., 13-15 June). 
-Furthermore, the FDA established other categories for products that at the time were not then 
recognised as carrageenan. Furcellaran, an extract of seaweed which is now recognised chemically as a 
carrageenan, extracted from the seaweed Furcellaria was listed separately as were combinations of 
carrageenan and certain emulsifiers and 'salts' of carrageenan (Appendix 2.3). 
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new understanding of preventive, scientific pre-detection based risk. Thus, 
with the scrutiny of saccharin and cyclamate and the outpouring of concern 
that followed, the calculation and visibility of risks expanded. Or as Hilts 
(2003: 206) remarks, 'Americans had entered the age of risk assessment'. 
The regulation of carrageenan under the food additive category 
21CFR172.620 is based on detailed risk assessment that defines where and 
how it may be used in food; it cannot be used (legally) without such 
authority. Thus, 'a food additive that does not have regulatory food approval 
is not a food additive' (Seisun 2002: no page). Aside from the key role of 
regulation in determining the spaces and places in which carrageenan 
circulates, regulation is entangled with particular understandings of the•
category of risk. In this view, regulating use is a mode of calculation and 
mitigation of risk, working as a category that is more than simply a 
declaration of safety. Rather, it defines how it is possible to talk about 
carrageenan, who should talk about it, and that it must be visible to 
consumers. The transition from GRAS to regulated food additive modifies 
carrageenan's non-dangerousness within discourses of risk. As a regulated 
food additive the safety of carrageenan no longer exists without a relationship to 
risk. 
Interviews with key (scientific) informants in the industry during fieldwork 
in Maine, US, in June 2002 and at the International Seaweed Symposium in 
Bergen, Norway, in 2004, reveal that as a regulated additive carrageenan is 
considered superior to GRAS because its status as an additive is based on a 
solid body of scientific evidence. Marinalg International is a seaweed 
industry body involved in regulatory issues, and its president observed of 
European legislation 'the E number is your guarantee that it is safe' 
(Rasmussen, 2004, pers.comm., 24 June). In this view, visibility as a regulated 
additive signifies non-risk. One industry representative suggested the GRAS 
category listing for Chondrus extract should be scrapped, saying that 
'Chondrus extract isn't made anymore, so it's there [in the regulation] and 
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not used and it should be removed but every time somebody goes to the 
FDA and says to remove it they say oh we have more important things to do' 
(Bixler, 2002, pers.comm., 16 June) 26. 
Two issues emerge from these statements. First, despite a commonly held 
view amongst industry members that regulated additives are safe, safety in 
the regulated category is based on the calculation of risk and, in later 
chapters, I explore how risk flows over into public concern about 
carrageenan. Second, because of the association with risk in the regulated 
category, I argue that GRAS continues to work for carrageenan in a different 
capacity, about which I will elaborate after clarifying the current status of 
carrageenan and the GRAS category. 
In the public domain, both within and beyond the borders of the US, the 
GRAS label often erroneously appears in both expert and popular 
contemporary accounts of carrageenan (see for example Population Council 
2002; Reilly 2003; Tobacman 2001; van de VeldeLourenco et al. 2002). That is, 
despite wide circulation of a myth about carrageenan as GRA9 7, Chondrus 
extract (carrageenin) is listed as GRAS but carrageenan is not (US Code of 
Federal Regulations ss 21CFR182.7255 and 21CFR172.620; Bixler, 2002, 
pers.comm., 16 June; Stancioff, 2002, pers.comm., 15 June). Chondrus extract, 
still exists 'on the books' of FDA food regulation under s.21CFR182.7255. 
Notwithstanding the exclusion of carrageenan from the GRAS category, food 
companies voluntarily register expanding numbers of substances as GRAS 28 . 
In contemporary discourse it can be seen that rather than continuing to 
function within Castel's typology of dangerousness the GRAS category 
26 Harris Bixler is Chief Executive Officer of the carrageenan blending company Ingredients Solutions 
Inc. He was formerly an employee of FMC Biopolymers/ Marine Colloids, has fulfilled various roles on 
the Executive of the International Seaweed Association and represented the interests of the Seaweed 
Industry Association of the Philippines in bodies such as Marinalg. 
27 0ne source of the myth of GRAS was a report written in 1972 that had proposed amendments to the 
FDA listing of carrageenan, however the regulations were not modified. For a discussion of the 
confusion around this report see Tobacman (Tobacman 2001). 
28 In 1997 the FDA developed a simplified notification system in order that companies could 
voluntarily register products as GRAS. 
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incorporates a non-calculative rationality of uncertainty. Risk may provide a 
backdrop to the development of carrageenan within the regulatory 
environment; however the GRAS category, involving uncertainty without a 
relationship to risk, sidesteps risk calculations in new public health when 
there are issues related to market development. GRAS is useful within the 
food industry for various reasons: under the regulations, pre-market 
approval for use is not required (promoting uncertainty as a measure of 
safety.) FDA 'comments are the source of (independent) expertise, and FDA 
listing can protect manufacturers against litigation. As O'Malley (2000) 
proposes, there are limits to the actuarial or calculative rationality of risk as a 
mode of governance, particularly as it curtails entrepreneurship. In this 
proposition, entrepreneurship enables a different kind of future, not one that 
is calculated and predicted but risk taking and necessarily, distinct from the 
past: 
uncertainty is a characteristic modality of liberal governance that relies 
both on a creative constitution of the future with respect to positive and 
enterprising dispositions of risk taking and on a corresponding stance of 
reasonable foresight or everyday prudence (distinct from both statistical 
and expert-based calculation) with respect to potential harms (O'Malley 
2000: 461). 
Risk is one modality of governance, but it is not (necessarily) the only one to 
have an effect on carrageenan or to interface with prudent subjects. While 
GRAS is no longer deployed in the regulatory environment concerned with 
food uses, the same is not true of the regulation of pharmaceuticals. 
Although by no means the only example of uncertainty in governing 
carrageenan, through the example of an emergent pharmaceutical, 
Carraguard, I now explore how uncertainty in the regulatory environment 
enables the rapid development of new technologies. 
Risks and uncertainties: pharmaceuticals and Carraguard 
As it stands, carrageenan is not permitted for use as an active ingredient in 
any pharmaceutical formulation; indeed it is only permitted for use as an 
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excipient29. Regulations for pharmaceuticals are extremely complex, and are 
more specific than is the case for most food products involving very 
particular specifications of process, composition and manufacturing (Lard, 
Hastings & Feigal 1994). Therefore, rather than assessing the overall system 
of pharmaceutical regulation in relation to carrageenan, I focus instead on 
the one pharmaceutical product in the pipeline that uses carrageenan as an 
active ingredient: Carraguard, a technology for the prevention of HIV/AIDS. 
Advocates of Carraguard and some of the other microbicides have proposed 
that they be developed for non-prescription, or over-the-counter (OTC) use 
to enable easy access by consumers (Heise 2002; McGrory & Gupta 2000). 
OTC is then a category with particular importance to prudent consumers 
because it takes out the step of arranging appointments with doctors and 
accessing prescriptions; furthermore, it changes the nature of encounters 
between users and pharmaceuticals. Prescribed 'pharmaceuticals involve 
experts as intermediaries, while OTCs are considered 'safe enough for self-
use' (Farley 1995: 5). The aim to develop Carraguard as an OTC then implies 
and demands that users be or become prudent consumers, a prospect 
explored at length in chapter six. Moreover, in the current regulatory 
environment OTC and prescription drugs are categories subject to different 
but overlapping systems of regulation and of risk calculation. I limit the 
following discussion to the regulatory situation of Carraguard as an OTC 
product because of its particular relevance to my focus on prudentialism. 
Carraguard enables proximity between the new public health goals and 
individuals, and as I explore in chapter six, facilitates the extension of the 
new public health into global realms of health provision. 
The US Population Council's website detailing the development of 
Carraguard sums up many of the issues involved in requisite testing and 
29 Excipients are regulated as substances that are non-active but used in pharmaceutical products to 
perform a range of functions. Carrageenan is permitted for use in the preparation of topical lotions, in 
toothpaste, for tablets and in oral syrups. As with food, carrageenan is used for its functional 
properties. 
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regulation for an OTC product, not least the manner in which the GRAS 
status of Chondrus extract is deployed in relation to OTC pharmaceuticals: 
Carrageenan compounds are on the U.S.. Food and Drug 
Administration's list of GRAS (generally recognized as safe) products 
for consumption and topical application 30. This classification gives 
Carraguard a number of advantages, including the need for fewer 
standard preclinical tests for regulatory approval and a greater 
likelihood that a carrageenan-based microbicide, such as Carraguard, 
could be made widely and easily available (Population Council 2004a: 
no page). 
The wording of the status of carrageenan in relation to GRAS is very specific 
- carrageenan compounds being on the list of FDA is not the same as 
carrageenan being on the list. Under no federal regulation is 'carrageenan' 
• directly classified as GRAS. This concern with wording may be considered 
mere semantics: on the one hand Chondrus extract is, after all, carrageenan 
(following the redefinition of carrageenan as a regulated food additive) but 
not all carrageenan is extracted from species recognised as Chondrus crispus. 
On the other hand, a more interesting question to ask is how is the GRAS 
category usefully deployed and to what effects in the constitution of 
prudentialism? My reading is that because the safety of carrageenan as a 
regulated food additive is measured in relation to risk, GRAS is important to 
the development of OTC products because it signifies safety without a 
relationship to risk - thus reducing the burden and costs of proof. While 
there is clear value to the developers of new pharmaceuticals in the category 
GRAS, there may also be a consequence for prudent consumers if the GRAS 
category modifies perceptions of risk associated with these developments. 
The example of OTC and GRAS demonstrates the liberating effect of 
uncertainty on the development of new products - safety with no risk attached 
is important to the rapid (ergo, profitable) development of new OTC 
products. Establishing safety through association with prior use is the 
3oThe wording of the GRAS status of carrageenan here differs from an earlier brochure developed by 
the Council in which it states 'The Population Council is required to seek FDA approval of the product 
as an active pharmaceutical ingredient even though it has the GRAS food-additive classification' As 
stated previously, as regulatory definitions stand, the statement that carrageenan is GRAS is incorrect. 
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simplest and most cost effective way of getting carrageenan to be listed as an 
'Approved Pharmaceutical Ingredient' (API). In the pharmaceutical process, 
a product with GRAS status and recognised use as a pharmaceutical 
excipient, may advance through the process of approval more rapidly. 
Regulating Carraguard for OTC products provides one example of the ways 
in which not all categories used in regulation are based on systemic, 
predetective risk. 
At the same time, the levels of uncertainty that are acceptable in such 
situations have limits. In the regulation of pharmacueticals, risk assessment 
occurs alongside another calculus of probability: effectiveness. For example, 
carrageenan is listed as haring been used as an ingredient in OTC laxative 
and weight reduction products. Under the 1938 Federal Food Drug and 
Cosmetic Act the rules governing pharmaceuticals had been based solely on 
an assessment of safety. In 1966 those rules were modified to include 
consideration of effectiveness. A review of all 512 OTC drugs subsequently 
found that 75 of them lacked evidence of effectiveness (Farley 1995: 4). Under 
CFR 310.5453, carrageenan is still listed as an ingredient in OTC drugs 
(Appendix 2.3) but based on 'evidence currently available, there are 
inadequate data to establish general recognition of the safety and effectiveness 
of these ingredients for the specified uses' (Food and Drug Administration 
2004); my emphasis. Proving effectiveness is a costly and lengthy process. 
The addition of effectiveness to the regulatory environment for 
pharmaceuticals has had a chastening effect on the development of new 
pharmaceuticals. As detailed by a 'call to action' report emanating from the 
advocacy group, Global Campaign for Microbicides, there has been a distinct 
lack of interest from pharmaceutical companies in developing microbicides. 
'Large pharmaceutical companies - the normal engines of product 
development - have been reluctant to invest in microbicides because of 
concerns about scientific uncertainty' (Heise 2002: 7). The report concludes 
that public health groups, non-profit entities and academic researchers are 
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crucial to the development of products such as Carraguard. Here then is 
another dimension to the effect of risk on carrageenan: risk taking in the 
development of microbicides is not being borne by the state or free-market 
entrepreneurs, but by prudent entrepreneurs. Uncertainty and risk can also limit 
the economic risk taking and creative futures capacity of the free market. In 
summary, uncertainty may also be understood as a category important to the 
developments within the new public health and prudentialism. In 
responding to health issues as pressing as HIV/ AIDS, the onus of 
responsibility transfers away from the free market and state to the realm of 
regulated freedom. 
Regulation is just one of the manifestations of risk that profoundly alter the 
environment in which carrageenan circulates. A move towards 
prudentialism does not suggest that other factors are not at work. Polyvalent 
discourses of risk and uncertainty modify the boundaries of prudentialism, 
paradoxically encouraging both risk aversion and risk taking. Moreover, 
factors of risk may not always be measured in relation to the calculation of 
risks in an epidemiological clinic within a population, rather I argue, they are 
also calculable in relation to risks to the body politic and to a politics of 
health as an issue of security. Protecting the body politic has implications for 
carrageenan because such concerns have partly determined the foods and 
pharmaceuticals in which carrageenan occurs. 
A healthy body politic: war, dairy and children 
The rise in use of carrageenan as an industrial additive is often associated 
with events surrounding the Second World War (Chopin 1998; MacFarlane 
1961; McHugh 2003) and to the category of food circumscribed as dairy 
(Chapman, VJ 1980; Lewis, Stanley & Guist 1988; Neushul 1987). In this 
section I explore the overlapping concerns of risk and the body politic; the 
rise of dairy as a particular category of food with symbolic values in war and 
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with a specific relation to women and children; and the development of 
carrageenan as an industrial additive associated with all these concerns. 
War can be treated as both 'a contagious disease of the body politic and an 
addictive drug with a unique capacity to temporarily restore political health' 
(George 2002: 163). War transforms spaces, it has the capacity to unify 
populations at the same time it threatens to undermine them. As a unified 
whole there is a sense that disease (and war) threaten not only individuals 
but the body politic, requiring strategies that also address the unified whole. 
'The body is a model which can stand for any bounded system. Its 
boundaries can represent any boundaries that are threatened or precarious' 
(Douglas 1966: 115). Thus as Waldby (1999) has emphasised, whenever 
public health is invoked, it is this collective, composite body that is the focus 
of strategies of mitigation. However, as the example of the Iraq war 
demonstrated in the preface to this .thesis, calculations and strategies of 
mitigation occur even when the threats to the body politic are based on (mis) 
calculations of risk. 
Franklin D. Roosevelt began his famous 1937 Quarantine speech in Chicago 
with the observation that 'war is a contagion'. Likening the expanding 
militarism of Germany, Italy and Japan to an epidemic, Roosevelt responded 
to war with the medical equivalent - to quarantine the US against the 
expanding disease, 
AND MARK THIS WELL: When an epidemic of physical disease starts 
to spread, the community approves and joins in a quarantine of the 
patients in order to protect the health of the community against the 
spread of the disease (quoted in George 2002: 163). 
The common analogy that is made between disease and war refers, as 
George (2002) suggests, to the likening of the health of nation to the health of 
the body. It is a trope for what war does to the body politic, but also for its 
containment. 
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Before 1939, the Japanese had been the principal worldwide producers of 
agar. Indeed there is, arguably, a direct association between Japan and 
seaweed/hydrocolloids since 'seaweed as a source of hydrocolloids dates 
back to 1658, when the gelling properties of agar, extracted with hot water 
from a red seaweed, were first discovered in Japan' (McHugh 2003: 2). Agar 
had numerous uses in foods, bacteriological applications and industry, and 
had a well-developed international market. According to Chapman, because 
of the importance of bacteriological work during the war, 'every, country 
conserved its stocks with great care and research was immediately 
undertaken in order to provide agar from local seaweeds' (Chapman, VJ 
1970: 175). Geopolitical concerns, and a narrative of self-sufficiency during 
wartime extended to seaweed extracts: 'Even if the cost of local production 
surpassed the price of imported material, it would be important as a measure 
of national security to develop all domestic resources' (Chapman, VJ 1950: 
100). Circumstances created a domestic demand for raw materials, 
particularly between 1942 and 1947 when the US federal government issued 
a 'freezing order' on Japanese agar. Domestic demand for raw material led to 
experimentation with alternative seaweed-derived substances. In this view, 
indigenous seaweed was not simply an alternative to imported seaweed; its 
production was an issue of domestic security, thereby protecting the US 
body politic from contagion and shoring up the boundaries of state. 
Thus the issue of security extends to concerns internal to nations, including 
the US, and has direct implications for the seaweed industry and related 
hydrocolloids. For example, at the time of the First World War, there was an 
acute shortage of acetone, needed in the manufacture of cordite that was a 
propellant used in most British ammunitions. In California, the Hercules 
Powder Company developed a method of producing acetone by fermenting 
kelp and as a result the Californian seaweed industry became the largest kelp 
harvesting industry in the world at that time (Neushul 1987: 2). The Kelco 
Company, established in San Diego in 1927, built on the methods developed 
by Hercules for the harvesting and transport of kelp and became the first US 
63 
company to successfully extract the hydrocolloid, algM, from seaweed for 
post war uses. 
Dairy in war 
One of the first major markets for carrageenan was in fluid milk: 'the first 
real application for carrageenan was, in the modern world, to preserve the 
homogenisation of evaporated milk' (Bixler, 2002, pers.comrn., 16 June). Very 
small amounts of carrageenan added to evaporated milk prevented 
separation of fat and whey in the milk and increased • shelf life and 
transportability. 
Consider the following extract from a history of the Carnation Company, a 
division of the Nestle Company: 
American mothers found it a perfect blend of convenience and sound 
nutrition for growing children. Cans of evaporated milk even saw action 
during WWI, WWII and the Korean War as 'American soldiers carried 
them into battle. The inhospitable conditions in which these brave men 
and women often found themselves made a versatile food product like 
CARNATION Evaporated Milk standard issue (Nestle Company: no 
page). 
The overlay of motherhood, convenience, nutrition, war and children in the 
Nestle history of evaporated milk acts as a metaphor for the constitution of 
the US body politic. The use of carrageenan within dairy products was the 
material manifestation of particular ideas about risk and about culture and 
nationhood. The functional properties of carrageenan were used for 
modifications through which American ideas about superior foods and the 
constitution of perfect social bodies became possible. 
. 
Milk had been used as an" infant food from the 1840s in small amounts, but in 
the later part of the nineteenth century milk was increasingly viewed as a 
'miracle food' and, as such, began to be developed as a commodity. In 
keeping with developments in public health, the particular role of dairy as a• 
nutritional category owes much to scientific discovery and promotion of milk 
as a source of newly discovered vitamins. Milk's miracle status as food was 
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reinforced especially, suggests Levenstein, for a particular understanding of 
the vitamins necessary for .growing children (Levenstein 1,988: 150). 
Moreover, DuPuis (2002) traces the miracle status of milk to earlier 
developments that are more cultural statements of a national subject 
position. For example, she suggests that at different times, milk represented 
the urban elites' vision for a perfect society in its whiteness, its appeal to 
nature and the countryside, and in the transformation of the socially 
constructed relationship between mother, child and nation. In this view, milk 
is a technology of nationalism with healthy milk-fed children the window to 
the future (Stratford 1996, 1998b). 
Thus children and war are topics of particular importance to the rise of dairy 
products as a concern of an emergent new public health movement, a symbol 
of social and economic advancement, and a significant new market for 
hydrocolloids including carrageenan. 
Between 1929 and 1936 Kelco personnel conducted research to refine algin to 
a point that it could be sold as a food stabiliser. In 1935 an employee of the 
Foremost Dairy Company suggested to Kelco that algin could be used in ice-
cream (Neushul 1987). Two years later Kelco began to produce a product 
named 'Cocoloid' to suspend cocoa in chocolate milk. Between 1935 and 1939 
US consumption of algin for milk and ice-cream accounted for half the total 
output of algin in the US (Chapman, VJ 1970; Neushul 1987). The extraction 
process developed by Krim-ko derived a gel from Chondrus cris pus seaweed 
resulting in a commercial product whose name reflected a substance with 
broader recognition in the existing market; it was known as Carragar (a 
neologism of carrageenan and agar) (Chapman, VJ 1950). Thus as Lewis et al. 
(1988: 219) summarises, 'the modern carrageenan industry dates from the 
1940s, receiving its impetus from the dairy industry'. 
The fervour for milk reform was fuelled by dramatic shifts in a mentality 
about health related to the increased role of expertise in determining the 
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order of nutrition (DuPuis 2002; Levenstein 1988) and by the developing 
understanding that health risks were preventable through the knowledge 
gained in the 'epidemiological clinic' (Castel 1991; Nettleton, Bunton & 
Burrows 1995). In this view, nutritional information and scientific principles 
determining what Americans should eat (and Levenstein notes, sometimes 
without much evidence) shaped understanding and effort to reform food 
provision towards human health for all. 
Thus it is possible to reconstitute the discussion of the rise of dairy both as a 
phenomenon of a body politic at risk, and as a factor influenced by the turn 
to a new understanding of public health and risk. In relation to carrageenan, 
the constitution of dairy created the opening for its development as a 
substance to be added to fluid milk products. Because fluid milk was 
particularly sensitive to contamination and impurity (as opposed to solid 
milk products such as cheese for example), perfecting its provision for 
nutrition required significant scientific, technological and organisational 
mastery over the conditions of its production and transportation. It was 
paradoxical that fluid milk should be valued for its natural simplicity, 
'despite its fresh, untouched appearance, fluid milk is an industrial food' 
(DuPuis 2002: 160). 
Milk is a potent symbolic food that, over time, has been incorporated into 
different discourses of public health, ranging from those associated with 
discourses of nutrition to those related to the protection and maintenance of 
the body politic. Moreover, protecting the body politic from outside 
contagion has its counterpart in contemporary threats of external origin such 
as HIV/ AIDS in developing countries (chapter six). 
Concluding remarks 
In this chapter, I have traced a variety of events related to carrageenan and 
regulation in the twentieth century food and pharmaceutical industries to 
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developing ideas about risk, health and the well-being of populations. It is 
clear from this exploration however, that risk is only one mode of calculative 
rationality that provides a specific context through which to examine the 
constitution of carrageenan. Moreover, prudent consumers not only 
encounter risk rendered visible through intermediaries such as food labels, 
but also via entrepreneurship and uncertainty. 
As O'Malley (1996) points out, risk has a certain polyvalence - risks can have 
different kinds of meanings in different contexts, as well as other modes of 
rationality that have their own effects on carrageenan. Risks may be 
calculated differently when the permable boundaries of state are modified by 
threats to the body politic. Uncertainty, though only explored briefly here, 
has its effects as well, albeit in this example, bypassing some of the more 
demanding aspects of risk assessment rather than modifying them. For 
carrageenan, risk is one component of a diverse set of governmental 
rationalities and assemblages of technologies which has material and 
semiotic effects in the relationship between individuals and their food and 
pharmaceutical 'choices'. I have suggested that understandings of risk (and 
to a lesser extent uncertainty) have produced particular ways of describing, 
circumscribing and manufacturing carrageenan. In the turn to neo-liberal 
forms of risk prevention and minimising uncertainties there is a paradox: 
preventive strategies in relation to health that render substances visible may 
increase (the sense of) health risk. In the quest for safety, labelling 
carrageenan as a regulated food additive involves 'postulating a risk' (Castel 
1991) that prudent citizens may then combat. For carrageenan, the transition 
in regulation from GRAS to regulated food additive involved a fundamental 
reconstitution of the notion of risk, such that risk has come to be associated 
with carrageenan whether or not there was any danger. Furthermore, prevention 
is a mode of rationality that is more than just constituted by expert 
knowledge through individuals, self-regulating subjects actively constitute 
prevention through entrepreneurship. The developing uses of carrageenan 
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must then be understood to be effected by the political actions of prudent 
consumers; individuals are not merely the recipients of these changes. 
To this point, I have described carrageenan as fairly unproblematic.
• Although there are variations on how this seemingly innocuous white 
powder derivative from seaweed is constituted in different contexts it is, in 
all the cases mentioned here, a referent with a level of durability: it is 
carrageenan. Moreover in the domain of communication between prudent 
consumers and the regulatory frameworks that reveal them, carrageenan 
appears relatively uncontested as safe. Choosing to consume carrageenan in 
this context is a matter of choosing also to assess a substance that has been 
identified, revealed and promoted. However in the following chapter I 
consider how knowledge of carrageenan is rather more complex; and how 
contested meanings have implications for prudentialism. 
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Illustration: Drying Irish moss: seaweed harvester Maine, US, 1973. 
Source: Courtesy Salt Institute for Documentary Photography, Portland, Maine, US 
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Chapter 3 
Conteste.d carrageenans • and 
the limits of choice 
...it is precisely in the politics and epistemology of partial perspectives 
• that the possibility of sustained, rational, objective enquiry rests 
(Haraway 1991: 287). 
Understanding how a biopolitics of risk manifests requires attention to the 
processes, institutions, discourses and technologies through which the 
program of government is enabled. In the previous chapter I showed how 
the significance of food labels is elevated beyond simply revealing the 
ingredients; as a result of reading labels, prudent consumers are aligned with 
a contemporary program of governing the health of populations. The referent 
carrageenan becomes an 'indirect mechanism' of contemporary neo-liberal 
governance of health (Brown, T 2000: 1275). Carrageenan, then, is 
represented on the label such that any individual is enabled, for reasons of 
health, to choose 'rationally' whether they wish to consume the products 
they have secured. 
However, in the unravelling of events in which chemists, entrepreneurs, 
harvesters, regulators, food labels, consumers and others are implicated, 
hundreds of carrageenan identities circulate. Carrageenan may be referred to 
as Irish moss extract, Chondrus extract, Danish agar, Furcellaran, Gelose, 
Hypnean, Carraghenate, Seaweed gum, Carrageenin, Iota, Lambda, Kappa, 
Lamda-kappa, Kappa-lamda, Kappa-2, Theta, Pi, Xi, Mu, E407, E407a, G4S-
DA, G4S-DA2, Philippines Natural Grade, Processed Eucheuma seaweed, 
refined carrageenan, semi-refined carrageenan, blended carrageenan, 
degraded carrageenan, poligeenan, Gelcarin, Viscarin, carrageen moss 
extract - among others. The carrageenan-on-labels is a visible referent of the 
program of governance that is, as Haraway (1988) suggests, reductionist; it is 
the denouement of science for public consumption, while alongside it exist 
multiple, and in some instances contested, carrageentms (including, but not 
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limited to, the examples listed above). Yet carrageenans may be of particular 
relevance,, and be visible, in different spaces such that singularity and 
plurality are not necessarily in conflict. 
Different 'bodies of learning' and institutions share knowledge (savoir) 
amongst members that unite them as an epistemic community (Foucault 
1989). Such communities have common ways of seeing particular problems 
or issues that together mould authoritative discourse and social practice. 
Liberal rule involves a proliferation of expertise, authorities and institutions 
through which carrageenan, risk, uncertainty and subjects may align. Rather 
than one form of expert knowledge producing carrageenan, there are many 
epistemic communities that both render carrageenan knowable and 
calculable, and produce alternative and sometimes conflicting knowledge 
about it. In the contest over some identities of carrageenan between and 
amongst different epistemic communities, different carrageenans 
periodically unsettle what carrageenan-on-labels refers to or comes to be 
attached to. Such identities enmesh material and metaphorical difference - 
they describe both differentiations in the material constitution of carrageenan 
and implicate different epistemic communities including chemists, 
phycologists, marketers, health professionals and other technical and trade 
expert groupings. Moreover, these communities are not (necessarily) bound 
by the geographies of space. The globalisation of meanings attached to 
carrageenan through the flows of knowledge within epistemic communities 
creates de-territorialised pools of information on which to draw. 
In what follows, I consider how carrageenan is constituted amongst two 
epistemic communities of relevance to the carrageenan industry - chemistry 
and trade. My aim is not to provide any comprehensive list of partial 
perspectives of carrageenan, but to demonstrate that they exist. I then 
explore how partial and contested carrageenans are reconfigured in the food 
regulatory environment and examine the virtual impossibility of containing 
the (now visible) risks associated with them. 
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In the process I consider the contingency of scientific knowledge that reveals 
carrageenan, and ask how (and if) prudent consumers are enabled to make 
so-called rational choice. First, I explore the politics and problematics of 
prudentialism where there is an epistemology of singularity (or 
reductionism) in governing risk at a distance. Food label descriptions involve 
categorising carrageenan to maintain the categories as ontologically stable. In 
order for labels to work as categories of risk calculation, carrageenan may not 
exist as a plurality of meanings (at least not for the production of label-
reading prudent consumers). I then examine how different identities, 
chemical formulations and processes produce carrageenan as a plurality of 
carrageenans but attempt to reinscribe singular carrageenan where risk and 
public consumption is concerned (to circumscribe the plurality of .meanings 
in the public sphere). Finally I build on social studies of science and 
technology in viewing the constitution of knowledge (carrageenan-on-labels) 
as an exercise of power (Cruikshank 1994; Foucault 1984; Haraway 1988). 
Three issues emerge in this task, first (how) is 'carrageenan' less stable as a 
category than might be expected by the expert renderings on food labels; 
second (how) does the lack of spatial fixity of risk modify efforts to stabilise 
carrageenan; and third (how) do efforts to categorise carrageenan and 
contain risk problematise prudentialism, raising questions about the 
emancipatory extent of these new territories of government. 
Chemically simulating carrageenan 
For many years Chondrus extract was a black box technology such that 
properties of gelling, stabilising and thickening were known but there was 
limited understanding of the constituents of carrageenan or its means of 
operation. Over time, knowledge of carrageenan has been developed 
amongst different epistemic communities, such that it now refers to a range 
of substances with different properties. The expansion of knowledge about 
carrageenan has led to a situation in which, as one industry expert described 
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it, there are 'no barriers ... in the manufacturing of carrageenan products, 
carrageenan product lines' (Foss, 2002, pers.comm., 20 June). Chemists, 
polymer scientists31, engineers, laboratories, laboratory technologies and so 
on; make carrageenans visible and knowable via different processes, 
technologies and modes of analysis. In short, they are heterogeneous and 
simulated as well as real. 
One chemistry book circumscribes carrageenan as a 'family of gel-forming, 
viscosifying polysaccharides that are obtained commercially by extraction of 
certain species of red seaweeds' (van de Velde & De Ruiter 2002: 247). A 
chemical definition has reach in scientific circles: it is authoritative, and well 
maintained in chemistry books and, through the connections of scientists, of 
codes and regulations. Chemical definitions of carrageenans, however, are 
intricate tapestries that take meanings from the classification of idealised 
structures and the technologies that produce or reveal them. Amongst others, 
Latour has emphasised how systems of classification interact with so-called 
natural entities (such as a seaweed extract) to produce hybrid forms that 
incorporate the 'natural' product and 'social' form of measurement (Bowker 
& Star 1999; Latour 1993; Murdoch & Lowe 2003). According to Latour it 
should not be assumed that the science and actors such as carrageenan are 
dissoluble. Rather he suggests, the science that classifies and divides actors 
such as carrageenan is part of the heterogeneous matrix of carrageenan 
. (Latour 1997, 2002b). Thus rather than a simple act of identifying divisions 
within a complex substance like carrageenan, the act of division guarantees 
the creation of hybrid forms. What is more,. 'the interaction between 
classificatory division and heterogeneous relation ensures that classificatory 
schemes continually struggle to keep complicating entities at bay' (Murdoch 
& Lowe 2003: 319). Consequently, it would be expected that what is 
understood as a process of refinement to the science that renders 
carrageenans knowable, rather than assuaging all conflict over definitions of 
31 Polymer science is concerned with the chemistry and physics of substances composed of 'chains' of molecules 
(or monomers). 
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carrageenan, requires continual maintenance and protection from 
destabilising forces. 
One source of 'complicating entities' are earlier definitions of carrageenan 
that exist within already established heterogeneous networks some of which 
are particularly resistant to change. At interview with me, Dimitri Stancioff 
expressed his frustration at working for a carrageenan producing company 
in the regulatory environment of the FDA, 'Nomenclature is difficult, 
especially when you are working with people in government. They think 
once you've said this is such and such, and you change it [pause] well it's 
impossible' (Stancioff, 2002, pers.comm., 14 June). Perhaps impossible is too 
strong a word; however it is clear that, in the US at least, the nomenclature 
for carrageenan is durable within the regulatory environment in part because 
of the length and complexity of interactions in which it is enmeshed. In line 
with theories from within ANT I have emphasised that the multiple 
definitions and ways of calculating and measuring carrageenans are 
themselves part of a productive process of constituting carrageenan. The 
distinction that is assumed between carrageenan and the act of describing or 
delimiting what carrageenan is (and all its attendant technologies) is artifice; 
multiple hybrid carrageenans circulate that are not independent of the modes 
and systems of classification. Moreover, the stability of hybrid forms can be 
seen to be tentative when displaced or replaced in different contexts, or when 
constituted by different forms of representation - a discussion of which now 
follows. 
While ANT has been slower to incorporate discussions of the importance of 
visual images and representations, carrageenan's heterogeneous networks 
may also include, or in some views be displaced by, visual representations of 
carrageenan. Baudrillard (1988; 1994) suggests that in the scientific quest to 
know, representations begin to circulate in ways not simply divorced from 
the original, but no longer with equivalence to an original: 
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the logical evolution of a science is to distance itself increasingly from its 
object, until it dispenses with it entirely: Its autonomy is only rendered 
even more fantastic - it attains its pure form (Baudrillard, 1988: 7). 
At the molecular level of description, carrageenan does not in fact exist, but 
rather is represented as the basic structure of a network upon which other 
elements hang like various-length necklaces with combinations of pendants. 
The metaphors used in chemo-taxonomy for the basic structures of the 
'generic name' or 'family of carrageenans' are made up of a 'backbone', and 
represent an 'ideal structure' (van de Velde & De Ruiter 2002; van de 
VeldeKnutsen et al. 2002). 
The pure form of carrageenan is a series of idealised structures whose 
representation uses number and letter codes, and two- or three -dimensional 
schematic diagrams (Figure 3.1). Here carrageenan is represented by 
chemical notations detailing a range of ideal types with particular chemical 
characteristics, based on visual models in different configurations of tspace 
plane, spatial, three-dimensional and computer models (van de Velde & De Ruiter 
2002). According to Baudrillard, simulations 'feign ... what one doesn't have' 
(Baudrillard 1994: 2). However ANT views the visual practices of science in 
social constructionist terms. Simulations reflect how the 'human hand' and 
visual image are bound together in heterogeneous networks. The problem, 
suggests Latour, is that there is an expectation about the rational 
disembodied nature of scientific objectivity. 'Objectivity is supposed to be 
acheiropoiete, not made by human hand. If you show the hand at work in 
the human fabric of science, you are accused of sullying the sanctity of 
objectivity, of ruining its transcendence, of forbidding any claim to truth, of 
putting to the torch the only source of enlightenment we may have' (Latour 
2002b: no page). For theorists of ANT, the material is what holds society 
together, knowledge of carrageenan cannot be separated from the 
technologies of knowledge and systems that produced it. 
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Figure 3.1 Carrageenan: a schematic representation of an 'ideal' structure 
Baudrillard's theory of simulation suggests that society as a whole is 
increasingly organised through models and codes. The distinction between 
the materiality of carrageenan and the model of ideal carrageenan becomes 
blurred such that the model becomes the basis of the real; or in Baudrillard's 
terminology, carrageenan enters the realm of the hyper-real. In this view, it 
would be expected that the ideal types represented by chemical formulae 
begin to circulate as agents of what carrageenan is or comes to be. 
The hyperreal for Baudrillard is a condition whereby the models replace 
the real, as exemplified in such phenomena as the ideal home in 
women's or lifestyle magazines, ideal sex as portrayed in sex manuals or 
relationship books, ideal fashion as exemplified in ads or fashion shows, 
ideal computer skills as set forth in computer manuals, and so on. In 
these cases, the model becomes a determinant of the real, and the 
boundary between hyperreality and everyday life is erased (Best & 
Kellner 1991: 119). 
In this view carrageenan circulates as an ideal type with various chemical 
identities that may be measured using a variety of different machines and 
calculations. Material technologies such as nuclear magnetic resonance 
spectroscopy machines (NMR) reveal carrageenan in relation to ideal forms, 
from where they are mobilised within heterogeneous networks: 
Nowadays NMR spectroscopy (both 1H- and 13C-NMR) is one of the 
standard tools for the determination of the chemical structure of 
carrageenan samples. The NMR spectroscopy of carrageenans is used in 
industry and for research with different approaches corresponding to 
different ultimate goals or interests (van de VeldeKnutsen et al. 2002: 74). 
The technologies of NMR, scientists, laboratories and textual renderings of 
'fact' are some of the factors that feed into a network that constitutes 
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different carrageenans. Beyond the rendering of NMR machines, there is no 
singular carrageenan, but rather blends of carrageenans. The variable extracts 
of seaweed complicate what is circumscribed . as carrageenan, seaweed 
extracts vary from sample to sample, location to location, source to source, 
and may all have a different composition of elements. Moreover, 'even small 
variations in composition can have an enormous influence on their functional 
properties. For instance carrageenans containing irregularities (around 3%) 
'give much better gelling properties in dessert applications' (Rollema & van 
de Velde 2003: 1). Carrageenan(s) is, in this case, the model upon which 
irregularities are positioned as deviations from the real. Chemical 
laboratories and NMR spectroscopy (or other modes of chemical analysis) 
are key to how carrageenan is mobilised within chemo-taxonomies; and 
within industry accounts of functionality. One such account follows. 
In March 2002, one of FMC Biopolymer's employees, Gordan Guist, guided 
me on a 2.5 hour tour of a carrageenan-processing factory in Rockland, 
Maine. Unstructured conversations with Guist and one other employee 
. encountered during the tour of factory, were audio-taped and transcribed. 
The data were analysed to ascertain carrageenan's visibility through the 
various stages and processes in the factory. Extracts from the tour 
commentary provide useful examples of the processes involved in both 
rendering carrageenan visible and knowable, and in constituting carrageenan 
according to the spaces in which it exists, and the desires or ambitions of 
those directing its development. 
As the seaweed enters the factory it is a heterogeneous collection of 
spatialised material and non-material factors: carrageenan does not arrive in 
the factory in a pure form. Depending on where it is grown, how it is 
harvested and how any particular harvesting community treats it, seaweed 
arrives in the factory as an aggregate of social and material factors and 
carrageenans. As we enter one of the testing rooms, Gordon Guist impresses 
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on me the point that knowing the 'raw material' is knowing a composition of 
, elements: 
Gordan: We have raw materials testing laboratory with our wizard of 
weed, Walter. 
Duika (to Walter): What are you testing for? 
Walter: We test for moisture, sand, salt. On each weed sample we give it 
a log number, what it is, supplier, date it came in, process and then we 
do a phenol assay - to see what it is supposed to be ... [then test for] 
moisture, sand and salt. 
Testing utilises categories of expected seaweed properties based in part on 
records of place, time, method and batch, and models and techniques of 
measurement, to determine specific properties of the seaweed. The 
geographic account of the seaweed provides background data upon which to 
measure its material significance. For example, moisture varies according to 
how much and where it has been dried, and that can occur at various stages 
from harvesting to sale. Sand, salt and water measurements contribute to the 
anticipation of carrageenan content and the relative value of the seaweed. 
Various compositions of sandy, salty, moist seaweed result in differential 
returns. After the sand, salt and moisture tests, the washed sample is 
inspected for seaweed that is not carrageenan-bearing and then the 
actual carrageenan is extracted from it. At this point of the 
scientific rendering of actual carrageenan, any knowledge of its functional 
properties is undeveloped. Knowing carrageenan in the factory involves 
recognising its unique, if predictable, functional properties. Guist explains 
that samples are then tested for particular qualities: 
Gordon: For this one we'll do a viscosity, a water gel, we'll get a 
penetration and a dessert gel and might do - like cottonii, we might do a 
milk gel. 
Tests vary on the basis of seaweed type; expectations about the particular 
functional properties for 'cottonii' seaweed varying from those of, say, 
Chondrus cris pus. But further, the enrolment of use factors contributes to the 
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sorts of tests, as well as chemical modifications, that can result in different 
functional properties. In the processing room, Guist explains how a process 
of heating and the addition of an alkali break down the seaweed. He 
continues, 
so at some point we are going to pump this heated solution through 
inline mills; this just chops up the seaweed and aids in the breakdown 
and getting the carrageenan into solution. Then we pump it into holding 
tanks. We allow the seaweed to sit for a period of time, depending on 
the application. If it is a gelling application it may require 40 hours 
because it is a chemical modification [that] occurs; by knocking off 
sulfates, an anhydrogalactose ring is formed and this gives 
carrageenan its gel potential. Now if you are looking for a lambda 
carrageenan that is non-gelling you don't modify any at all, so we hold it 
for a much shorter period of time in the tank. 
Different processing techniques can modify the carrageenans that are 
produced. As the process progresses and the knowledge of carrageenan is 
broken down into constituent parts, emergent carrageenan is considered in 
terms of the particular qualities of the batches of carrageenans. The 
constituent properties of different seaweeds, their techniques of analysis, and 
the desired uses of them, are modified using knowledge of time and 
chemical properties. Additional chemicals produce various blends of 
carrageenans with different functional properties. Processing seaweeds for 
carrageenan may or may not involve chemical modification and can be 
achieved by different methods. The exact details of methods of production 
do not circulate in the public sphere, but general descriptions of the 
approaches can be accessed in numerous publications (Bixler 1994; McHugh 
2003; van de Velde & De Ruiter 2002). 
In chemical terms, carrageenan is a model that stands for numerous chemical 
combinations in a range of substances with recognisable properties that may 
be modified for particular uses. Within industry, carrageenan circulates as a 
model upon which to know (and manufacture) a range of functional 
properties. Carrageenan is revealed differently within epistemic 
communities, but also across them as the following discussion of commercial 
naming demonstrates. 
79 
Industrial naming: terms of exclusion 
Greek terms - principally iota, lambda and kappa - are used in industry to 
describe particular gelling, emulsifying and stabilising properties of ideal 
type carrageenans. Despite the more exacting chemical number and letter 
codes for carrageenan developed over the past 30 years, older chemical 
definitions - Greek terms - have continued to circulate in both scientific and 
trade circles, and are viewed within industry as names 'of the trade'. The 
following selection, from an Food and Agriculture Organisation (FAO) 
introduction to hydrocolloids by McHugh (2003) in A guide to the seaweed 
industry, is typical of accounts in which 'lambda, kappa and iota' are utilised 
to associate functional properties with uses and origins: 
Table 3.1 Commercial uses of carrageenan 
The carrageenans of commercial interest are called iota, kappa and lambda. 
Their uses are related to their ability to form thick solution or gels, and they vary as follows. 
Iota Elastic gels formed with calcium salts 
Clear gel with no bleeding of liquid (no syneresis) 
Gel is freeze/thaw stable 
Kappa Strong, rigid gel, formed with potassium salts 
Brittle gel forms with calcium salts 
Slightly opaque gel, becomes clear with sugar addition. Some synaeresis 
Lambda No gel formation, forms high viscosity solutions 
The carrageenan composition in red seaweeds differs from one species to another 
Chondrus crispus mixture of kappa and lambda 
Kappaphycus alvarezii mainly kappa 
Eucheuma denticulatum mainly iota 
Gigartina skottsbergii mainly kappa, some lambda 
Sarcothalia crispata mixture of kappa and lambda 
Source: McHugh 2003: 61. 
According to one industry representative, the terminology is still used 
because 'it is a question of technical support' (Foss, 2002, pers.comm., 20 
June). Naming carrageenans requires the incorporation of sophisticated 
technologies. Furthermore, the continued mapping of lambda, kappa and 
iota to particular seaweed species and particular functional properties 
achieves a variety of purposes; it may simplify knowledge for buyers on one 
hand but, on the other, such simplifications also serve to obfuscate, exclude 
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and produce economic value. The carrageenans 'of commercial interest' have 
transactional value among processors and food, pharmaceutical and 
industrial manufacturers. In simplifying terminology, the sophistication of 
chemical analyses comes to be located with key players (and places) in 
industry. Concomitantly, processing companies benefit from the ability to 
produce product lines of carrageenan as always partially revealed. By naming 
a product lambda with customised functional properties for particular uses, 
a level of invisibility has economic advantages - it is not reproducible 
without sophisticated and expensive technologies and can be sold as a more 
expensive speciality product. 
The uses of Greek terms connote associations that the newer chemical 
taxonomies do not. As Bowker and Star (1999: 5) remark, 'each standard and 
each category valorises some point of view and silences another. This is not 
inherently a bad thing - indeed it is inescapable. But it is an ethical choice 
and as such it is dangerous, not bad, but dangerous.' The valorisation of 
functional uses over chemical formulation creates a situation in which the 
carrageenans of commerce circulate in the public sphere of markets and 
industry as a delimited range of types. Carrageenans of commerce are 
recognised by types. 
Paradoxically, scientific advancements in analytical chemistry and the 
developments of more sensitive technologies render carrageenans more and 
more visible and minutely differentiated. Meanwhile, the networks in which 
carrageenan is enrolled in trade are constituted as a specific range of 
carrageenans, and on food labels as carrageenan, E407 and E407a. The 
significance of these views is that where 'carrageenan' appears on food 
labels, to carrageenan processors and chemists it is a (relatively) 
undifferentiated, sign value of many carrageenans; without these 
knowledges carrageenan involves a different set of calculations. Thus rather 
than one product, knowledge and production of carrageenan varies between 
and within epistemic communities such that carrageenan is internally and 
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exogenously a network. The social and spatial reach of carrageenan is immense, 
but is also subtle and highly differentiated. 
While carrageenan describes a network of factors between epistemic 
communities the term carrageenan may be likened to what Bowker and Star 
(1999: 297) term a 'boundary object'. Boundary objects arise over time from 
durable co-operation among epistemic communities. They are 'working 
arrangements that resolve anomalies of naturalization without imposing a 
naturalization of categories from one community or from an outside .source 
of standardization' (Bowker & Star 1999: 297). In chemical terminology, on 
food labels and industry parlance, carrageenan is a descriptor that resolves 
the anomalies of difference between communities and enables 
communication between them. Carrageenan has reach through technologies 
of communication. However, the calculation and description of carrageenan 
is only one factor of the network through which it is revealed, as carrageenan 
may become linked to other concerns such as those of risk and health. 
Releasing the genie: degrading carrageenan 
Carrageenan is the most thoroughly studied polysaccharide that has 
ever come down the pipe (Bixler, 2002, pers.comm., 16 June). 
In a geopolitics of singularity, risking the consumption of carrageenan is an 
either/ or proposition that disallows the possibility of partial perspectives. 
However since the 1970s, a substance described as degraded carrageenan has 
emerged around which questions of carrageenan safety as a whole circulate. 
In what follows I provide some background to the development of degraded 
carrageenan and the subsequent health scares concerning it. The 
development and surveillance of degraded carrageenan provide further 
insights into the changing modalities and rationalities underlying the new 
public health and risk calculations. Moreover, the status of carrageenan as a 
boundary object is profoundly problematised by degraded carrageenan, 
raising important questions about the limits of prudentialism. 
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I asked Harris Bixler why carrageenan is so well studied: 
Ah ... because it goes back - now there's some more history for you. In 
the early 1960s Glaxo - that is now GlaxoSmithKline Beecham (at that 
time it was a separate pharmaceutical company in England), had 
developed with a French associated company a product called Ebimar, 
which was carrageenan that helped in the curing of peptic ulcers - well I 
say cure, but whether it was a palliative or cure we don't know. But it is 
an anti-histamine. So they knew that if they could get people to eat 
quantities of carrageenan it would be helpful. If you try to get somebody 
to eat high molecular weight carrageenan it would gag a maggot - I 
mean its really slimy stuff. So Glaxo scientists came up with this idea - 
well we'll degrade it. We'll chop up like spaghetti and we'll make 10% 
solutions and you can drink it (2002, pers.comm., 16 June). 
Through a process known as degradation with acid (or depolymerisation), 
the chemical structure of carrageenan was modified along with its gelling 
qualities. Degraded carrageenan was developed in the 1950s as a powder 
that could be mixed with a liquid without forming too strong a gel in order 
that a larger dose of carrageenan could be administered. Stancioff explained 
the development of degraded carrageenan as follows: 
What we wanted to do was basically take the piece of string and cut it, 
that was the idea - but what happened was that some of the string was 
being destroyed (Stancioff, 2002, pers.comm., 14 June). 
In Stancioff's analogy, the idea that the string could be 'cut' as opposed to 
'destroyed' suggests degraded carrageenan did not meet the chemical 
typology of an ideal type carrageenan. The analogy of a string usefully 
describes the chemical understanding of carrageenan as a polymer chain 32; 
that is, repeating units of similar chemical structures in a string or chain. 
Continuing the analogy, the length of the string not only modifies the gelling 
quality of the carrageenan, but also determines molecular weight, which 
becomes 'lighter' if cut - although different ideal type carrageenan(s) are also 
understood to vary in molecular weight. In this view, degraded carrageenan 
refers simultaneously to a literal chemical process to 'reduce the complexity 
32 A polymer is a substance with a molecular structure built of a number of repeating units of molecule(s) 
(monomers) bonded together. In the case of carrageertn or other biopolymers, these units are understood to bond 
together in a chain of repeating lengths. 
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and the integrity of the structure of an idealised carrageenan molecule, and 
metaphorically to a process through which the meaning of carrageenan is 
reduced or debased. With a shortened polymer chain (in chemical terms), a 
reduced viscosity (in functional terms), and a positive association with 
medical uses for peptic ulcer, the degraded form of carrageenan was named 
Ebimar and sold over the counter in France (Informatics Inc. 1972; JECFA 
1974) among other pharmaceutical applications (Cohen, S & Ito 2002). 
In the late 1960s, Marcus and Watt, two researchers working under contract 
to the developers of Ebimar were employed to undertake research to establish 
the mechanism through which degraded carrageenan worked. During 
animal experimentation with both degraded and undegraded or native 
carrageenan, Marcus and Watt (1969) discovered that, at certain doses, both 
could produce ulcerations in the caecum of the guinea pig, but ulcerations 
were more severe with the degraded form 33. They concluded the 
'significance of our results in relation to human ulcerative colitis is at present 
only speculative and must await more comprehensive investigation' (Marcus 
& Watt 1969: 188S). In 1969, carrageenan use was already widespread and as 
Marcus and Watt reported, at the time of their publication there had been 'no 
reports of adverse effects' associated with carrageenan usage (Marcus St Watt 
1969: 187S). As the results of Marcus and Watt's investigation were 
speculative, any action to modify its use in the general population would fall 
• into the logic of preventing risk through biopolitical interventions in public 
health. 
One effect of the research of Marcus and Watt was an increased surveillance 
and risk profiling of carrageenan. Moreover, increasingly issues of safety 
became an international concern given the global reach of the carrageenan 
33 In contemporary scientific experiments, degraded carrageenan is widely used in medical testing 
procedures for conditions of inflammation. At high doses, both the so-called native and degraded 
forms of carrageenan produce lesions under certain conditions and in certain species of animals. 
Degraded carrageenan is used widely in laboratory experiments to produce a standard 'rat paw 
oedema model' for testing anti-inflammatory drugs (see for example: Winter CA, Risley EA and Nuss 
GW (1962) Carrageenin induced oedema in hind paw of the rat as assay for anti-inflammatory drugs. 
Experimental Biology and Medicine, vol. 111, pp.544-547). 
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industry. 'Speculating a risk' required a response. Industry members 
conducted further studies involving other kinds of animals that 'had to be 
done to stave off the claims that were brought up by Watt and Marcus' 
(Bixler, 2002, pers.comm., 16 June). As detailed in toxicological reviews of 
carrageenan, since 1969 scientific assessments of carrageenan have included 
short-term and long-term generational studies involving different dosages of 
degraded and non-degraded forms, and various animal studies including 
rats, mice, rabbits, resus monkeys, squirrel monkeys, pigs, gerbils, baboons, 
hamsters, ferrets, chick embryos and dogs (Cohen, S & Ito 2002; Greig 1999; 
JECFA 1974, 2001; Tobacman 2001). Despite the increased attention to 
carrageenan, in no regulatory environment has it been recognised or 
reported to produce adverse effects in humans sufficient to warrant it be 
discontinued for use. The most recent review of carrageenan emanating from 
the JEFCA for example, •maintains the status of carrageenan as a safe 
additive, with an Acceptable Daily Intake (ADI) 'not specified' (JECFA 2001). 
However, restrictions on the use of carrageenan were enforced - but not 
universally, a topic taken up momentarily. 
Before considering the modifications to food regulation that followed various 
'risky' revelations about degraded and/or low molecular weight 
carrageenan, it is worth considering the effect of speculations and obliged 
responses. Without commenting on the substance of the many reports on 
carrageenan since 1969, the timing of their emergence supports an argument 
that the proliferation of studies were initiated by suspicion, consistent with a 
biopolitics of risk. Furthermore, the chemical industry in general had been 
shaken by a series of high profile controversies. Two cases in particular are 
widely viewed to have had a major impact on the public perception of risk 
associated with the chemical industry. In 1961 Thalidomide was withdrawn 
from the market following the revelation of links to foetal abnormalities. In 
1962 Rachel Carson published Silent Spring, drawing public attention to the 
harmful effects of pesticides such as DDT (Heaton 1994; Smith 2001). 
Carson's book was a particularly potent factor in the formation of 
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environmental movements around the world and in challenges to the 
authority and adversarial approach of 'man's' scientific dominion over 
naturem. Nerlich's study of metaphor in Silent Spring demonstrates that the 
rhetorical effect of the book is to constitute a dualism between the 
artificial/unnatural and natural/environment. Using the title to exemplify 
the dualism, Nerlich suggests 'silence evokes death, the end of nature, the 
unnatural and artificial, emptiness and sterility, whereas spring is usually 
associated in western culture with birds, singing, new beginnings, life, 
unspoiled nature, and wilderness' (Nerlich 2003: 118). Silent Spring has been 
' the topic of much academic scholarship and although there are many 
avenues and overlaps that could be explored in its significance to the debates 
over carrageenan, I only point to them here. For the purposes of this chapter, 
the significance is that the bad publicity generated by Silent Spring and 
Thalidomide contributed to a background hum of anxiety about chemicals 
and the chemical industry in the public sphere - related to dualistic visions of 
nature/society - occurring at a similar time frame to the emergence of 
concerns about health risk and carrageenan. 
Once revealed as a risk it is no longer possible to argue that carrageenan is 
safe, that it bears no relationship to risk; the risk-genie cannot be put back in 
the bottle. As a result, and given that the network in which its risk profile is 
established is not outside of 'objective' scientific studies of carrageenan risk, 
the status of carrageenan's safety as a food additive is susceptible to 
destabilisation. In this particular case, carrageenan safety is contingent as 
competing for and against arguments in scientific accounts (re)construct it in 
terms of risk. 
While the risks raised by Marcus and Watt were not geographically located 
(carrageenan was used in similar products across the food industries of the 
US, Europe and Australia for example) the responses to the scare about its 
34 Feminist scholarship on Carson and Silent Spring points to the gendered nature of 
nature/society/science and attacks on Carson, and to more subtle readings of the gendered nature of 
science and scientific research. See for example (Smith 2001). 
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potentially harmful effects varied. Comparing carrageenan food regulation in 
the EU and US, for example, reveals that the EU (and its former structures) 
has consistently pursued a more risk averse strategy. For example, 
carrageenan is not permitted as a food additive in baby formulae in the EU 
but is in the US. Moreover, in 1972 the FDA reviewed carrageenan safety in 
light of Marcus and Watt's research, amongst other studies of carrageenan 
and risk (Informatics Inc. 1972). 
The 1972 monograph on carrageenan, contracted by the FDA to the 
Informatics Inc company, reproduces an accumulation of scientific 
arguments typical of more recent reviews (For example Cohen, S & Ito 2002; 
JECFA 2001). The monograph documents scientific literature on carrageenan 
published around the world for the period 1920-1970 and includes the 
following factors: summaries of animal studies; nomenclature of carrageenan 
and seaweed types; early visual diagrams of 'proposed' structures for 
carrageenan; tables and text detailing studies and comparisons of animal 
studies involving guinea pigs, rats, gerbils, rabbits, monkeys, hamsters, mice, 
guinea pigs and baboons; tables and text documenting levels of consumer 
exposure to carrageenan through food consumption; evidence of long-term 
and short-term animal studies including studies of carcinogenic status; 
teratogenic studies (to check for possible significance to birth defects); and 
studies with different carrageenan types. Amongst the 68 pages there is only 
one paragraph in which 'man' [sic], carrageenan and safety occur in the same 
section, reproduced in full as follows, 
A preparation of degraded carrageenan. (der. E. Spinosum), Ebimar, has 
been used in France for over fifteen years as a chemotherapeutic agent 
for peptic ulcer. Bonfils reports that two hundred patients receiving 
Ebimar at a dosage of 5g/day for six months to two years were 
monitored closely, and radiological examination was performed at 
intervals of not greater than four months. None showed any signs of 
ulcerative colitis (Informatics Inc. 1972: 18). 
Whilst there was no evidence of dangerousness or harm to human bodies, 
there was a large body of evidence suggesting risk. Futurity then, takes 
precedence over the past. Dimitri Stancioff attended the meeting at which 
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the Informatics report and motion to modify the regulations for carrageenan 
were discussed: 
I was at the meeting so I remember it all very clearly ... we had a large 
number of people from FDA ... and people from industry. We had the 
director of the medical college came down with the research Dr 
Goldberg had done; he supervised most of the studies - a specialist in 
cancer, particularly of the intestinal tract. They argued that they could 
not see any problem, the problem seemed to be with guinea pigs at high 
doses and the rat studies indicated that the likelihood of having a 
problem with degraded carrageenan, even in rats, there didn't seem to 
be any results that indicated any ... problem. But [in] the undegraded 
carrageenan, the regular standard carrageenan, they found no problem, 
and even [among] the guinea pigs, with the regular carrageenan, the 
effect was much less. So [the] FDA decided ... so they decided to let 
carrageenan continue ... oh yes people from the infant formula 
companies were very very concerned because they said we cannot make 
these products without having a stabiliser in them because they just 
don't work right; so that also helped to sway the FDA people. So they 
decided that they would review everything and write a new regulation 
for carrageenan. But at the time they would just limit the molecular 
weight to a miminum of 100 000 daltons; the average weight should be 
above 100 000; this was the work that we did, which corresponded to a 
viscosity of approximately 5 centipoise at a concentration of 1.5% at 75 
degrees C. They were content with that but we should do more studies. 
The Albany medical college said we should study [resus] monkeys 
which, in fact, they had already started [and] studies had been made in 
Denmark on pigs. All this information was being put together and FDA 
kept an eye on this. 
But then questions started arising immediately among those who were 
concerned ... Marcus and Watt came out with more papers saying they 
found lesions in rats and mice. We continued more studies in BIBRA in 
the UK [British Industrial Biological Research Association] [that were] 
very highly regarded. And they tested not only rats and guinea pigs but 
several other things, resus monkeys, gerbils; they came up again with 
carrageenan seemed to be okay if it was not degraded. At that time the 
EC also decided, they came up with a definition of carrageenan, they 
didn't come up with any molecular weight but the carrageenan should 
not be degraded (Stancioff, 2002, pers.comm., 14 June). 
Common to both Stancioff s report of the meeting and the Informatics report 
are the scientific calculations of risk through which evidence of safety can be 
measured. There were no discussions of the socio-political context under 
which the research was conducted. 
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Whatever the apparent risk, carrageenan is claimed to be safe on food labels. 
One method for assuring safety is to exert influence, indeed, determine what 
constitutes carrageenan. Within the regulatory environment, following many 
often-contradictory studies about the safety of degraded carrageenan, 
discussed fully in the following chapter, an absolute distinction has been 
made between degraded (chemically produced) and native carrageenan. 
However, in expert literature degraded carrageenan is commonly positioned 
in relation to native carrageenan. A 1974 Joint FAQ/WHO Expert Committee 
on Food Additives (JECFA) review of carrageenan exemplifies the 
relationship as it was represented at that time: 
Degraded carrageenan is prepared from the extract of Eucheumn spinosum 
by partial hydrolysis 35 using dilute HCI36, followed by purification. The 
sulfate/galactoside ration is the same as in the native form but the 
molecular weight is only 20 000. This material is not used by food 
manufacturers but is sold as an antipeptic agent on the continent (JECFA 
1974). 
As the JEFCA review notes, the form of degraded carrageenan was not used 
in the food industry. However degraded carrageenan was, by association, 
related to undegraded forms, particularly those with low molecular weight. 
Using the network analogy, the deployment of these terms in the regulatory 
environment for carrageenan increased an already complex ontological 
status of carrageenan (lambda, kappa, iota and so on) involving restricting 
the molecular weights, native and non-native forms through which 
carrageenan could be known. 
From one perspective, speculations about risk and subsequent 'positive' 
reviews of safety can be seen to reduce uncertainties and thereby minimise 
danger. Through risk assessments and reviews, carrageenan is proven 'safer' 
than if the sceptical studies of its efficacy had not been done. But, on the 
other hand, the presence and/or aggregation of risk concerns multiplies the 
domains within which associations between carrageenan and risk can be 
35 A chemical reaction in which water reacts with a compound. 
• 36 Hydrochloric acid. 
• 37 The sulphate! galactose ratio refers to the 'backbone' structure of the ideal carrageenan types. 
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made. Van Loon (2003) describes as a 'second order virtual-symptomatic' 
system the augmentation of risks bought about by technological attempts to 
contain risk. As the example of carrageenan shows, once a risk associated 
with ulcerations in guinea-pigs had been revealed, further methods for 
assessing the risk were used - and the risks multiplied. As I have noted 
elsewhere, the attempt to overcome risk contributes to the proliferation of 
risk (Burges Watson 2004).. 
The possibility of a relationship or equivalence between carrageenan and 
degraded carrageenan heightens perceptions of risk associated with the 
substance. Maintaining a demarcation between the two then becomes linked 
to ideas about what is safe and what is not. One result is a process of 
translation in which the focus of carrageenan's surveillance is oriented away 
from safety in general terms, and towards whether carrageenan is degraded 
(also delimiting the possibility that degradation may be partial or may occur . 
by so-called 'natural' means). Perhaps unsurprisingly, in 1989, a working 
group of the American Medical Association, the US Adopted Names (USAN) 
Council, deployed novel nomenclature for degraded • carrageenan: 
poligeenan. The manager of regulatory affairs for FMC Bioploymers was 
quoted in a Newswire report after the acceptance of the new term: 
Low molecular weight derivatives had erroneously been referred to as 
'degraded' carrageenan in some literature. By this action, we can now 
communicate the fact that there are two distinct products -- carrageenan 
and poligeenan -- with different characteristics and different 
applications' (PR Newswire 1989: no page). 
As the institutional reaction of FMC Biopolymers suggests, the distinction 
between degraded and native carrageenan did not, in fact, produce a 
demarcation that was sufficient to allay fears about the risk profile of 
carrageenan. 
Despite efforts to dissociate the degraded form from the range of 'typical' 
carrageenans, a notion of equivalence remains in much contemporary 
literature. Even when concerns were •raised about the potential of degraded 
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carrageenan to produce health effects in the 1990s by carrageenan's 'Rachel 
Carson', Joanne Tobacman (chapter four), regulatory authorities responded 
by arguing that native form was not found to pose any threat to human 
health in the amounts consumed (JECFA 1974, 2001). 
To summarise the problematic of carrageenan's risky profile, the ideal of 
safety relies on sustaining a network in which an increasing number of risky 
elements must be (re)stabilised as safe. A 'second-order virtual symptomatic 
system' is created from the multiplied domains of assessment; creating in its 
wake, contested carrageenans. 
The limits of choice 
The example of degraded carrageenan demonstrates that in order for 
carrageenan to remain 'safe' for human consumption, scientific knowledge 
and expertise are enrolled to continuously reproduce a bounded and 
simplified view of carrageenan. On one hand the limitations imposed upon 
carrageenan's description, as it appears on labels, is also a (dangerous) 
choice; it is the outcome of debates and contested expert knowledges that 
represents what may be considered the best of what is available to science. 
But the information is translated and, in the case of carrageenan, the 
translations are not universally the same. Labels such as E407 or E407a or 
carrageenan are meaningless unless one can also trace their origins, but the 
carrageenan of the food label is simulacrum. Carrageenan is idealised, 
simulated, contingent and a boundary object; a representation. It exists 
across a range of different epistemic communities, and there are consistent 
elements that flow across some locations, but not others. The carrageenan 
that is revealed within the 'likely' spaces of consumers of public health is not 
an impartial rendering. The knowledge of carrageenan is situated, and 
within each utterance of a name exist various associations and linkages, 
physical and social, that tie carrageenan to particular regimes of knowledge 
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and power. Yet for prudent consumers of health, the knowledge of 
carrageenan is presented as a choice. 
As others have cautioned, the ideal of active citizenship promises 
unrestrained freedom and freedom to choose - yet often overlooks the 
constraints through which that freedom is granted, and the obligations that 
'freedom' demands (Petersen & Bunton 2002; Rose 1999). Moreover, for 
prudent consumers the complexity of science that renders carrageenan, and 
risk, knowable is, to use a geographic metaphor, displaced and distant 
(Jackson 1999). Rather than attaching significance only to the visibility and 
construction of risk, there are questions of the spatiality of risk: the distance 
that exists between prudent consumers and the risk calculations amongst 
epistemic communities that I have hitherto described in relation to 
carrageenan, demonstrate there are limits to 'informed' choice. As Whatmore 
• describes consumer experiences of food in general, "the mark of 'consumer 
choice' belies a diminshed understanding of, and control over, what it is we 
are eating and the social conditions under which it is produced"(Whatmore 
2002: 36). Rather, the carrageenan of food labels is metonymy, and choice is 
not so much freedom from political restraint as it is to be informed (as 
artifice) about what the political restraints are. Moreover, under the terms of 
new public health, choosing carrageenan is an obligation. 
Haraway (1991: 191-2) offers an alternative to the kinds of scientific 
reductionism that produce the carrageenan of food labels. For her, the 
answer to objective enquiry lies in 'partial, locatable, critical knowledges 
sustaining the possibility of webs of connections called solidarity in politics 
and shared conversations in epistemology'. The appeal to criticality in 
knowledge is all very well, but for the practices of self-governance how does 
one fit that on a label? Given the new responsibilities of self-governance, I 
now turn to an exploration of the constitution of carrageenan in the media. In 
particular, I analyse the Internet as an enabling tool in the range of 
communication technologies through which science knowledge is 
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increasingly mediated (Petersen & Bunton 2002: 184). Specifically, I explore 
the case of a controversy involving the contested knowledges of carrageenan 
and carcinogenicity and their implications for public health. 
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Illustration: The Irish Frankenstein, 1843 
Source: Library of Congress, Prints and Photographs Division 
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Chapter 4 
Fabricating science fictions 
and diasporic communities 
of carcinogenicity and 
health 
It is difficult to recognise a wolf in sheep's clothing (Tobacman 2002: 
A176). 
'Carrageenan is a wolf in sheep's clothing,' says Dr. Joanne Tobacman, 
an assistant professor of clinical internal medicine at the University of 
Iowa in Iowa City (Gordon 2004: no page). 
In this chapter I examine how carrageenan is constructed as a risk factor 
through the calculation and translation of risk. I explore how carrageenan is 
constituted as a carcinogen, and detail the unfolding controversy in which 
the various stakeholders attempt to assert their power over the description 
and (allegedly) risky profile of carrageenan. The chapter documents the 
events surrounding a widely publicised controversy over the safety of 
carrageenan concerning ulcerations and carcinogenicity, different elements 
of which have been profiled in chapter two. 
In the October 2001 edition of Environmental Health Perspectives (EPH), an 
online peer reviewed journal on environmental factors and human health, a 
scientific literature review of carrageenan safety appeared. Written by US 
based researcher, Joanne K. Tobacman (2001) the article reviewed 45 animal 
studies on carrageenan, ulcerations and carcinogenicity, and advised that 
there was (already) enough evidence to 'support an argument to reconsider 
the advisability of use of carrageenan as a GRAS 38 food additive' (Tobacman 
2001: 992). Along with some of her earlier, less publicised studies of 
carrageenan and comments about them, Tobacman's paper was widely 
38 As detailed in chapter two, there is confusion over the regulatory status of carrageenan under FDA 
regulation. Strictly speaking, carrageenan that is used in food and pharmaceuticals is not listed on the 
official GRAS list of items. 
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quoted in the international media (for example Chapman, J 2001; Krantz 
2002; Sicherman 2001) and appeared on numerous Internet sites (for example 
Cohen, R 2004; Farlow 2004; Well 2004a). Through mediated accounts and 
among members of the seaweed and food industries, the studies and 
pronouncements were central to a controversy that sent 'ripples around the 
world' (Krantz 2002: 1A). 
Using the metaphor of the network and processes of translation from within 
studies of ANT (Latour 1991; Murdoch 1997; Whatmore & Thorne 1997), I 
consider how carrageenan and cancer are brought into proximity as a 
network, and through translation, spread across globe. The chapter is 
divided in two. The first section considers Tobacman's problematisation of 
carrageenan as an effect of the calculation and translation of carrageenan/risk 
in the passage of communications and carrageenans within and between 
scientific knowledges. In the second section, I examine how the stability of 
risk is transformed through expanding networks of risk and via 'disaporic' 
communities of health: virtual communities that exist 'only to the extent that 
their constituents are linked together through identifications constructed in 
the non-geographic spaces of activist discourse, cultural products and media 
images' (Rose 1996: 333). I consider what the controversy reveals about the 
location, role and reflexivity of communities in formulating health 
knowledges. In the process of tracing the discursive construction of 
carrageenan as a potential carcinogen I discover that the Tobacman 
carrageenan cancer scare is maintained by individuals and in communities 
whose members share understandings of risks comparable to Potts' (2001; 
2004) ecological approach to health. 
A wolf in sheep's clothing? 
Tobacman's EPH review suggested that the weight of evidence against 
carrageenan was sufficient to warrant its use be 'reconsidered'. The data 
upon which the review was based were generated by the scare over Ebimar 
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outlined in chapter two. As detailed, the growing field of risk assessment 
and the revised system under which proof of safety was required, as well as 
the development of degraded carrageenan/poligeenan and demonstrated 
links to ulceration and tumours in some laboratory animals at certain doses, 
generated a snowballing interest in carrageenan safety (in general). The 
increase of reports, safety profiles, organisations and risks associated with it 
amplified the intensity of carrageenan's surveillance, thereby network-
lengthening the risks (Whatmore & Thorne 1997). For Tobacman, rather than 
proving safety, the weight of evidence was one among other factors that 
combined to produce and expand the risk. In a telephone conversation with 
me on 3rd December 2003, Dr Tobacman speculated about the links between 
data and risk when she said: 
I guess that underlying this issue is the consideration about how much 
data are sufficient to make a judgement about carcinogenicity? Many 
animal studies demonstrating ulcerations and neoplasms from 
carrageenan exposure were completed decades ago. What evidence and 
how much evidence does it take to lead to changes in policy and 
behaviour? 
Tobacman's position on carrageenart emanates from within an episteme of 
environmental epidemiology and preventive oncology, through which 
evidence of safety (in the regulatory authority's view) could be transformed 
into evidence of risk. Tobacman described her interests as follows: 
I'm interested in preventive oncology. I have trained in Internal 
Medicine and then in the Medical Oncology Branch and the 
Environmental Epidemiology branch at the National Cancer Institute 
(Tobacman, 2003, pers.comm., 3 December). 
Preventive oncology was a term first used in 1975 to describe a new 
speciality research area of preventive medicine (Reynolds 2001). It is a 
technical means for preventive interventions in public health issues related to 
cancer. Reynolds (2001) describes two distinct lines of intervention within the 
field. Primary interventions are those involved in such things as treatment of 
malignant lesions or responses to screening mammography. Secondary 
interventions identify such things as air pollution or 'industrial incursions' 
(Reynolds 2001: 340); a typology of interventions that accord with transitions 
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from 'old' to the new public health. Tobacman's research on the lifestyle 
factors of diet in relation to breast cancer prevention fit within the latter, and 
thus within the general rubric of a biopolitics of preventive health. Locating 
cancer and its mitigation in populations and via their dietary practice is a 
'particular objective reality about which one can have knowledge' (Dean, M 
1999b: 107). The rationality underlying a biopolitics of prevention, as I 
suggested in chapter one, also underlies regulatory approaches; however the 
'objective reality' dbout which Tobacman claimed knowledge was based on a 
different rendering of that knowledge and the interpolation of risk. 
Rather than carrageenan being the key element in Tobacman's research 
agenda, it was one of a number of factors through which cumulative 
associations were made amongst the risk of breast cancer, women's health, 
population and environment via her research on carrageenan in the 
laboratory. I asked Tobacman specifically about her interest in carrageenan: 
Carrageenan, as you're aware, has been widely used experimentally for 
several decades. I became interested in mammary myoepithelial cells 
predominantly because they are absent in invasive mammary cancers. I 
thought that was significant, but was not being studied very much. I 
was working with the myoepithelial cells in the lab, and was studying 
their ionized calcium using confocal microscopy 39. I wondered what 
effect carrageenan would have on the cells, since it forms gels with 
calcium. Surprisingly, I found that carrageenan was very harmful to the 
cells (Tobacman, 2003, pers.comm., 3 December). 
Tobacman's laboratory research was principally concerned with the 
environmental epidemiology of cancers, but more specifically was related to 
breast cancer and its appearance in a particular (and less studied) cell type. 
As commonly used inflammatory agents in laboratory experiments (such as 
39 Confocal mircroscopes, unlike the more traditionally used electron microscopes, enable a new time-
space imaging of the objects of study. While electron microscopes require thin 'slices' of the object 
through which to view a snapshot of its two dimensional characteristics, confocal microscopy utilises 
laser technologies and a sweeping of the object by pinpointed light enabling an 'optical sectioning' of 
the object to produce a representational three dimensional image. Confocal microscopy is a recent 
innovation and is being widely adopted, particularly within biological sciences. Hum writes that the 
relevance to biological science is that 'changes in living cells can be studied over time' (Hum 1988) The 
technology of image production enabled by the confocal microscope in ANT terms, is part of the 
technology of knowledge. Chapter three also makes reference to the use of images and representations 
within scientific practice. 
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the rat paw oedema model) some carrageenans were already items in the 
laboratory toolbox. Experimental uses of 'carrageenan', histories of risk, 
mammary cells grown in a laboratory, cancer, a research gap and the various 
technologies within the laboratory, supported the development of a 
suspicion about carrageenan. Carrageenan was thus incorporated into 
Tobacman's research program on myoepithelial cells rather than the other 
way around. Surialink Associate David Myslabodski commented on 
Tobacman's myoepithelial research in interview with me: 
The whole approach may be flawed. You just cannot test a product 
against any type of cells. Aren't you first required to show that the agent 
has 'natural' access to the cells? That is, if carrageenan in real life never 
comes in contact with these cells what is the point? (Myslabodski, 
pers.comm. 2005, 20 January). 
• 
Tobacman's research did not explain how the association between 
carrageenart and mammary cells involved and required the participation of 
the researchers hand. As Murdoch (2001: 118-19) puts it, there has been an 
'exchange of properties between entities' such that the 'complex ecology' in 
which Tobacman's research is situated is part of the co-construction of 
carrageenan as a factor in cancer in myoepithelial cells. 
Furthermore, after an association between carrageenan and myoepithelial 
cells had been made, Tobacman's research reoriented towards carrageenan 
as the key actor. Translation is a process in which the original is no longer the 
same as that which preceded it (Brown, SD 2002; Latour 1991; Murdoch 
1997). Such a refocus in research interest may be understood to affect a 
process of translation; Tobacman's research reorientation and carrageenan as 
a risk factor in breast cancer. 
The EPH article was not the first published by Tobacman on the topic of 
carrageenan and cancer, but it followed several investigations of 
relationships amongst mammary carcinoma, carrageenan and cancer more 
Surialink is a web-based network of 'seaplant professionals' and information source on commercial 
seaweed industries. www.surialink.com . 
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generally (Tobacman 1997, 1998, 2001; Tobacman et al. 2002; Tobacman, 
Wallace & Zimmerman 2001; Tobacman & Walters 2001). Placing the article 
in context with her other research, it can be seen that the review accumulated 
suspicions of risk into one document. On this basis it is worth reflecting 
further on how risk accumulation (the lengthening of networks of risk) 
occurs. A publication outlining the breast cancer and carrageenan research 
usefully demonstrates the process of network lengthening. 
A media release issued from the press office at the University of Iowa 
following the publication of Tobacman's (1997) paper illustrates the 
speculative nature of the breast cancer research and associations with 
carrageenan as an object of risk. Provocatively entitled 'Food additive may have 
breast cancer-causing properties' (Ohman 1997: no page), the review 
demonstrates how a narrative of risk about carrageenan and breast cancer 
unfolds as a network of associations. Embellishing the concern through 
association with everyday items of consumption the release begins: 'Lambda-
carrageenan, a food additive widely used in milk products such as infant 
formula, pudding, ice cream and whipped cream, may have cancer-inducing 
properties'. Lambda-carrageenan is a specific representation of a particular 
type of carrageenan linked to various production processes, seaweed species 
and locations. The specificity of 'lambda-carrageenan' in Ohman's press 
release does not match up with uses of lambda-carrageenan within industry 
accounts or the title that suggests the concern relates to the sum of 
carrageenan as a 'food additive'. Moreover, lambda-carrageenan has a 'very 
small' market share in comparison with the kappa, iota and kappa-lambda 
type carrageenans (Myslabodski, pers.comm. 2005, 20 January). 
The second paragraph relates an already established association between 'a 
form of' lambda-carrageenan and ulceration leading to cancer in animals - 
establishing its credentials as a potential risk. Next, the release states that the 
'facts of ulceration' made Tobacman wonder if the additive also affected 
breast cells in a way that might lead to cancer - a suspicion that, it is 
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suggested, led her to test lambda-carrageenan by adding it to tissue cultured 
cells in a laboratory. Finally the author of the piece asks 'Do these findings 
mean that lambda-carrageenan, which has been on the market since 1937, is a 
cancer-causing food additive?' Here the answer is less accusing than the title 
of the press release suggests. Tobacman is quoted saying '''We can't say that, 
yet ... We have taken one step forward and found an interesting association. 
Having new territory to explore with regard to environmental agents that 
may be smoking guns with regard to breast cancer is good news to cancer 
epidemiologists who have been looking for an environmental aetiology for 
breast cancer". Finally the release states that Tobacman is seeking funding 
for further studies (Ohman 1997: no page). 
Various dimensions of preventive actions against risk are demonstrated by 
such a narrative: the tendency of media accounts to embellish the risks 
(Boyne 2003; Fowler 1991; Lupton 2004); how finding new territory to explore 
has currency in research; and that deducing new territory may not emanate 
from experience of observable phenomena in human bodies, but from 
accumulations and extrapolations of calculations of risk. In the case of 
Tobacman's research, probability about breast cancer was advanced through 
the construction of new associations. Breast cancers, cancer, ulcerations and a 
form of lambda-carrageenan came together as an effect of a 'mass of currents 
rather than a single line of force' (Whatmore & Thorne 1997: 291). 
It is possible to trace a similar process of accumulation of negative 
associations forged by Tobacman's publications leading up to the EPH 
article. Three papers associating carrageenan with carcinogenicity are 
demonstrated by laboratory experiments with breast cells (Tobacman 1997, 
1998, 2001). Tobacman's (1997) paper justifies the enquiry on the basis of the 
ubiquity of carrageenan in food, and existing studies of carrageenan and its 
effects on intestinal cells - the animal studies referred to in chapter two. The 
paper develops an association between lambda-carrageenan's use as an 
addition to foodstuffs and an enquiry on the effect of low-concentrations of 
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lambda-carrageenan on myoepithelial cells in a laboratory. The 
myoepithelial cells have lost their connections with the network space of the 
body and become instead part of the research network involving Tobacman. 
The abstract for . Tobacman's next paper, a presentation given in a session 
titled 'dietary factors' for the 1998 meeting of the International Society for 
Preventive Oncology in France, further reported effects of lambda-
carrageenan on myoepithelial cells demonstrated in a laboratory (Tobacman 
1998). The titles of the two papers forge different associations however. 
While the first remains within the laboratory ('Filament disassembly and loss 
of mammary myoepithelial cells after exposure to lambda-carrageenan'), the 
second extends the significance of the laboratory research beyond the 
laboratory ('Effects of lambda-carrageenan on human mammary 
myoepithelial cells and relation to mammary carcinogenesis') [my emphasis]. 
Expanding the network further, in the same year that the EPH review 
appeared, Tobacman and her colleagues' (2001) Medical Hypotheses article 
used an epidemiological technique known as a 'time-trend' analysis to 
correlate the increased use of carrageenan in the twentieth century with the 
increased incidence of breast cancer. The authors wrote that 'although time-
trend correlations represent a weak form of evidence, when significant 
positive correlations are found, they can support further evaluation' 
(Tobacman, Wallace & Zimmerman 2001: 596). The findings of the Medical 
Hypotheses article supported what Tobacman described as carrageenan's 
'candidacy'. for further consideration for its 'possible etiological significance 
in the increased twentieth century incidence of mammary . carcinoma' 
(Tobacman, Wallace & Zimmerman 2001: 596). 
Taken together, the titles and content of the EPH and Medical Hypotheses 
journals are indicative of the preventive, predictive scientific context in 
which Tobacmart's research was generated, and illustrative of how the 
accumulation of research contributed to network-lengthening the risk - 
progressively expanding the scales of carrageenan's risky significance. 
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Latour (1991) uses the term immutable mobiles to describe actors (themselves 
already networks) whose network stability is not disrupted by mobility 
across spaces and times. As an immutable mobile in the context of 
Tobacman's research, allegedly cancerous carrageenan holds together from 
the laboratory to the general environment of population health through 
interactions that include epistemological and governmental concerns. Via the 
discourse of environmental epidemiology, rules about the spatial (non) limits 
of the laboratory research are met and, by extension, enable the use for such 
research within other realms, for example - as I . will discuss presently - the 
mediated space of the Internet where prudent consumers are likely to 
encounter it. 
Moreover, in addressing the extracorporeal context of breast cancer and 
preventive ethos of actions in relation to it, (all) women and (all) carrageenan 
come to be remapped and placed even further under the risk spotlight. The 
case study offers a reminder of the constitutive power of risk and prevention: 
'Prevention' in effect promotes suspicion to the dignified scientific rank 
of a calculus of probabilities. To be suspected, it is no longer necessary to 
manifest symptoms of dangerousness or abnormality, it is enough to 
display whatever characteristics the specialists responsible for the 
definition of preventive policy have constituted as risk factors (Castel 
1991: 288). 
In contrast to Tobacman's epistemological framing, reactions to her work 
from within the seaweed industry and regulatory authorities point to the 
instability of cancerous carrageenan and suggest a differently constituted, 
though not unrelated understanding of risk. As I argued in chapter two, 
regulation also remaps the spaces of risk and health. In the April and June 
2002 editions of EPH a series of letters appeared on the subject of the review. 
Two of the letters were critiques of Tobacman's findings from the General 
Secretary of Marinalg International41, Pierre Kirsch; and from Phil Carthew 
41 Marina1g International represents the interests of the seaweed processing industry in relation to 
safety risks, before international regulatory agencies such as the Codex Alimentarius and the European 
Commission. 
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of the Unilever Safety and Environmental Assurance Centre 42 (Carthew 2002; 
Kirsch 2002). The counters to Tobacman's claim were fourfold, based on the 
weight of evidence supporting carrageenan use, the scientific credibility of 
Tobacman's results, animal studies and issues of dose. Kirsch (2002: A288) 
emphasised that, worldwide, food regulatory authorities 'unanimously' 
agreed on the safety of carrageenan as an additive when used 'at amounts 
only limited by the amount necessary to achieve its technical function'. 
Carthew (2002: A176) suggested that Tobacman had, among other things, 
'inappropriately extrapolated from animal data with regard to human risk' 
and not included certain critical studies in her evaluation of carrageenan. 
The animal studies and dose issues entail different tolerances to ideas of risk. 
In one article Tobacman raises the proposition that carrageenan exceeds the 
standards set by the 1958 Delaney amendment to the Food and Drug act in 
the US (Tobacman 2002: A176). The wording of the Delaney amendment was 
such that 'no additive shall be deemed to be safe if it is found to induce 
cancer when ingested by man or animal, or if it is found, after tests which are 
appropriate for the evaluation of the safety of food additives, to induce 
cancer in man or animal' (Dean, R 1989: 6). The legislation has been 
extremely controversial. Some argue that zero risk is necessary to protect the 
health of the members of the public, others that carcinogens occur naturally 
in many foods and are of little risk. Noah (1999: 34) suggests that the Delaney 
clause is used with less rigidity in food and drug law in the contemporary 
period because its wording preceded the kinds of sensitive technologies that 
now make negligible risks calculable. Where there is 'reasonable certainty of 
no harm', the Delaney clause is no longer used. Uncertainty is also a strategy 
of governance (O'Malley 2000). In animal studies, amongst different animals, 
carrageenans, degraded carrageenans, dosage levels and humans there are a 
vast array of possible associations and demonstrated contestation between 
different positions. Anything can be a risk (Ewald 1991). 
42 Unilever is one of the world's largest producers of consumer food products. Carrageenan containing 
foods under their 'portfolio include the diet product Slim-Fast. 
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A European Commission report, established with the express purpose of 
reviewing Tobacman's EPH and Medical Hypotheses papers, was particularly 
critical of her findings in relation to the Medical Hypotheses article . about 
which it concluded that it: 
did not support the hypothesis that breast cancer may be causally 
related to intakes of carrageenan and other water-soluble polymers used 
as food additives. The Committee noted that such correlations might be 
found for any dietary component or chemical to which there has been 
increasing exposure during the twentieth century (Scientific Committee 
on Food 2003: 6). 
In this view Tobacman had radically over-determined the hypothesis; rather 
than carrageenan as a (possible) factor in breast cancer, any dietary component 
with the conditional period of time associated with rising cancer rates, could 
be linked to breast cancer. The Committee's report suggested that the breast 
cancer scare was rather more akin to a wild guess than a search for 'objective' 
truth. However such a view fails to consider the discursive terrain of 
Tobacman's (or their) analysis and how such risks are constructed within the 
new public health. 
Thus far I have outlined some of the features of the controversy concerning 
the calculation of risk in relation to cancer and carrageenan generated by 
Tobacman's research. Although her work may be viewed as consistent with 
the rationality of preventive oncology - an assessment of acceptable 
uncertainty and the weight of global expertise dis-enabled her findings. The 
power of Tobacman's statements is enabled only by the connections that can 
be commanded because, as Latour suggests, without connections, statements 
lose their power (Latour 1997: 4). The weight of combined regulatory 
authorities and expertise was in sharp contrast to, and ultimately 
diminished, the lonely authority of Tobacman's research in the melange of 
scientific assessments of risk. 
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The force of risk is not simply in its calculation by Tobacman or her 
detractors; it also depends on what happens to the statements. The 'fate of a 
statement is in the hands of others' as the statement is transported and 
transformed (Latour 1991). Although Tobacman was not able to generate 
support within the regulatory environment, her research was not limited to 
that space of encounter. There is a spatial imperative in transport that 
suggests, in the case of the research message, the involvement of 
communication technologies. Tobacman's research was widely circulated in 
the national and international media, and appeared on numerous health 
related websites as I will presently detail. Stabilising the findings of the 
research may be achieved via both the hands of others and of self in the 
enrolments of material technologies of communication and the messages that 
are transported by them. 
Inculcating carcinogenicity 
On their own, Tobacman's research papers might have generated little by 
way of reaction from industry, regulatory authorities or the public. However, 
as the General Secretary of Marinalg suggested to a reporter from the De 
Moines Register, 'The problem is, as you probably know, she [Tobacmar] 
made a lot of noise in the press ... we had a lot of clients and consumer 
organisations who came back to us and said, what is this?' (Krantz 2002: 1A). 
Rather than analyse the range and extent of media reportage of Tobacman's 
findings, in the following section I consider examples of articles that were 
found through a LexisNexis 43 search that specifically mentioned her work. 
Perhaps not surprisingly, the articles I cite below include those from the 
Daily Mail and Star Tribune that were raised as significant in my interviews 
with seaweed industry members. 
The appearance of media articles generated responses from Marina1g 
(amongst others) as the representative organisation of the food hydrocolloids 
43 LexisNexis is a searchable database of more than 5000 global media sources. 
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industry (Marina1g International 2002). As has been argued in relation to 
genetic pre-detection, in presenting a risk, there is an implied obligation to 
respond (Hallowell 1999). 
An ,article in London's Daily Mail quotes Tobacman as recommending that 
people 'avoid ingesting' carrageenart, suggesting it posed a 'definite risk', 
and that 'it is possible people are developing gastrointestinal cancers and 
ulcerations through eating products containing carrageenan' (Chapman, J 
2001: 47). Bruce Sylvester, writing for McGraw Hill Company's Biotechnology 
Newswatch reported that 'a lot of people think it might cause cancer', quoting 
only the key features of Tobacrnan's EPH article as well as outlining her 
breast cancer and carrageenan research. The article quoted Tobacman in 
ways that suggested society was saturated by the risk posed by carrageenart 
such as, "It's all over the grocery store" Dr Joanne Tobacman, assistant 
professor of medicine at the University of Iowa in Iowa City told BTNW' 
(Sylvester 2001). The media article embellishes the risk by emphasising 'a lot 
of people', 'cancer', 'breast cancer' and the sense that it is impossible to avoid 
carrageenan. The media uses Tobacmart's authority in new ways to relate 
previously unrelated factors of risk, breast cancer and carrageenan. I asked 
Tobacman about the media articles: 
D: Many of the media sources you are quoted in suggest that 
carrageenan should be avoided .? 
J: I think there are sufficient data with regard to harmful gastrointestinal 
effects of carrageenan that it should not be included in food products. 
It's very difficult to study human intake of carrageenan, due to variation 
in carrageenan content of different food products and variation in 
individual intake day to day and over longer time intervals. Also, ethical 
issues limit study of direct effects of carrageenan exposure in people. I 
think that the animal data are consistent and compelling. 
The wording of the Daily Mail article did not reflect the imperative statement 
that the existing data 'should be sufficient to accept the harmful effects', even 
if that is how Tobacman framed the issue in her communication. Rather, as 
Latour (1997) suggests, the significance of the statement is never enough to 
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predict where it will go. For example, writing in the Star Tribune 
(Minneapolis) Al Sicherman argued that carrageenan is a cancer suspect, 
emphasising the discovery of carcinogenicity by Tobacman. The appeal to 
something newly discovered (rather than a reinterpretation of something 
already known) is perhaps not unexpected in the context of media's task to 
report the news as-it-happens. Moreover, the message was globally rendered 
without an awareness of the differences amongst national regulatory 
environments. The Jerusalem Post (Israel), despite reporting the JEFCA 
conclusions on carrageenan as a safe additive, also suggested that on the 
basis of the 1972 FDA report, there was 'no substantive regulation of 
carrageenan in food' [anywhere] (Siegel-Itzkovich 2001: 8). Thus carrageenan 
risk is decontextualised and recontextualised within the immediacy of virtual 
media health space. The media rework the time-space of the scare by 
bringing immediate news into a new realm of virtual time-space. 
The media articles did not question whether there was a risk associated with 
carrageenan, but made different statements about risks. Like the transition 
from GRAS category to regulated additive, through such accounts, 
carrageenan's mediated portrayal as a risk is rendered durable. Carrageenan 
no longer exists without a relationship to risk, and through the dissemination 
through the Internet and mediated accounts that render risks visible, this is 
true virtually anywhere. Risk is transmitted through the embodiment of 
carrageenan as a risk in communications technologies - carrageenan's risk 
becomes immutable. 
Diasporic communities of carcinogenity and health 
'Diasporic' communities, in the sense used by Rose (1996: 333), refer 
specifically to Internet based communities that are not reducible to time-
space coordinates, but which exist as community by virtue of informational 
interconnections and shared interests. The• Internet is recognised as a 
significant new source of public information about health risk and 
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prevention (Henderson & Petersen 2002; Parr 2002; Petersen & Bunton 2002). 
The presence of the Internet and information about carrageenan on health 
sites enables health consumers at a distance by bringing remote knowledge 
into close proximity. However, as the following example demonstrates, 
information about carrageenan and risk is also translated when it comes in 
contact with diasporic communities of health. 
In August 2002 a 'google' search using all of the terms carrageenan, Tobacman 
and cancer returned 51 websites. Using the same concurrence of terms in June 
2004, 186 websites documented a relationship between Tobacman's research, 
carrageenan and cancer. In the expanding networks suggesting links 
between carrageenan and cancer, information appeared on numerous health 
related websites (Table 4.1). 
In Petersen and Bunton's (2002) view the rise of virtual communities of 
health on the Internet is one effect of the weakening of health and welfare 
provisions under neo-liberal policies. However that does not mean that the 
institution of government is no longer involved. Alliances between health 
promotion campaigns and political activists of health through community 
groups (and there are many examples that might be cited from HIV/ AIDS to 
breast cancer) can target those at risk, (potentially) creating a new 
spatialisation of government through community (Parr 2002; Rose 1996). 
Internet-based communities may take a variety of forms, and unite 
communities of interest in all manner of heterogeneous networks. Of interest 
are the spatial qualities of such sites. Internet-based communities, suggests 
Rose (1996: 333), are diasporas insofar as they exist in a non-geographic space 
through the participation of images, cultural products and discourses that 
are shared amongst members. Such communities may have a shared 
identification or sense of fate, and via computer technologies and the 
networked space of the Internet, inhabit extensive spatial configurations. 
Moreover diasporic communities may be posed as a problem precisely 
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because such communities invoke a reach that is 'global', 'world' or 
'national' (Rose 1996: 333). 
Table 4.1: Selected Carrageenan/cancer resources on the Internet (accessed June 2004) 
Association Internet Address Description 
Crusader Enterprises thehealthcrusader.com  Offers to wield a 'sword of truth in a 
world of lies', through regular 
contributors to an e-zine that claims to 
expose the 'lies' of corporations and 
medical industries. Sell a variety of health 
supplements and accessories. Strong 
religious and natural health overtones. 
Dr. Christine H. 
Farlow, D.C. 
The Healthy Eating 
Advisor 
healthyeatingadvisor.com Offers a range of nutritional advice on 
'healthy eating' from Christine Hoza Farlow 
, a chiropractor with a speciality in 
nutrition. Consumer links to nutrition 
supplements tailored to individual needs 
through biochemical testing of urine 
samples, and books such as Farlow's Food 
additives: a shoppers guide to what's safe and 
what's not. 
Healing Well healingwell.com  Information and resources on disease, 
disorders and chronic illness established 
in 1996 by Peter Waite. Medical 
professional focus. US based but claims a 
global reach. 
HealthyPages and 
Prime Impact Events 
& Media (Ltd) 
- 
healthypages.net Complementary and Alternative Medicine 
directory for the UK, with added 
information resources on topical issues of 
public health. 
Weil Lifestyle, LLC drweil.com Based on the principles of 'integrative 
medicine' claims to treat the 'body, mind, 
spirit'. Consumer products include 
vitamin and mineral supplements. 
Dairy Education 
Board 
notmilk.com  Web site of controversial US anti-dairy 
campaigner Robert Cohen. Extensive list 
of articles opposing milk and other 
products. Contains multiple links to 
vegetarian and vegan organisations. 
A further geographic implication of virtual health provision after Parr (2002), 
has one possible trajectory; that virtual spaces liberate individuals from a 
governmentality of health. In this view, organisations that work together on 
issues of breast cancer, HIV/AIDS or other health concerns may act within 
the discourse of prudentialism; as people who invest in their own well-being 
by sharing knowledge (sometimes exerting influence that is problematised as 
excessive) or by actively resisting government at a distance. The entity that is 
the 'Tobacman carrageenan scare' is an opportunity to examine the workings 
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Of a politics of resistance to consider how websites construct or can be seen to 
participate (or not) in prudent diasporic communities in relation to 
carrageenan, health or other concerns. 
Amongst the first 80 hits from the google search, 20 report the publication of 
the EPH article in 2001 (the majority of which are on health websites); 29 
reproduce the title or abstract of Tobacman's journal articles; four are in-
depth comments from carrageenan-producing companies in relation to the 
Tobacman scare; five are from US based companies which utilise 
carrageenan. Only six health-related websites comment beyond the initial 
media reports about the scare (Table 4.1). 
It is noteworthy that all the companies that respond to the controversy about 
carrageenan's carcinogenicity have a natural health focus. The natural health 
focus of debate is mirrored by the six Internet health sites in Table 4.1, which 
identify questions of carrageenan's natural health status and/or associate 
carrageenan's risk status with particular products recognised as natural 
and/or organic. Indeed, organic soy milk is central to the most outspoken and 
detailed statements against carrageenan (Cohen, R 2004; Weil 2004a). 
Two sites critical of carrageenan contain written material by the same author, 
Robert Cohen, on the sites notmilk.com and healthycrusador.corn 44 . Dupuis 
(2002: 215-218) writes about Cohen's activities as a key activist in an anti-
milk movement and author of a controversial book Milk: the Deadly Poison. 
She describes his book as a 'compilation of every critical statement ever made 
about milk' and, in contrast to the perfection narrative of milk, as a 'classic 
downfall narrative taken to the extreme' (216). In her view, there is a 
similarity to the perfection and downfall narratives in that both attempt to 
create a 'perfect politics' in which no form of compromise or negotiation is 
necessary (DuPuis 2002: 217). Accordingly, it is possible to view the 
• 44 The article also appears in a print edition of Health Crusador, the bi-monthly health newsletter 
'Cnisador' , April 15, 2004. 
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carrageenan cancer scare as embodying a political incorrectness that poses a 
problem for carrageenan's detractors. Before. assessing this proposition, it is 
worth establishing the political tone of the other sites that debate the 
carrageenan scare. One is principally devoted to a lengthy critique of Robert 
Cohen's work and the critique of carrageenan from the founder of Vegsource 
Interactive, a health information site on plant based diets (Nelson 2002). Two 
are alternative health sites that reproduce news articles about the EPH and 
Medical Hypotheses papers with added commentary. Two are question and 
answer sites run by independent health practitioners, but both comments 
about carrageenan refer to questions about the safety of so-called 'natural' 
soy milk. 
Exploring the other side of the debate, two prominent organic soy milk 
companies in the US, White Wave and Eden Foods produced public statements 
critiquing Tobacman's research and statements in support of the research 
(Esko 2004; White Wave Company 2004). Metagenics, a natural medicine 
therapies company based in California, not only argues against Tobacmart's 
findings but, based on research showing carrageenan has anti-viral and 
cholesterol lowering properties, foretells the development of new ,(all 
natural) carrageenan health technologies (Minich 2003). On its website, Toms 
of Maine, a manufacturer of health care products such as toothpaste, claims 
to only use natural ingredients and describes carrageenan as a 'naturally 
sourced material' (Toms of Maine 2004: no page). 
The location of the debates within what might be termed a diasporic natural 
health community (because their scope and reach remain unclear) can be 
seen to unsettle the assumptions about the use of carrageenan as a natural 
product in food, and the 'perfect politics' of such a position. A press release 
issued by FMC Biopolymer in 1999 notes that there has been a trend towards 
hydrocolloids including carrageenan because of a widely-held belief that it is 
a natural ingredient (FMC Biopolymer 1999: no page). The market value of 
natural food products aside, the particular focus on natural and organic 
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products draws on • more desirable rhetorics, and dualisms between 
nature/society. The perfect politics of communities of interest in the reaction 
to the Tobacman cancer scare can be placed in the context of the expansion of 
interest in natural/organic foods and movements more generally. 
The rise of an organic food movement in the US and elsewhere has been 
debated by geographers and others in terms of its significance as a new social 
movement (Cwiertka 1999; DuPuis 2002; Guthman 2003). Guthman (2003) 
describes this debate as one in which the organic Movement is viewed either 
as a form of political opposition to industrial food, or in terms of the 
construction of taste as a product of the manipulation of the consumer 
through relations of production and provision (a broadly Marxist view). One 
difference in the two positions concerns issues of reflexivity and agency. A 
further possibility not raised in these accounts is the desirability of 'natural' 
consumption, and that 'perfect politics' incorporates prudent behaviour in a 
unique way. 
• Of examples related to the case of Joanne Tobacman's work on carrageenan 
and risk, all four themes emerge - political opposition to industrial food, the 
market manipulation of taste, rhetorics of desire, and a reflexive form of risk 
aversion in managing uncertainties that can be associated with discourses of 
new public health. 
Cohen's (2004: no page) diatribe against carrageenan for example, is directed 
as much against industrial culture as it is a defence of natural or organic food. 
The risk associated with carrageenan is embellished through association with 
substances recognisably industrial in character like 'alkali solvents', 
Ivaseline', 'paints', 'monosodium glutamate', 'aspartame' and suggesting 
that 'carrageenan is the magic ingredient used to de-ice frozen airplanes'. 
However while he does question the natural status of carrageenan, Cohen 
also critiques the category of natural. 'Carrageenan is about as wholesome as 
monosodium glutamate (MSG), which is extracted from rice, and can equally 
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be considered natural'. Combining the two so-called risks has the effect of 
intensifying the scare. But at the same time Cohen remarks that 'just because 
something is natural, doesn't mean it is safe ... Got poison? You will if you 
eat the black dots on the 'eyes' of potatoes' (Cohen, R 2004: no page). 
In a similar vein, Dr Mercola's Natural Health website, which advertises its 
credentials as 'the world's most visited and trusted natural health website', 
links carrageenan to risky concerns about processed food. The lone comment 
from Dr Mercola following an expose of the Tobacman EPH article is: 'just 
because a food additive appears to be natural, like something from seaweed, 
does not necessarily mean it is harmless. The general rule: Follow the eating 
plan and minimize processed foods' (Mercola 2001: no page)[emphasis in the 
original]. Although Mercola's statement is an acceptance of certain limits to 
the perfect politics of natural (ergo healthy) food, nowhere is there an 
equivalent expression of compromise or negotiation suggesting processed 
foods might not (always) be harmful. 
The controversy about carrageenan emanating from within the alternative 
health movement is perhaps best represented by the face-off between the 
position of the well-known advocate of 'integrative medicine' Dr Andrew 
Weil, and the response from the macrobiotic/organic food company Eden 
Foods. Eden Foods responds to what its makers deride as 'inaccurate 
information' on the Weil's health website where it is recommended people 
avoid products containing carrageenan (Weil 2004a: no page). The 
. integrative medicine envisioned by Weil is a reaction to what he considers a 
health care system that is now 'dysfunctional', related to the unintentional 
erosion of patient-physician relationships within biomedical models of 
disease (Snyderman & Weil 2002). It is worth reproducing definition of 
Snyderman and Weil's integrative medicine 45 and to consider the overlaps 
with key features of a biopolitics of preventive health: 
45 There is some controversy over the use of the term 'integrative medicine' amongst different accounts. 
I refer here only to the definition used by Weil in (Snyderman Sr Weil 2002) 
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Integrative medicine is the term being used for a new movement that is 
being driven by the desires of consumers but that is now getting the 
attention of many academic health centres. Importantly, integrative 
medicine is not synonymous with complementary and alternative 
medicine (CAM). It has a far larger meaning and mission in that it calls 
for restoration of the focus of medicine on health and healing and 
emphasizes the centrality of the patient-physician relationship. In . 
addition to providing the best conventional care, integrative medicine 
focuses on preventive maintenance of health by paying attention to all 
relative components of lifestyle, including diet, exercise, stress 
management, and emotional well-being. It insists on patients being 
active participants in their health care as well as on physicians viewing 
patients as whole persons - minds, community members, and spiritual 
beings, as well as physical bodies. Finally it asks physicians to serve as 
guides, role models, and mentors, as well as dispensers of therapeutic 
aids (Snyderman & Weil 2002: 396). 
Consumption, preventive health care focusing on lifestyle factors and active 
participation are all virtues of prudent health seekers. The difference is not in 
the constitution of the individual as a cautious subject of risk, but in the 
source and access to a new form of expertise and the spaces of that expertise. 
Dr Weir s website demonstrates a preference for natural and organic 
products, and a series of different forms of ancient wisdom and traditions 
taken from Japan and China. The founders of Eden Foods, established in 
Michigan in the . late 1960s, trace their philosophical origins to the 
macrobiotics movement and the Japanese Zen master George Oshawa. The 
company promotes, and its activities are based on, organic agricultural 
practices and small-scale family farming, organic and 'traditional Japanese' 
foods - including seaweed products. For both companies, the 'commercial 
(re)production of imaginative geographies' involving China and/or Japan tie 
into much more complex rhetorics of desire (Brown, T & Duncan 2000; Cook 
& Crang 2002; Cwiertka 1999). Such rhetorics may modify, and also feed into 
discourses within the new public health. Weil advocates a natural health 
approach to cancer prevention including recommendations about the 
consumption of natural Japanese and organic foods, soymilk, omega-3 fatty 
acids, green tea, and vegetables; and advertises and sells his books and 
nutritional supplements towards this goal (Weil 2004b: no page). Dr Weil's 
approach is a biopolitics of preventive, organic, natural and traditional 
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health consumption. A study of lifestyle magazines and Internet sources of 
CAM in the UK reveals a striking similarity with the Internet sources I 
consulted on natural health and carrageenan, that mass-mediated CAM (or 
integrated health approaches) is at its most fundamental a consumer 
movement, and one that offers new proximities to the new public health 
through a 'sensuous, seductive and erotic world' (Doel & Segrott 2003: 750). 
Moreover, as a newly marketed consumer movement, preventive health care 
focusing on lifestyle factors, alternative therapies and active participation - is 
not dissimilar from representations by Eden Foods. The company statement 
issued 'in response to consumer concerns' offers reassurance that Edensoy is 
safe, healthy, nourishing and that consumers may drink it with 'peace of 
mind' (Esko 2004: no page). Its lengthy retort invokes the JEFCA and FDA 
literature, as well as traditional uses of Irish moss seaweed. A marketing 
executive from Eden Foods writes that the process for extracting carrageenan 
'can be easily duplicated in the kitchen by boiling red seaweed wrapped in 
cheesecloth', and that 'We hold documentation showing that absolutely no 
chemicals are used in producing our carrageenan' (Esko 2004: no page). 
In these views it is not the question of how safety and risk are Measured, but 
another, where health resides, which intrigues. One possible response is 
somewhere outside industrial culture, beyond the medical model, and in an 
'alternative' consumer culture. Doel's and Segrott's (2003) elucidation of the 
phenomenal growth of CAM and integrated medicine approaches in the UK 
asks a question that is also relevant here: (how) are prudent subjects associated 
with alternative health movements? 
A virtual geography of an ecological oncology 
bodies in virtual space ... are open to inscription from the fractured 
discourses which their owners encounter and propagate. Nowhere is 
this more obvious than when considering discourses of health (Parr 
2002). 
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Writing on breast cancer activism in the US and UK Potts, (2004: 144) shares 
with Tobacman a combination of two already-blurred subject positions. 
Tobacman is critical of the lack of regulatory attention to the extracorporeal 
spaces through which breast cancer risk may be assessed and mitigated. Like 
her, Potts identifies as an activist and academic involved in a 'breast 
cancer/environment movement'. She suggests that 'alternative experts in the 
breast cancer/environment movement have undertaken reassessment of the 
date on suspected bio-hazards, by questioning, for example, the ADI 
(acceptable daily intake) assumptions of a suspected carcinogen' (Potts 2004: 
138). Like Tobacman, in advancing her position she advocates enrolling those 
outside the biomedical model. 
In Potts' (2001; 2004) view the re-examination of the aetiology of breast 
cancer involves a fundamental rethinking of the spaces upon which risk is 
inscribed. An 'ecological approach' to public health protection 'shifts the 
aetiological enquiry from the individualized, the personal, the interiorized 
space emphasized by the genetic and screening discourses of cancer, to an 
assertion of the significance of the outer, shared, public space' (Potts 2004: 
135). Potts positions her, research and activism as incorporating a broader 
view of health that attempts to reincorporate the social dimensions of 
disease. In her view, the breast cancer movement has been successful at 
reinterpreting breast cancer as a disease that is experienced by individuals, 
but which is also located within a collective environmental space. Her view 
of cancer activism as a reinterpretation of the spaces of health and ill-health 
however, may be less resistance to dominant discourses of new public health 
than it is an alternative form of relationship consisting of a 'naturalised' and' 
prudent individual to a biopolitics of health. Rather than asserting, as she 
suggests, the legitimacy of 'lay expertise' in challenging the governance of 
health via biomedical models and biopolitics, the example of carrageenan 
suggests it is very difficult to resist the lure of health consumption. Rather 
than an ecological/social view, the 'environment' typified within the 
carrageenan example signifies a reified, imaginary ecological space that 
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offers a safe haven from the toxic 'other' space of contemporary culture. In 
other words, what all these perspectives share, to greater or lesser extent, is a 
biopolitics of preventive health and a dualistic conception of nature/society 
and inability to reconcile the interconnections. Because of the dualistic mode 
of thinking, carrageenan poses problems for the separation between nature 
and society. In one 'domain' it. is a natural product that may be extracted 
from seaweed in the local space of the home and, in the other, is an 
industrially produced food additive. The relationships among consumption, 
neo-liberalism and nature are not evident in the discourses of participants in 
the controversy. 
As it stands, carrageenan's status as a food additive has not greatly suffered 
as a result of negative publicity. I found little evidence of companies turning 
away from carrageenan. Only one, Stonyfield Farm, the largest producer of 
organic yoghurts in the US, modified its production after receiving consumer 
calls that were in response to media reports about Tobacman's EPH article. 
Dianne Godbout, the Consumer Relations Coordinator for Stonyfield Farm, 
informed me in an email communication on 27th March 2002 that 'Our 
quality assurance looked into the report and thought it would be best to take 
the side of caution and remove it from our ice cream and yoghurts'. 
The regulatory status of carrageenan in the US has not been reviewed on the 
basis of Tobacman's findings. However the same is not true in the EU. In 
March 2003, the Scientific Committee on Food (SCF) of the European 
Commission, consisting like JEFCA, of independent qualified experts on 
fields such as toxicology, chemistry, medicine and nutrition, reviewed 
Tobacman's 2001 papers from .EPH and Medical Hypotheses (Scientific 
Committee on Food 2003). Although the report was critical of many (if not 
most) of Tobacman's findings, there was one issue upon which the 
Committee felt further research should be undertaken - the possibility that 
'native' carrageenan could be degraded either by processing techniques or by 
acids during digestion. Like earlier controversies over baby formula and 
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carrageenan mentioned in the previous chapter, the perception of risk in 
Europe was deemed serious enough to warrant a response. Thus regardless 
of the critique of Tobacman's research by the JEFCA, the EU enacted new 
regulations to limit the amount of low-molecular weight carrageenan used in 
food (European Union 2004). The regulations, to take affect in April 2005, are 
based on the report of the SCF which concluded: 'if feasible, a molecular 
weight limit of not >5% below 50 kDa should be introduced into the 
specification, in order to ensure that the presence of any degraded 
carrageenan is kept to a minimum' (Scientific Committee on Food 2003: 6). 
The SCF report did not suggest there should be no degraded carrageenan in 
food, but rather suggested limits on low-molecular weight carrageenan. Yet 
the EU regulation specifically states that 'Carrageenan shall not be 
hydrolysed or otherwise chemically degraded' (European Union 2004). 
Moreover, websites of US based companies that utilise carrageenan represent 
a strict demarcation between the degraded and undegraded forms. For 
example, an Eden Food 'facts report' on carrageenan states: 
There are two types of carrageenan, undegraded (food-grade) and 
degraded (hydrolyzed with acid). Undegraded carrageenan has been 
used on a huge scale in food production worldwide since the 1930s, and 
its safety has been assured by the FDA Gras status ... Chemically 
treated, degraded carrageenan however, is a known carcinogen (cancer 
causing agent) and is not used or permitted in food production, but is 
frequently used to experimentally induce intestinal inflammation in 
animal studies (Esko 2004: no page). 
One conclusion that can be drawn from the Eden Food example is that the 
carrageenan industry has created a rod for its own back in perpetuating a 
politics of singularity and the myth of exact 'types' of carrageenan. While the 
definitions of degraded/poligeenan and undegraded forms were instigated 
in part to allay fears, these definitions may yet fuel further anxieties if (and 
when) degraded carrageenan, in whatever amount and through so-called 
natural processes, is (re)discovered in food. 
Furthermore, assuaging anxiety may involve addressing more than the 
regulatory environment. As I have argued, Tobacman's research went 
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beyond the calculation of risk in directly challenging the risk calculations of 
two of the foremost regulatory agencies worldwide, and advocated active 
resistance to these positions. Tobacman responded to the 'anti-program' of 
the regulatory authorities by seeking to enrol the participation of others in 
her cause. Neither has Tobacman relinquished her campaign against 
carrageenan using the 'power' of politicised natural health/alternative 
communities. 
Duika: Do you feel your research is taken as seriously as it should be? 
Joanne: No, but the regulatory climate is 'loose' and there has been so 
much disinterest in regulation for many years. One of the people I have 
spoken with is Dr Sidney Wolfe, who is Director of the Health Research 
Group of Public Citizen. Public Citizen has been very involved with some 
of the initiatives to remove harmful drugs from the market. I am hopeful 
that they will take on the carrageenan issue as well. 
The Health Research Group of Public Citizen is a consumer advocacy group 
established by Ralph Nader in 1971. As it stands, Public Citizen does not 
publish information on the topic of carrageenan or of carrageenan safety, 
however the attempt can be viewed as an ecological activism in the quest to 
enrol and recruit prudential consumers of health towards her cause. 
Furthermore, industry has entered the contest over carrageenan's 
representation in the 'diasporic' debates on the Internet. FMC Corporation 
purchased the domain name www.carrageenan.info on January 28, 2004. 46 
The website contains information linking to amongst others, the JEFCA 
report that shows carrageenan safe (but not visible are any links to show the 
industry connections of the site itself). A 'google' search on the term 
carrageenan or carrageen in January 2005 returned carrageenan.info as the 
only sponsored link; thus assuring a primary position and 'positive - review' 
for those 'prudential consumers who might seek information using this 
method. 
46Afilias, established in 2001 is a top-level domain registry for sites ending '.info'. The Afilins global 
registry database was searched on a one off basis on January 14, 2005 at http://www.afilias.info/cgi-
bin/whois.cgi. 
120 
Concluding remarks 
In this chapter I have focused on a controversy surrounding the safety of 
carrageenan which I link to the political rationality of risk and its expression 
within the material and non-material dimensions of the new public health. 
Using the network analogy I have shown how, in forging associations 
between speculative calculations of risk, there is a transformative effect on 
carrageenan and the spatial topologies of public health. The chapter has 
described the process through which the valorisation and identification of 
risk accumulate and highlights how different discourses in the new public 
health may come into conflict. In this case study, preventive oncology, 
regulation of risk and prudent consumers of health are all incorporated 
within a biopolitics of preventive health discourse despite conflict between 
them. In particular the chapter has emphasised the emergence of an ecological 
prudentialism that espouses resistance to a biopolitics of health at the same 
time it is incorporated within it. 
I have also explored how risk is constituted through a process of network-
lengthening and translation such that calculations of risk become factors of risk. 
The example of carrageenan suggests that calculating risk is an unstable 
process in which a continuing cycle of programs and anti-programs produces 
greater and greater complexity and uncertainty. The paradox of expanding 
risk assessment is that it becomes harder to prove carrageenan safe. 
Moreover, as public health is increasingly governed through community, the 
location of risk disperses and becomes virtually immutable. 
At the same time, while risks may be masked and/or made proximate by 
other more desirable rhetorics nurtured within consumer culture, the 
prospect of resistance to dominant discourse appears mute. The example of 
cancerous carrageenan suggests that active supporters of the biopolitical 
model are alternative communities that might be more commonly associated 
with opposition to neo-liberal modes of governance. This paradox, is less 
surprising than it may seem as the power of freedom is championed by both 
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ends of the political spectrum. The problem of risk perception associated 
with carrageenan is then related to ideas of freedom and choice - topics 
taken up in the next chapter. 
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Illustration: 'Too much free will', The Guardian 
Source: Thompson (2004) 
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Chapter 5 
Choosing health: What ever 
happenedto the McLean 
burger? 
Our customers will recognise the choice and Variety on the menu and 
that we support them by providing relevant nutritional information so 
they can make informed • decisions. They know their own diet and 
lifestyle best (McDonald's UK Press Office 2004: no page). 
As an enabling technology for the prevention of obesity, a low-fat burger 
introduced to McDonald's outlets in the United States in 1991 would seem a 
win-win for all concerned. In the McDonald's McLean Deluxe burger, 
consumers were able to have their cake and eat it, to consume a fatty tasting 
burger that, thanks to the addition of carrageenan to the ground beef patty, had a 
reduced fat content. In the figure of the McLean, it seemed, the cultural 
dimension of food choice could be bypassed altogether by reformulating the 
extracorporeal space of food rather than expecting or demanding reflexivity 
in the behavioural practices of eating. Health advocates and others were full 
of hope for the expanding low-fat food choices that would follow the 
McLean in the battle against the obesity epidemic. Prospects for carrageenan 
producers in the market for low-fat foods were excellent. 47 The McDonald's 
company could look forward to higher profit margins for McLean products 
than for 'regular' burgers, and could (be seen to) conform to public health 
guidelines. 
The McLean flopped. McDonald's withdrew it from the market in 1996 and 
introduced a premium, fat dense, Arch Deluxe beef burger. Despite the 
return to fat, from the year 2000 onwards, popular press articles reported the 
introduction of numerous so-called healthy food items to McDonald's and 
47 Annual consumption of ground beef in the US in 1991 was 7 billion lb (3.175 billion kg) (Huffman and Stevenson, 
1991). Given that annual production of carrageenan was approximately 9000MT in 1991 (Bixler, 1996) if all the . 
ground beef in the US had been reformulated to be low fat, and if carrageenan been used at the recommended level 
of 0.05% in all burgers, the market for carrageenan would have increased by 1587.5 MT, or 17.6% per annum. 
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other fast-food outlets such as Wendy's, Burger King and Taco Bell. Low-fat 
and low-carbohydrate composition foods, salads, fruits in bags and veggie 
burgers were among the products developed to change consumer 
perceptions about fast-food outlets as unhealthy. However in current media 
accounts about this shift in marketing, the spectres of earlier food 
innovatives, such as the McLean burger, loom large. In articles that 
specifically mention it, the McLean appears as a portent of failure: a symbol 
of the inability of fat-free fast-foods, or new developments low-fat/low-carb 
technologies, to limit the further expansion of waistlines; and of the non-
performance of individuals to meet their responsibilities as self-regulating 
and prudent subjects of risk. 
Despite the development of new technologies such as the McLean, several 
authors have noted how the provision of choice (within a sphere of freedom) 
often fails to reach goals suggested by strategies of prevention (Crossley 
2004; Hallowell 1999; Henderson & Petersen 2002; Valentine 1999). People's 
choices about health and food are known to be extremely complex, involving 
cultural and other factors that extend beyond the rational expectations 
calculated and disseminated in expert accounts (Bell, D & Valentine 1997; 
Brown, T & Duncan 2000; Henderson & Petersen 2002; Murcott 1998, 2001; 
Probyn 1999, 2000; Wynne 1996). The complexity of choice is limited by 
situated social identities, diverse cultural framing of bodies, and variations in 
understanding illness and health in different contexts. What is understood as 
choice is not consistent across different publics or different individuals. Thus 
choice comes into conflict with the aims and discourses of health promotion 
and prevention. 
Taking the contingent nature of choice and limits of freedom into account, I 
now consider what can be gleaned about prudentialism from the failure of a 
technology that promotes choice and signifies freedom. I look beyond 
carrageenan's literal values in modifying the fat content of the McLean, to 
examine its functionality in a symbolic network that incorporates issues of 
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food, health, risk and prudentialism. First, I briefly review the 
problematisation of obesity in setting the scene for the development of the 
Mclean and the spatial configurations it gives rise to. Second, drawing on the 
perspectives of key informants in the carrageenan industry and developers of 
the McLean, I detail the constitution and subsequent failure of the McLean in 
the marketplace. How did the McLean fail? Third, I consider media 
representations of the failure, resurrection and mobilisation of the McLean in 
popular press articles appearing four years or more after it had been 
withdrawn from the market. I examine the discourses of public health that 
underlay the newsworthiness of media narratives. 
The chapter demonstrates that the media reproduce and embody a particular 
risk rationality, which, among other things, (re)constitutes individuals as 
prudent subjects. Furthermore, it highlights how the development of the 
McLean has been drafted anew to tell particular stories about the past, 
present and future of prudentialism and technological food innovation. 
These tasks permit me, in short, to consider the currency of risk in the socio-
political transformation of a 'fast' food and its articulation in a critical 
geography of public health. 
The will to health: obesity and risk 
A politics of urgency and the obesity 'epidemic' 
Concerns about obesity have been present in the Anglo-American sphere 
since early last century. However as Levenstein (1993: 202) documents in the 
US, and equally true elsewhere, these threats were rarely taken to refer to, 
and focus on, the health of populations as has been the case from around the 
1960s onward. In keeping with the discourse of the new public health, 
obesity has become a pressing health issue for populations and not simply 
individuals. Furthermore, there has been an increased attention to moral and 
behavioural conduct of individuals in relation to obesity (Stratford 1998a, 
1998b). 
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Before exploring the health focus of current efforts towards obesity, it is 
worth remembering that the aesthetic of slimness has a long history; take, for 
example, the use in the west of corsetry throughout much of the period from 
the 1500s to the early 1900s (Stratford 1998a, 1998b) or the use of dieting, very 
much in mode from the 1920s (Levenstein 1988: 205). Feminist accounts draw 
attention to the gendered nature of the 'ideal body' within the social context 
of patriarchy that have, at many times and places in history, constructed 'fat' 
women's bodies as transgressing the spaces of the normal; as 'bodies out of 
bounds' (Bordo 1993; LeBesco & Braziel 2001; Orbach 1985) 48. In turn a 
pathologising of fatness as transgressive has led to what as Besco and Braziel 
term the 'trope of the symptomatic fat body' (LeBesco & Braziel 2001: 3). The 
common acceptance of fatness as indicative of negatively ascribed 
behaviours and ways of being in the world places the fat body as a trope for 
all manner of other disorders. Obesity may be cast as an internal problem, a 
lack of will power, a failure of the self. Commonly many people (in particular 
women) pursue the slim body, often at great personal cost, through active 
self-management. Bordo (1993) has argued that anorexia and obesity reflect 
elements of consumer culture - the first as a form of excessive prudentialism, 
the second as excessive consumption. Some feminists have espoused 
resistance to the normalising tendencies of bodily ideals and sought to re-
colonise 'corpulence' as an object of desire and beauty (LeBesco & Braziel 
2001). From all these perspectives it can be seen that obesity is profoundly 
problematised such that it is a geographic issue (Bell, D & Valentine 1997; 
Valentine 1999); a feminist issue (Fallon, Katzman & Wooley 1996; Orbach 
1985) and a sociological issue (Crossley 2004). 
The question of the aesthetics of the ideal body is only one factor in current 
tendencies to pathologise obesity, which is constructed as having serious 
48 Critiques of new health-related discourses about obesity point to pronounced judgements against fatness in 
American society. In Bodies out of Bounds, a collection of essays on fatness, fitness and diet industries, one aim is to 
explore how 'fat' is a socially constructed phenomenon (LeBesco and Braziel, 2001). In the same collection, Hartley's 
(2001) reading explores the gendered nature of fatness, arguing that discourses of fatness apply in particular 
(patriarchal) ways to women's bodies. She suggests normal body ideals for women tend towards smallness, even 
'invisibility'. In this view, fatness is more transgressive for women than is the case for (most) men. 
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implications for the health of the body politic. In the contemporary 
expansion of official health discourses associated with the new public health, 
various institutions, scientists, equipment, reports and means of assessments 
were enrolled in support of a mode of presentation of obesity in which it was 
targeted as an urgent problem for America and for individuals, as it 
simultaneously (re)inscribed the boundaries of normalised healthy bodies. 
The obese body became an act of transgressing not just gender norms, but 
the normalised spaces of 'healthy' bodies such that fat is a 'four letter word' 
(LeBesco & Braziel 2001: 2) increasingly for everyone. 
New public health discourses have increasingly promoted prudentialism 
such that, in the US, 'Every authority, every institution in our society urges 
us to fight our fat' (Seid 1989: 15). One institution producing facts about the 
obesity crisis - representative of the turn to prevention and prudentialism, 
and with a key role in promoting a politics of urgency about that crisis - was 
the US Office of the Surgeon Genera1. 49 The Surgeon General's various 
influential reports on the state of the nation's health have been powerful 
catalysts for regulatory reform in relation to obesity. The Report on Nutrition 
and Health in 1988 and the Surgeon General's Call to Action to Prevent and 
Decrease Overweight and Obesity in 1991 raised the status of obesity to suggest 
that 'overweight and obesity have reached nationwide epidemic proportions' 
(U.S. Department of Health and Human Services 2001: v). Through the 
expertly derived calculations of an epidemic, as Levenstein (1993: 242) 
suggests, obesity had entered the spaces of the already-healthy population to 
become a problem for 'most' Americans. 
Consistent with the preventive turn in new public health, the Surgeon 
General's Call to Action to Prevent and Decrease Overweight and Obesity was 
typical of the problematisation of obesity in that it was measured in relation 
to risk of other diseases. Measurements of population health in terms of 
49 Since 1968 the Office of the Surgeon General in the US has been a figurehead in prevention and health promotion 
strategies. Although originally established as a treatment focused agency, in 1968 the role of the office was reformed 
from bureaucratic management of the Public Health Service (among other responsibilities) to an independent 
advisory body on issues of public health of the nation. 
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mortality rates were augmented by statistical and epidemiological accounts 
of possible future conditions of ill-health. The report suggested that '300,000 
deaths per year may be attributable to obesity', but the potential of other 
diseases provided the evidence to support more extensive preventive actions 
to combat the 'epidemic'. Conditions such as type 2 diabetes, heart disease, 
stroke, hypertension, gall-bladder disease, osteoarthritis, sleep apnea, 
asthma, breathing problems, cancer, high blood cholesterol, complications of 
pregnancy, menstrual irregularities and depression were amongst the health 
conditions that the report suggested could be prevented through weight 
control (U.S. Department of Health and Human Services 2004 50 In 
summarising the contents of the report in this manner, I do not question the 
seriousness of any of the health conditions that are mentioned, but rather 
emphasise how such estimations bring the future to account in the present and 
re-map the relationships among individuals, health, practices of 
consumption and governance in these concerns. From below, prudent 
consumers were incited to action; from above, government efforts focused on 
reforming the food acquisition environment in order that they could act. All 
around, consumer products, convenience foods and profits suggested that in 
the possibility of prevention was also a potential market, and one whose profit 
motivation made any moral commitments to health questionable (Braziel & 
LeBesco 2001). 
The McLean was one material technology that articulated the new public 
health concern with a generalised move towards prevention, through which 
individuals were able to regulate their behaviours. Simultaneously, 
prevention technologies such as the McLean target the fat body as 
transgressing the space of the normal and the extra-corporeal space of 
consumption. The construction of technologies to mitigate obesity in such 
50 Many other reports and public bodies have documented and facilitated the nationalisation of the obesity 
epidemic and turn to prevention strategies. The emphasis has been on risk reduction as exemplified by reports such 
as The National Research Council report Diet and Health: Implications for reducing chronic diseases and risk (National 
Research Council, 1989). The reports emanating from the NRC and other public health institutions are also 
underlain by scientific calculations of risk, identifying such things as the increased consumption of energy through 
fat and fat components, and the growing medical awareness of links between fat consumption and coronary heart 
disease and cancer. 
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manner (re)produces a particular vision of bodies and their relations with 
health, and extra-corporeal spaces and lifestyles as targets for mitigation. 
Provision, promotion and surveillance: hallmarks of prevention 
In 1989 the US Institute of Medicine (IOM) established a Committee on 
Dietary Guidelines to determine the best way to change eating patterns and 
reduce diet-related chronic illnesses (Institute of Medicine 2001). The TOM 
report was published in 1991 and identified three tactics for achieving this 
aim. The first was to alter the food supply by subtraction, addition and 
substitution to foods. Modifying the food supply included reducing fat in 
meat and cheese (subtraction), fortifying foods with nutrients (addition) and 
replacing fat in foods (substitution). The second tactic involved 'altering the 
food acquisition environment' by providing a variety of food choices greater 
than normal, labelling food to increase consumer information (chapter two), 
and giving point of purchase advice (Institute of Medicine 2001: 25). The 
third tactic suggested modifying nutrition advice from both public and 
private health information services. 
Healthy People 2000, a report issued by the US Public Health Service, 
supported the aim of food modification. Significant for the food industry 
were prescriptive statements to 'increase to at least 5,000 brand items the 
availability of processed food products that are reduced in fat and saturated 
fat', from the 2,500 reduced fat items that could be purchased in 1986 (US 
Department of Health and Human Services 2000: 125). While public health 
discourses were promoting reduced fat foods, various consumer groups, 
including the Centre for Science in the Public Interest (CSPI, see chapter 
two), had also stepped in to the fray to assist in producing and marketing 
more fat-modified foods. Dietary recommendations targeted high fat foods 
and recommended replacement with low fat alternatives (Peterson, S et al. 
1999; Schwenk & Guthrie 1997). 
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In a political environment characterised by obesity-angst, various new fat-
replacement technologies were developed throughout the 1980s and 1990s 
(such as Olestra51, Salatrim52, Microparticulated Protein Product (MPP) 53 and 
Fantesk54) but each required testing and regulatory approval before use. 
With a long history as emulsifier, stabiliser and thickener, carrageenan was 
already an approved substance for foods. In the early 1990s carrageenan 
began to be marketed as one of the first of a range of fat-replacement•
technologies (Kurtzweil 1996) 55. In the meat industry for example, 
carrageenan began to be more widely used in the 1980s and 1990s as 
Stancioff explained: 
The USDA is involved with anything to do with meat. So the recipes 
have to be known and approved by the USDA. So if you want to pump 
carrageenan into ham, you are out of luck unless you get permission 
from USDA; they were reluctant to do that, adding water to ham. But 
then with all this trend toward low fat and low calorie they began to 
allow things like carrageenan and other substances and phosphates and 
salts to be used, not only as preservatives, but to hold moisture to retain 
plumpness of meat, sometimes just to reduce the fat content (Stancioff, 
pei.s.comm., 15 June, 2002). 
Thus carrageenan producers were among the first to benefit from the risky 
opportunity of fat-modified foods in the name of a product that would be 
'win win' for government, industry and for the nation's health. New public 
health concerns with promotion, prudentialism and prevention legitimated 
increased modification of food, led by health experts and regulators. It was 
into this favourable space that the McLean emerged. 
51 From the initial subnUssion to the FDA for approval of Olestra in 1987 it was not accepted as suitable for food 
until 1996 (Ralston, 1996). 
52 Salatrim an acronym for 'short and long-chain acid triglyceride molecules' is a , family of fat-replacement 
technologies that was filed with the FDA in 1994. 
53 A protein based substitute used commonly in dairy foods, designed specifically for fat-replacement and came 
into common use in the early 1990s. 
54 Developed by the USDA and based on a combination of starch or gum with small amounts of oil. The sole rights 
for production were sold to the Opta-food company in February 1995. 
55 The early fat-replacement technologies used carbohydrate as the major ingredient. Avicel, a cellulose gel, 
Carrageenan, and Litesse, a polydextrose substance are recognised by the FDA as the 'first' fat-replacers. All three 
products had a long history of use in food for other purposes. Avicel as a food stabilizer, Carrageenan as an 
emulsifier, stabilizer and thickener, and Litesse as a humecant. 
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A technological fix: the McLean Deluxe 
Die McDonald's McLean Deluxe: 1991-1996 (RIP) 
In March 1991 McDonald's introduced a new beef burger based on a 
formulation called AU Lean: the McLean Deluxe. AU Lean was the creation 
of researchers at Alabama Agricultural Experiment Station at Auburn 
University (Bixler 1996; Shell 2002; Stevenson 1991) in collaboration with 
FMC - the parent company of the carrageenan processing company FMC 
Biopolymers referred to in preceding chapters (Bixler 1996: 42). 
The AU Lean formulation of ground beef, 0.5% carrageenan, 0.2% 
hydrolysed vegetable protein, 0.4% salt, and 10% water, was reported to 
have less than 10% fat and approximately half the calories of a 'regular' 
burger (Egbert et al. 1991; Huffman & Stevenson 1991) 56. The key to the AU 
Lean was carrageenan, the water binding properties of which overcame the 
problem of dryness that would be associated with fat reduced beef that had 
no additives (Egbert et al. 1991; Troy, Desmond & Buckley 1999). Consumers 
were consulted and surveyed using statistical comparisons between the 
McLean and a 'regular' burger (Table 5.1). The results suggested the 
developers were on to a winner. 'Eating qualities were rated on a 1 to 8 scale 
(1 = extremely undesirable and 8 = desirable) and other qualities are given as 
percentages' (Huffman & Stevenson 1992: no page). In the 1980s and 1990s 
demand for beef 'plummeted' in the US as consumers were reported to have 
responded to increased concern about cholesterol and turned away from beef 
(Levenstein 1993: 253); hence the economic imperative to boost sales. 
AU Lean was touted as a revolution in food and immediately targeted at 
particular publics. According to developers, the McLean appealed to people 
who were not already conscious about dietary fat. 'A large segment of today's 
consumer population is health conscious and concerned about dietary fat. 
56 The study was funded by the Beef Board and Alabama Cattleman's Association and managed by the Beef 
Industry Council of the National Live Stock and Meat Board. 
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These consumers avoid meat products with a high fat content, such as 
ground beef' (Huffman & Egbert 1990: 5). 
Table 5.1 Results of consumer survey of AU Lean, Alabama Agricultural Experiment 
Station 1999 
Eating Traits 20% Fat I AU Lean 
Juiciness 5.8 6.7 
Tenderness 5.6 6.6 
Flavor intensity 5.2 6.4 
Overall acceptability 5.4 6.8 
Cooking Traits (%) 
Moisture 55.8 66.3 
Fat 19.2 8.2 
Protein 24.8 24.5 
Source: Huffman and Stevenson 1991: no page. 
Targeting ground beef implied that those consumers who had made the 
switch away from beef would return to beef, and those who continued to eat 
high fat ground beef, if enabled though provision, would become more 
prudent. Targeting fast-food outlets mapped onto particular spaces and 
publics as at risk: AU Lean was investigated in a USDA pilot study for 
possible use in the National School Lunch Program, and for hamburgers in 
Disneyland and Disney World theme parks (Stevenson 1991: no page). All 
three locations appeal to mass audiences and, while it may be overstating the 
significance of the particular place-based settings, in these locations the 
McLean targeted particular consumers - children and those already partial to 
a style of consumption in the manufactured 'real' 57. As Baudrillard has said 
of Disneyland, 
Disneyland is there to conceal the fact that it is the "real" country, all of 
"real" America, which is Disneyland (just as prisons are there to conceal 
the fact that it is the social in its entirety, in its banal omnipresence, 
which is carceral). Disneyland is presented as imaginary in order to 
make us believe that the rest is real, when in fact all of Los Angeles and 
the America surrounding it are no longer real, but of the order of the 
hyperreal and of simulation (Baudrillard 1988: 154). 
571 refer here to Baudrillard's theory of simulation in which he advances the proposition that we have entered an 
era of consumption where models of the real have replaced the real. Baudrillard blurs the distinction between the 
two, suggesting that Disneyland is now the model for what 'real' America is (Best & Kellner 1991). There are 
interesting overlaps in the constitution of the McLean in terms of questions of 'authenticity' and the boundaries 
between what is consumed as a simulation and what is 'real'. In this view, the constitution of the McLean may be 
considered as the model of an ideal burger, such that the criteria for a fat-laden burger is thereafter made by 
comparison with the McLean. 
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Like Disneyland, the McLean is a simulacrum that conceals the carcereality 
of food choice. The McLean also conceals the uneven geographies of 
consumption, how eating burgers at McDonald masquerades as free choice 
but is bound by the power of market forces and advertising budgets; and the 
(uneven) dependencies on lifestyles of convenience and fast-foods. It is 
worth reiterating Dean's (1999a) contention that factors of risk often map 
onto older social divisions such as class and disadvantage, as 'well as 
between populations whose members actively seek such things as 'low-fat' 
alternatives and those targeted for interventions because they do not. For 
people on limited budgets, higher fat foods are commonly cheaper such that 
food choice may be linked to economic disadvantage (Valentine 1999). 
Moreover, as discussed in chapter two, children's bodies are subject to a 
greater intensity of risk surveillance and intervention than is generally the 
case for adult bodies. While the McLean was an intervention intended for 
certain publics, consistent with the new public health, the whole population 
came under the public health and manufacturers gaze: the McLean acts 
across geographical scales that encompass both the micro-terrain of bodies 
and through the (re)construction of social spaces of inequality and 
universality. 
The developers of AU Lean saw the McLean as just a first step in a range of 
foods to allow American consumers in general to have their cake and eat it 
too. A 1991 press release from the Auburn University suggested that the 
AU Lean story is not just about a one-time, one-product development. 
Plans call for a family of meat products that will offer American 
consumers healthy diet options without giving up the meat they desire 
(Huffman (Sr Stevenson 1991: no page). 
Moreover there was a high priority attached to achieving the goal of 
provision. The construction of obesity as an 'epidemic' generated a politics of 
urgency about developing modified fat products. For the McLean, the 
normal trial period that would pre-empt the introduction of a new food 
product was expedited: 
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As might be expected, commercial acceptance of AU Lean came in a 
hurry. McDonald's was first, going nationwide in March 1991 with its 
own version of the Auburn mixture after a short marketing test in 
selected cities. This burger, selling under the trade name McLean 
Deluxe, is now offered in 8,800 outlets and is gaining wide acceptance 
(Huffman & Stevenson 1991: no page). 
According to Huffman and Stevenson (1991) the reason for the burger's 
speedy introduction was the broad-based and pressing concerns about 
nutrition and health that, because of the dominant market position of fast-
food, provided the greatest opportunities for fast results. 'The fast-food 
industry was the first target for acceptance of AU Lean, since this represents 
the largest market for ground beef. Getting a low-fat, healthy hamburger into 
the fast-food chains was thought to offer the greatest potential impact on 
nutrition and health' (Huffman & Stevenson 1991: no page). New public' 
health works through a heterogeneous assemblage of factors in which the 
McLean was embroiled. The desire to produce a low-fat burger was 
associated with governmental ideas of health, consumer concern about 
cholesterol and the decline in demand for higher fat beef. Notwithstanding 
the commercial urgency experienced by the McDonald's company in the 
effort to deal with competitors and be the first fast-food outlet to produce a 
low-fat burger, the sense of urgency to achieve this aim was amplified by the 
turn to the new public health and calculation of obesity as an epidemic. For 
the development of the McLean, the sense of urgency was compounded even 
more because of McDonald's iconic status in these concerns, which 
subsequently fuelled consumer initiated bad press for McDonald's, the 
passage of the Nutrition Labelling and Education Act (NLEA), and targeted 
interventions on fast-food. 
In April 1990 one of a series of unfavourable full-page advertisements 
directed against fast-food, and in particular McDonald's, appeared in leading 
newspapers58 around the US. One advertisement was headlined, 'The 
58 The advertisements appeared in among others, the New York Times, Washington Post, USA Today and Wall Street 
Journal. 'The Poisoning of America' advertisements focused on McDonald's, but attacked all fast-food chains for 
high levels of saturated fat and cholesterol. Sokolof was identified as a 'crusader' who was motivated by his 
experience of a heart attack which he attributed to.poor diet (Gibson 1990) 
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Poisoning of America! Part III'. The advertisement included a picture of a Big 
Mac hamburger and some McDonald's french-fries with the statement 'your 
hamburgers have too much fat' (Gibson 1990: B3; McKee 1992: 30). Phil 
Sokolof, multi-millionaire founder of the National Heart Savers Association 
(NHSA) and food activist, sponsored the advertisement reputedly 'to 
persuade McDonald's to come out with a reduced-fat hamburger (the 
McLean) and Congress to pass the Nutrition Labelling and Education Act' 
(McKee 1992: 31). In 1990 the exact details of the NLEA labelling 
requirements for foods had not been formalised, it was known that the total 
calories derived from fat per serving; as well as the grams per serving of total 
fat, would be required on food labels (Figure 5.1). 
At the time, the Food Marketing Institute (FMI) was one of many 
organisations that argued that saturated fat had become the major concern of 
US consumers. A feature story in the food industry magazine Food Product 
Design reported that: 
The food industry is responding to consumers' demand for lower-fat 
foods by developing low-calorie fat replacers. The urgency to provide a 
nutrition-conscious public with lower-fat foods will be even more 
pronounced when the amount of fat and unsaturated fat in foods is 
required on labels (Willkes 1991: no page). 
While industry members claimed that consumer pressure provided the 
impetus for the changes, the urgency for low-fat foods was further 
intensified by the imminent possibility that, with the visibility of such 
concerns, consumers would become informed and increasingly self-reflexive 
about their food choices in relation to fat in meat and other products. 
Nutrition Facts 
Serving Size: 1 sandwich • 214g 
Amount Per Serving 
Calories 340 
Calories from Fat 
108 
  
% DV 
   
Total Fat 12g 	 18% 
Saturated Fat 4.5g 	 22% 
Cholesterol 60mg 	 20% 
Sodium 810mg 	 34% 
12% 
8% 
Sugars 8g 
Protein 24g 	 48% 
Vitamin A 8% 	• 	Vitamin C 15% 
Calcium 15% 	• 	Iron 25% 
*Percent Da ilg Values (DV) are based on a 2,000 caloi re diet. Your dailg 
value mag he higher or lower depending on your calorie neeth: 
	
2,000 	2,500 
Nutrient 	 Calor is 	Calories  
Total Fat less than 	65 g 80 g 
Saturated Fat 	less than 	20 g 	25 g 
Cholesterol less than 	300 mg 	300 mg 
Sodium 	 less than 2400 mg 	2400 mg 
Total Carbohgdrat es 	 300 g 375 g 
Fiber 	 25 g 	30 g 
1 g Fat = 9 calories 	1 g Carbohgdrate = 4 calories 
1 g Pro tein = 4 calories 
Percent of Calories from: 
Fat-31.8% Carb-43.5% 
Protein-28.2% 
Total Carbohydrate 
37g 
Dietary Fiber 2g 
Figure 5.1 Nutrition Label for the McLean 
Source: McDonald's pamphlet 1991 
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In summary, the McLean was a micro-technology for the management of an 
issue in public health of particular populations, conceived at the macro-scale 
of population health (see Rose 1999: 5). The burger was entangled in an 
assemblage of risk calculations and a will to prevention from above and 
below that was intensified through making fat visible (in certain ways), and 
augmented by the active participation of individual prudent citizens and 
organised groups such as the NHSA and the CSPI. The McLean was 
conceived as a meticulous simulacrum, arranged and designed to achieve 
what prudentialism on its own could not - a scientific and technologically 
inspired provision of choice in places already choice disadvantaged. 
Simultaneously, the fast-food joint is represented as a governable space with 
particular characteristics, amenable to governmentally inspired investment 
in its reformation. 
Initially the McLean was welcomed by consumer groups concerned with 
health and attracted considerable media attention. Phil Sokolof described the 
McLean as a 'victory for the American people' in an ABC World News report 
on March 15, 1991. The CSPI maintained its positive stance on the new 
development into 1995, as reported in the Chicago Sun-Times. 
McDonald's McLean Deluxe has the best nutrition profile of all fast-food 
burgers, according to a study released by the Center for Science in the 
Public Interest, the group that brought you news of the best and worst 
Chinese, Mexican and Italian food and movie popcorn. You could eat 
five McLean burgers, the center says, and still not get the fat you'd find 
in one Burger King Double Whopper with cheese (Chicago Sun-Times 
1995: 10). 
However, almost immediately questions began to arise about the McLean in 
popular press articles concerning a variety of fears about its consumption 
that revealed other dimensions of food choice. The body is 'geography 
closest in', marking the boundaries between self and • other, inside and 
outside. Within cultural geography food is recognised as a liminal substance 
that may be simply mundane sustenance or may embody values and 
associations that, through eating, cross the boundaries of body geographies 
(Cook 1996; Guthman 2003; Probyn 1999; Valentine 1999). In this way the 
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process of eating can involve the incorporation of desires and dreams, or be 
'invasive, intrusive and contaminating' (Valentine 1999: 334). As such, food is 
recognised as a powerful metaphor for an ethics of existence (Probyn 2000). 
The McLean appeared in media articles as contaminating the body through 
association with technology as other to nature and society. A New York Times 
article linked the development of the McLean with dystopian images drawn 
from science fictional characters heralding a new era of functional foods. 'A 
technological triumph, maybe. But is America ready to eat like the Jetsons? 
... Food technologists see the McLean as a precursor to simulated fish fillets 
• and french fries fortified with cancer-fighting phyto-chemicals' (O'Neill 1991: 
1). 
Other articles referred to the polluting potential of the McLean as an all too 
natural 'seaweed burger' (Peterson, L 1991; Schlosser 2001). A Washington 
Post report detailed a television advert for Hardee's fast-food chain in which 
a Hardee's restaurant manager stated, 'I've heard that McDonald's uses 
seaweed and additives, and we would never consider using fillers, flavor 
enhancers, [brief pause] seaweed ...'. Except as a food additive seaweed is not 
commonly consumed in the US and the incitement to disgust revealed 
deeper cultural, moral and ethical orderings associated with .food choice 
(Miller, WI 1997; Probyn 1999). Hardee's advanced such fears to promote the 
goodness of its own low-fat burger. Moreover, in the same article the 
Washington Post writer exposes his xenophobia by casting seaweed as an 
ethnicity capable of a polluting effect; 'Japanese' food: 
I called McDonald's. 
I spoke with their head chef, Toshiro Fujitsu, and ... no, I'm just kidding. 
Actually, I spoke with Terri Capatosto, director of 'media relations 
(Kornheiser 1991: F1). 
The cultural and aesthetic dimensions of food choice and questions of the 
McLean's authenticity were among factors that limited the chance of its 
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success. The developers considered the McLean had been 'tailored to meet 
the needs of the diet conscious consumer' (Huffman & Egbert 1990: 27). From • 
this viewpoint, people would eat the McLean because it was a rational, 
healthy choice; because no change was required in sensorial taste; and 
because the reconstitution of the McLean does not modify cultural values of 
eating a fast-food burger. Given its rapid rejection, the last concern was 
clearly disputed as soon as the McLean entered the market, however there 
were more than cultural and aesthetic reasons for this. 
The McFlopper 
... after a year on the market and an estimated [US]$70 million in 
research and marketing costs, the McLean Deluxe apparently doesn't 
have many people biting. Call it the Flopper (Farhi 1992: D10). 
In February 1996, the McLean was withdrawn from the market. In a 
presentation to the 15th International Seaweed Symposium (published in the 
journal Hydrobiologia), Bixler summed up his reading of the McLean burger 
as a marketing disaster: 
The McDonald's McLean hamburger was a marketing mistake as will be 
many of the hydrocolloid fat substitutes that have flooded the market in 
recent years. In the case of low fat hamburger[s] the marketeers forgot 
that people don't go to McDonald's for nutrition; they go for fast service, 
uniformity, and a familiar taste or mouthfeel. And they certainly weren't 
highly motivated by the higher price McDonald's decide to charge for 
the• product. FMC (Philidelphia, PA, US) and Auburn University 
(Auburn, AL, US) collaborated on what was certainly a technical tour de 
force, but J.Q. Public wasn't impressed. Iota carrageenan will swell in 
cold water, so it can be mixed with fresh ground beef. It also has enough 
fat-like characteristics and moisture binding ability to make up for some 
of the lost succulence and the dry taste of lean beef hamburgers, but it 
still was not enough to mimic the attributes of a regular-fat-content 
burger (Bixler 1996: 42). 
In Bixler's view various factors contributed to consumers' rejection of the 
McLean: McDonald's was not a suitable venue for nutritional food; the burger 
was rated lower than other products in terms of its monetary value; and, while 
its technological sophistication was impressive, it did not provide sensory 
experience equivalent to a full-fat burger. Based on these concerns the 
consumers' choice not to consume was rational. 
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Indeed others in the food manufacturing and carrageenan industries 
suggested that the technology had fundamental flaws associated with the 
failure to adequately test the new burger before its introduction (Thorn 2002: 
102). One key informant from FMC Biopolymers suggested that the 
McDonald experience was that they replaced fat in hamburger, which is 
fine for a freshly cooked burger, but it doesn't age well on the heating 
rack with infrared lights on it (Foss, 2002, pers.comm., 20 June). 
Under conditions likely to be experienced in a fast-food outlet, where 
products must withstand time under heat, the McLean shrivelled like 
seaweed drying on a beach, and the advantages of carrageenan were lost 
such that the texture became as one commentator put it, 'like a hockey puck' 
(Shell 2002: 197). 
Moreover, the low-fat market was viewed by some within the carrageenan 
industry as a food fad that, with or without the McLean, was unlikely to 
represent any long-term change in food habits. Using the example of various 
other diet-related products, Bixler (1996) demonstrated the boom and bust 
nature of diet-related food products containing carrageenan (Figure 5.2). 
YEAR 
Figure 5.2 Industry representation of fast-food failures 
Source: Bixler 1996: 42 
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In an interview that I conducted with Bixler in 2002, he reiterated the faddish 
nature of diet foods: 
you know, we go through fat foods every 5 years it seems, and that low 
fat craze did lift the carrageenan demand, but it fell just about as quickly 
as it lifted it, it's not all that popular today (Bixler, 2002, pers.comm., 16 
June) 
The boom and bust nature of diet products, an approximate five year cycle in 
relation to the carrageenan products in Figure 5.2, occurred during the 
period identified as the new public health with its characteristic prevention, 
promotion, prudentialism and multi-causal approach to risk factors (Brown, 
T & Duncan 2002). Figure 5.2 suggests that diet products such as Metrocal, 
Cambridge Diet, Slimfast and the McLean had instant market impact, but 
ultimately failed to capture public imagination - they were not durable as 
material technologies of prevention. All 'failed' in the market. The 
enthusiasm followed by rapid decline in the shape of the demand for snack 
pack and Cambridge does suggest a boom-bust consumer product; however 
the curve in the McLean and Metrocal indicates that these products were 
(slightly) more enduring. Arguably, this pattern could be related to 
prudentialism and the enthusiasm of consumer groups for the McLean, or to 
individuals adopting the McLean as a 'prudent' choice. 
A second feature of the graph is the unmistakable success of the real 
winners' - processed turkey and ham (Bixler 1996: 42). These products are 
also low-fat with the addition of carrageenan, but are not promoted for low-
fat qualities as diet products, but for monetary value, demonstrating the 
rationality of economic choice. Moreover the success of processed turkey and 
ham can be partly attributed to the changed regulation's regarding the use of 
carrageenan in food 59; a present and unintended effect of risk discourse 
about prevention. Taking these points into consideration, the successes and 
59 Use of carrageenan in poultry products is also attributable to new processing methods developed in Europe to 
maintain the moistness and texture of cooked products. It is not accurate to suggest that the use of carrageenan in 
poultry can be attributed directly to regulatory change, however it may be one factor in its acceptance. 
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failures of diet products suggest that prudentialism also has a geography and 
one that does not easily map onto groups already marginalised by their 
socio-economic status. Low-fat may be less a rational choice based on 
aesthetics or health than one based on economic hardship and social milieu. 
To this point, I have explored the constitution and mobilisation of the 
McLean as a governmental technology of health promotion and prevention. 
Individuals were enrolled, mobilised and constituted as prudent consumers 
and, through consumer pressure groups, were engaged to support the 
McLean's speedy development. I have suggested that the McLean was a 
failure in technological and cultural terms, and that its mobilisation as a 
consumer health product limited its chance of success. On this basis, it may 
be considered rational that consumers did not buy it. As various 
commentators have noted, risks may be debated and constructed as 
universal by experts, but they are experienced in particular and local settings 
(Brown, T & Duncan 2000; Lupton 1999a; Valentine 1999; Wynne 1996). For 
the McLean, as well as being a technological failure, the universalising 
tendencies of the new public health did not match up with the realities of 
everyday life. 
Media and the McLean 
Was the McLean simply introduced too rapidly? Certainly its technological 
shortcomings might have been ironed out with more research and 
development, but is it possible that individuals were not ready for the 
McLean, that they were not yet sufficiently prudent to accept the modified 
food environment? Examining media articles that have appeared• between 
March 1999 and March 2004, I address Brown and Duncan's (2002) concern 
for the workings of the new public health, by exploring how individuals 
respond to prudentialism in the wake of the McLean's failure. 
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In March 2004, I searched LexisNexis 60, a comprehensive database of global 
new sources, which includes newspapers, news transcripts, wire services, 
trade journals, and newsletters, for the terms 'McLean' and 'McDonald's' in 
the previous five years (a period returning sufficient data for analysis, and at 
least two years after the McLean had been withdrawn from the market). The 
LexisNexis search produced 83 hits, of which 70 were domestic US sources, 
seven Canadian, three international (no place identified), one Indian and one 
Australian. The American domination of media accounts is reasonable given 
that the McLean burger was only introduced into the US market. All of the 
articles about the McLean appear between eight and 13 years after its 
introduction, and four to seven years after it was withdrawn from the 
market. In all of the media accounts, the McLean burger is history such that 
its incorporation in these stories immediately suggests a concern or interest 
in failure of the prudent subject - in effect also stabilising the discourse of 
prudentialism. 
Despite the evidence suggested by key informants in the carrageenan 
industry, not one of the 83 articles about the McLean mentions its 
technological shortcomings. Only one, in the Canadian broadsheet The 
National Post, enunciates any negativity about flavour or textures of the 
McLean, and even there the suggestion is disputed. A lone paragraph quoted 
the expert opinion of Professor Anderson from the Department of Nutrition 
at the University of Toronto: '"I liked it", he recalled, "It had freshly sliced 
tomatoes and a meat patty with a plant-based binder in it that made the meat 
stick, in the absence of much fat. But it flopped. People complained it tasted 
like cardboard" (Hutchinson 2003: A10). The article suggests that consumer 
complaints were in contradistinction to his so-called expert view. That expert 
opinion favoured the view that failure was consumer driven rather than 
derived from any technological shortcomings of the burger. 
60 LexisNexis is a searchable database of more than 5000 global media sources. 
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In the articles I surveyed the McLean was no longer represented as a failure 
of a technologically innovative health product, or as failing because of its 
entanglement with the politics of acting at a distance. Significantly, the 
omissions of blame associated with the technology are replaced by blame 
that reconstitutes failure in the terms of discourses of the new public health. 
As Rose (1999: 32) suggests, 'governable spaces are not fabricated counter to 
experience; they make new kinds of experience possible'. Failure is not 
counter to the goals of new public health as its appropriation confirms the 
ideals of prudentialism. In contemporary media articles, the McLean is 
subject to flaws that reinforce the new public health, an exploration of which 
now follows. 
Like industry perceptions of the McLean's failure noted earlier, media 
articles emphasised marketing mistakes - and the failure on the part of 
McDonald's to understand what consumers wanted. In these views, 
members of the public either did not respond to the product as marketing 
experts anticipated, or had not been consulted: 'Food companies misjudged 
the public's appetite for nutritionally conscious products, generating such 
notable flops as Kellogg's low-fat Pop-Tarts, Kraft's reduced-fat Chips Ahoy 
and the. McDonald's McLean Burger' (Ignelzi 2004: 1). In this view, the 
'public's appetite' is reinforced as a catch-all phrase, suggesting, like new 
public health discourse, that there is or should be a unified public view on 
nutrition that is irreducible to situated experience of individuals in their 
daily lives. Yet other press reports suggested that fast-food companies had 
not conceived the hard sell required to modify consumer behaviour to this 
mode of thinking. One such article in the US edition of the Economist 
magazine stated, 'Selling unhealthy products may be difficult ... but selling 
health can be tough too' (The Economist (US) 2003: 12). In such a view 
marketing food depends on the active construction and sale of food as 
health-related. Arguably, consumers might not consider fast-food in such 
terms. 
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None of the articles that was analysed from the LexisNexis search mentioned 
consumer food choices in terms of the sorts of 'faddish' behaviour 
emphasised by Bixler. Food consumption was not then viewed in purely 
cultural/ aesthetic terms. However reference to consumer interest was a 
different matter. The media reported that 'consumers didn't bite' (Vilbig 
2001: 12); that 'it fell flat because of low demand' (Evans 2004: F1); that 
'nobody bought it' (Gharib & Yastine 2003); that 'it went nowhere' (Stainsby 
2001: no page); had 'anaemic sales' (Ecke 2003: 1A); and just 'didn't fly' 
(Rector 2002: 3F). 
Despite suggesting the McLean was a failure because of factors to do with 
marketing and consumer taste, blame was a common sentiment in many of 
the articles. Amongst media, industry and individuals accounts, the lack of a 
will to health is a shared strategy of blame. According to an article in the Copley 
News Service, a syndicated organisation feeding stories to various media 
sources in the vicinity of San Diego, consumers are not yet 'nutritionally 
conscious' (Ignelzi 2004: 1). Others point to the 'bloated prices' of the McLean 
in relation to other burgers, reducing consumers' perception of 'value' 
(Evans 2004: F1). From these perspectives the McLean was at least in part, a 
failure of the consumer to consume. 
Some authors questioned the morality of companies, one pair asking, 'Are 
the food companies serious, or merely engaged in public relations?' (Johnson 
& Fauber 2003: 01A). The difference between responding to consumer 
demands and public relations is moot, and yet the question is meaningful in 
that it suggests a distrust of the company's will to health. In an about-face 
from previous expressions of support for the McLean, the CSPI Executive 
Director argued: 'What the processed food industry wants is to get people to 
continue to eat processed food ... they don't care if the foods cause obesity or 
not' (Johnson & Fauber 2003: 01A). Other authors are forthright in suggesting 
that new food introductions are cynical exercises on the part of McDonald's 
to deflect criticism from obesity lawsuits, media, government and the public. 
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In this view, changes were not consumer-driven in the sense one might 
normally attribute to that phrase, but a response to obesity-related law-suits, 
or the healthy profit margins achievable from the production and sale of 
modified food products. 'McDonald's, like other chains, denied its changes 
have anything to do with lawsuits. "It's really all about the customer and the 
feedback that we've been receiving from the customer," says spokeswoman 
Lori Miller' (Evans 2004: F1). Such views focus responsibility for health on 
the consumer and construct economic space as merely responding to, and 
not constructive of, governmental spaces of health. The laws of supply and 
demand, and not of the new public health are what govern economic space. 
Hence as Rose (1999) has pointed out, economic space has its own temporal 
and spatial configurations under neo-liberal systems of governance, to which 
governance of spaces inscribed by such discourses as new public health, are 
expected to defer. 
While I have emphasised various public health concerns as they underlie 
contemporary images of the McLean, media accounts representing food risks 
often resort to controversy and dramatisation to increase a story's 
newsworthiness (Fowler 1991; Lupton 2004). In the articles I surveyed, the 
McLean was symbolically used, via accounts that appeared at the time of its 
introduction, to discredit new food modifications through dystopian images 
of frankenfood, culinary alchemy, a lab creation, from a test tube exhorting the 
experimental nature of such introductions. Some noted that there was no 
choice about such innovations, since food changes were already in 
development in the laboratories and marketing institutes of the various 
companies, and were inevitable because of the significant investments in 
their development. On the other hand, science was also presented in positive 
health terms, some authors noting the rise in popularity of 'functional foods' 
- or foods with added health benefits (May 2003: 1). The construction of 
nature/science in these accounts wavers, and exemplifies the difficulty of 
maintaining such dualisms as reified (Murdoch 1997). 
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Choice and the technological fix 
Unlike articles that appeared at the time of the introduction of the McLean, 
none of the later coverage mentions cultural concerns about 'seaweed' or 
taste. Upon reflection, these elements of an aesthetic-expressive dimension of 
the McLean vanish from popular accounts. In the mode of self-governance, 
the McLean is redeployed to promote prevention, choice and the 
technological 'fix', even in the face of disappointment. 
Like the critique of consumers' failure to embrace the McLean, the prospect 
that consumers or companies have the ability to change to new food 
products was represented in media accounts with a high degree of 
scepticism. 'Today it is far from clear whether the public will embrace the 
next generation of lower-fat brats [bratwursts] and McLean burgers ... 
Already there is ample evidence that it won't be easy for food companies and 
the public to change their ways' (Johnson & Fauber 2003). In this view the 
McLean exemplifies how consumers are (already) 'flawed' such that 
innovative health technologies (IHT) have little chance of success. However, 
some authors also deemed that choice was pointless because the 
development of IHTs was not really about healthy food choices anyway: 'as 
with the low-fat food trend of the '80s and '90s, people are flocking to low-
carb products with the misguided notion that these foods will automatically 
help them lose weight'• (Ignelzi 2004: 1). Some articles went so far as to 
suggest that fast-food and healthy food might be 'mutually exclusive' (May 
2003: 1) or even that fast-food is dangerous. Such representations place fast-
food deeply under a preventive health gaze, and deny the possibilities that • 
fast-food has other cultural values and may have importance as a form of 
voluntary risk taking in the construction of individual subjectivity (Lupton & 
Tulloch 2002). Furthermore, the consumption of fast-food may be related to 
temporal concerns; speed and convenience. 
An article in the Vancouver Sun discounts the possibility that manufactures 
can develop new food products able to match up with lifestyle realities: 
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"There have been a lot of attempts [to create healthy fast-food] and people 
are constantly saying they're concerned about health," Chan says, "but in 
reality, when they're time-strapped and under the gun, they go for what's the 
easiest." Fast-food just isn't fast enough for us' (Stainsby 2001: no page). 
Using this line of reasoning, food and health prevention have a temporal 
dimension that suggests an inverse relationship between health and speed. 
Time is money and fast-food is cheap, convenient and (therefore) unhealthy. 
However choice is complex and varies for many reasons, some of which have 
been identified in this chapter. What is understood as good for individuals 
by regulators and health professionals comes in conflict with the desires of 
individual consumers. The preferences through which people choose are 
situated within complex cultural/aesthetic concerns and socio-political 
orderings. 
Despite repeated suggestions that the McLean was a failure, that new 
technologies may not stem the tide of obesity, and in spite of the production 
of a level of distrust of such solutions, in media articles about the McLean 
burger there is a strong focus on consumer choice. Given that low demand is 
represented as a significant reason for failure, and that consumers 
voluntarily chose not to eat the healthier option offered by the McLean one 
might ask what kinds of choices are consumers and media demanding? 
In relation to the expansion of low-fat alternatives to fatty foods, one article 
suggests that 'choice is the key. We boomers know there's a problem with 
fast-food, but many of us also love its convenience and cheapness. The 
solution: give us a choice ... And something else: don't try to make burgers 
into health food by creating some heavily processed Frankenstein substitute. 
McDonald's just annoyed customers with the late, unlamented McLean 
burger ... With health and nutrition moving rapidly up our list of priorities, 
we do insist on having a choice' (Bryan 2002: D1). However the equation of 
choice, health and rational decision-making assumes that individuals can or 
will modify their choices and elevate the health concern over all others. 
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The constraints that limit choice - even in the terms of health - are 
acknowledged in media articles. Writing in the Poughkeepsie Journal (New 
York) Evelyn Gezo, a dietician, demonstrates the paradox of choice with the 
recognition of its inadequacy. Firstly Gezo asks if fast-food can change given 
the continuation of advertising, over-sized portions and all-you-can-eat-
buffets. The article implies food companies have changed, with Gezo 
pointing to the increasing popularity of salads and McDonald's new 'happy 
meals', containing salad and a pedometer. However, Gezo continues, 
'depending on the salad and salad dressing chosen, they can provide just as 
many calories and fat'. Finally she concludes 'most of us would agree that we 
don't expect all menu items to get high marks for being healthful, but as the 
number of health-conscious consumers eating meals away from home 
increases, it sure would be nice to have a choice' (Gezo 2003: D5). 
While consumers call for choice, food manufacturers also appear to 
understand that is precisely what they are doing - and indeed that people 
have a duty to make choices. On this matter, a number of articles raised the 
issue of obesity lawsuits in the United States. "The idea of suing McDonald's 
because you are obese is absolutely ridiculous. Just don't eat the stuff", said 
Jeff Kanter, an analyst who tracks food companies for Prudential Securities' 
(Koenig 2002: A3). 
An article from a Montana newspaper the Great Falls Tribune suggested that 
excessive consumption was a choice. 'Deb Hudson, of the Golden Corral, an 
'all you can eat' fast-food restaurant in Montana, was adamant that 
customers were not expected to eat too much - and it cost her business if 
they did: "Holy cow," she said, "there are people who can really put away 
the food. But", she added, "that's their choice " (Ecke 2003: 1A). 
Extending the notion of choice to individuals as consumers is a tactic of neo- 
liberal governance - choice is expressed as decisions taken in/by the market. 
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A piece by Charles Bernstein, editor of the chain restaurant industry 
magazine, The Chain Leader, argues the 'market should decide': 
Meanwhile, the Senate is eyeing potential bills for billions of dollars to 
'improve nutrition,' encourage more physical activity and devise ways 
of decreasing obesity-- all noble ideas but difficult to enact. There is a 
serious threat of government 'fat taxes' and 'snack taxes,' as well as 
potential lost sales or customers saying no to restaurants that don't have 
enough 'healthy' foods. I agree there should be healthful choices too. Yet 
as part of our free enterprise system, let's have consumers vote with 
their purchases as they did when they voted out McDonald's McLean 
burger. Let the market decide, not the 'nannies' and not the government. , 
Restaurants should not be scapegoats for society's ills. I side with CIA 
President Tim Ryan, who affirms that 'we're all going to die eventually, 
so let's get over it and enjoy our food. We should really eat what we 
want to eat' (Chain Leader 2002: 12). 
The suggestion that we eat what we want to eat implies that choice exists 
somewhere outside the social fray. In this scenario everyone is aiming for the 
same thing: a sense of choice is demanded - and to some extent produced. As 
Rose (1999: 10) argues 'ideas of freedom have come to define, the ground of 
our ethical systems, our practice of politics and our habits of criticism'. In the 
practice of freedom through choice there is also the maintenance of a system 
under which choice can be practised. As Dean (2002) also suggests, the very 
idea of empowerment of those 'powerless' (in this case those people who 
need the McLean to be able to enact choice) is problematised if the networks 
that enable that power are bought into focus. 
Present effects of risk and food 
Sense of choice may be provided through IHTs and art increased range of food 
items added to fast-food outlets menus. However, prevention and sense of 
choice have effects, not least of which include expanding the opportunities 
for business and profit from health into new arenas. The incentive to reorient 
the manufacture of foods for health and consumer preference may be 
financially lucrative for producers, a factor critiqued by a variety of authors 
(Fischler 1999; Goodman & Watts 1997). Goodman and Watts (1997: 243) for 
example, argue that 'this is not a trend likely to be discouraged by the food 
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industry, since it also represents a change with commercial possibilities'. In 
the .same vein, an FMC Biopolymers brochure highlights the attraction for 
companies, when it states that technologies such as carrageenan have 'the 
advantage of the fact that they comprise an extremely small part of the 
products to which they are added. While used in small quantities, they 
significantly increase the value of the end product' by many times what it 
costs to add them' (FMC Biopolymer 1999: no page). At the same time, not all 
developments in health promotion related to fat modification are always 
profitable. According to Coeyman (1995 :36), Ben and Jerry's ice-cream 
company did not gain from the low-fat craze and its potential for increased 
profits, or from increasing consumer choice. Mandatory labelling of the fat 
contents of products caused an 'unprecedented consumer reaction to the 
high fat content' and for the first time (though transitory) Ben and Jerry's 
experienced a quarterly financial loss. Moreover, for carrageenan producers 
the opportunities presented by fat-modification were less significant than 
initially had been expected. I asked Gordon Guist of FMC Biopolymers if the 
low fat market was dead for carrageenan. 
Fat replacement is a portion of the business but it is certainly not a 
significant portion at this point .... Low fat yoghurt market still a 
possibility but we haven't seen it much at this point (Guist, pers.comm., 
June 3, 2002). 
On the other hand, despite the failure of the low-fat McLean and other diet 
foods, carrageenan continues to be valued for its functional properties that 
both reduce fat and increase profits. 'Carrageenan with or without gum 
blends is the most widely used binder in the series of current low-fat meat 
products due to its ability to retain moisture' (Troy, Desmond & Buckley 
1999: 507). Extending the network of carrageenan beyond its functional 
properties, a further factor that has contributed to the increased use of 
carrageenan in meat was the changed regulatory environment - due in part 
to concerns about prevention of obesity. The material effects of prevention 
may become durable in unexpected ways. The difficulty for the consumer is 
knowing what the benefits are and for whom, as Bixler remarked of 
carrageenan use in reformulated poultry products: • 
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Although the consumer clearly gets a better product from this 
technology, the reason the use has grown so rapidly is the distinct 
advantages to the poultry processor. The first bullet, water binding, is 
the way the poultry processor improves the yield. Originally the 
processor was only interested in binding the water normally lost in 
curing and cooking, but the technology has now progressed to the point 
where 30% to 50% of added ingredients are injected into the meat. This 
really improves the yield, because salt water can now be sold at meat 
prices (13ixler 19.96: 43). 
This problematic effect of risk is not lost on consumers, and may be 
expressed as distrust of IFITs. The media is one source that has a tendency to 
reveal, in black and white terms, such economic benefits to companies. A 
report from Merrill Lynch, quoted in the Milwaukee Journal Sentinel for 
example, hints to the market benefits food modification for prevention: 'a 
mere 1% shift in spending in at-risk food categories such as cookies, lunch 
meats and cheese would translate to almost $1.5 billion in potential revenue 
for companies' (Johnson & Fauber 2063: 01A). 
One cost of prudentialism is that the habits of criticism are those of blame, of 
consumers, companies, marketers, restaurants and governments. In the 
example of the McLean burger I have highlighted the complex and 
heterogeneous set of factors through which food modification occurred such 
that there should be no easy targets for blame. Yet in mediated accounts 
targets are described, identified and singled out in ways that rarely 
incorporate such complexities and even less commonly attribute blame to 
particular systems of governing populations. 
Finally, prudentialism is a regulated freedom and one in which the appeal of 
'choice' is less emancipatory than might be expected. Purchasing salt water 
in reconstituted chicken is a choice under the terms of prudentialism because 
there is the opportunity to read the label as Bixler continued: 
There is no deception here, however, at least in the US. The label must 
clearly state that the product contains X% added ingredients, and it 
must do so in large letters. This does no't seem to deter the shopper 
looking for a bargain; since these products are usually priced below 
products without added ingredients. Needless to say, unless consumers 
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find something in these products to complain about, they will be with us 
for a long time to come (Bixler 1996: 43). 
Avoiding 'deception' however, requires that the consumer reads the label as 
a matter of course rather than as a matter of health. Prudentialism is then no 
longer a choice but an obligation. 
Moreover, freedoms may be more directly curtailed through discourses of 
prudentialism. On the 10th March 2004, the republican dominated US House 
of Representatives passed a bill entitled the 'Personal Responsibility in Food 
Consumption Act', by a margin of 276:139. Under the Act, yet to be passed 
by Congress61, individuals will no longer be able to sue companies for 
'frivolous' claims about obesity. The Act is designed: 
To prevent legislative and regulatory functions from being usurped by 
civil liability actions brought or continued against food manufacturers, 
marketers, distributors, advertisers, sellers, and trade associations for 
claims of injury relating to a person's weight gain, obesity, or any health 
condition associated with weight gain or obesity. 62 
Whether or not there are any possible benefits of modifying the food 
environment for healthy living, there is the potential for a reduced sense of 
the authority, applicability or benefit of transferring such responsibility to 
the realms of free market capitalism. 
61 The so-called federal 'cheeseburger' bill was amended and approved by the House of 
Representatives Judiciary Committee on May 25th, 2005 (H.R 554). Similar legislation protecting fast-
food industries from lawsuits have been adopted in some states. The first 'cheeseburger bill' (a term 
coined by the Congressional Research Service) was adopted in Louisiana in June 2003 and in 2004 
Arizona, Colorado, Florida, Georgia, Idaho, Illinois, Michigan, Missouri, South Dakota, Tennessee, 
Utah and Washington enacted measures to prevent lawsuits against fast-food industries on the basis 
that fast-food causes conditions such as obesity, diabetes or hypertension (Madigan 2005). 
62 The Office of the President issued a Statement of Adininstration Policy in relation to the Act on 10th March 2004 
"The Administration strongly supports House passage of H.R. 339. Food manufacturers and sellers should not be 
held liable for injury because of a person's consumption of legal, unadulterated food and a person's weight gain or 
obesity. H.R. 339 would help prevent abuse of the legal system and help curb the growing problem of frivolous 
lawsuits in the United States. At the same time, the legislation would carefully preserve the right of individuals to 
have their day in court with non-frivolous civil liability actions. These civil actions are enumerated in the bill and 
respect the traditional role of the States in our Federal system with regard to such actions. The Administration looks 
forward to working with Congress to make certain the legislation does not have unintended consequences as it 
moves forward". 
154 
Assembling the McLean 
In this chapter I have considered the failure of the McLean in an assemblage 
of forces constituting the new public health. Within this work, I have 
suggested the McLean is a failure not just as a technology, but as a material 
embodiment of the new public health. Yet, Dean (1999a: 145) suggests that 
failure is not the 'abandonment of the attempt to construct coherent 
programs of government', but a moment at which new forms of rationality 
and new technologies of governance may emerge. The McLean has not been 
revived, but there are other IHTs and tactics that may be employed in 
governing health. As it stands, the problematisation of obesity in terms of 
lifestyle factors open to the prudential consumer remain central to US public 
health policy. Opening an FDA sponsored workshop in November 2003, 
Anne-Marie Lynch underscored that centrality when she observed: 
The good news is that obesity and co-morbidities are preventable 
through healthy eating, nutritious food in proper amounts, and physical 
activity. And the bad news is that many Americans are not taking the 
steps to prevent obesity and its co-morbidities. The Administration has 
put forth a prevention agenda focused on a healthier U.S., which 
promotes four fundamentals of good health. These are: physical activity, 
healthy eating, regular preventive checkups, and avoiding risky 
behaviors (Food and Drug Administration 2003: no page). 
If the example of the McLean is considered as representative of more general 
responses to technological advancement in food and prUdentialism, there is 
reason to suspect a preventive, altered food environment approach to 
obesity. The McLean burger was not a success in improving health, and 
involved a technological blunder as much as it was underpinned by social or 
marketing mistakes. Furthermore, the McLean demonstrates how the 
discourse of choice may overlook the lived geographies of other forms of 
disadvantage, including the economics behind food decision-making. As 
well, in its wake, failure is the consumer's perception of the possibility of 
success. These media accounts suggest consumers will expect and even 
demand even more products like the McLean, but they do not expect them to 
work. 
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The limited success of a biopolitical intervention such as the fat modification 
of a fast-food burger provides a compelling example of the limits of choice as 
a strategy of health promotion and prevention. The biopolitical dimension 
refers to the ways in which strategies of neo-liberal governance reconfigure 
individual subjectivities as consumers of health within the free-market. The 
McLean example raises a problematic coalition between the medicalisation of 
obesity and the economic advantages for companies in reformulating food 
for health profit (though in the end, this did not eventuate for the McLean), 
and the economic realities of everyday life. 
The extracorporeal spaces of food in this example appear too complex to be 
reformulated when based only on rational health grounds. The provision of 
choice is unrealistic because there is an underlying assumption that prudent 
subjects value health as paramount in relation to other concerns. A 
governmentality of prudentialism may not 'produce' healthy subjects, yet it 
seems remarkably efficient at producing prudent subjects who value choice 
in situations decontextualised from factors that disenable them. As it stands, 
the McLean was limited in acting at a distance in public health. In the next 
chapter I consider a further example of carrageenan's incorporation into a 
technology of prevention that extends beyond the borders of US populations, 
and into the spaces of international health. 
Testing CarraguardTM 
What you need 
to know 
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Illustration: Cover page, information brochure on Carraguard clinical trials 
Source: Population Council 2004 
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Chapter 6 
The geopolitics of 
Carraguard® 
Carraguard is a carrageenan-based preventive technology in development by 
the Population Council, a US based philanthropic organisation, to mitigate 
the spread of HIV/AIDS and other sexually transmitted diseases. When 
applied as a gel Carraguard appears to provide a (partially effective) physical 
barrier to the virus that causes AIDS, as well as some other sexually 
transmitted diseases. It is designed for vaginal use and can be formulated to 
have either contraceptive or non-contraceptive effect (Population Council 
2002, 2004a). My analysis of Carraguard forms the final substantive 
component of my dissertation, extending and building upon the carrageenan 
actor-network traced in previous chapters. Carraguard provides an 
interesting actor-network through which to examine pharmaceutical 
industry responses to pressures for preventive technologies. My aim is to 
explore the extent, durability and transformations of or within networks that 
incorporate carrageenan and discourses of new public health and it is the 
geopolitics of Carraguard, from the micro-scale of (women's) bodies to the 
global scale of international politics, that is the chapter's primary focus. 
I begin by tracing both the actor-network of Carraguard as a material 
technology of prevention and its links to carrageenan and the new public 
health. Because Carraguard is a technology that obliges female users to be 
prudent, I argue that gender relations are implicit in Carraguard, for 
example, in the ways changing public health priorities feminize HIV/ AIDS. 
Moving from the new public health to broader issues of how Carraguard is 
represented, I consider how the media constitute and reflect public 
knowledge about carrageenan and microbicides and I examine the 
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geopolitics of such representations. The findings from the media analysis and 
secondary materials underscore a fundamental alignment between 
discourses of prudentialism and women's empowerment in the promotion of 
microbicides. 
The chapter incorporates data from secondary sources including Population 
Council documentation, microbicide advocacy publications, academic 
writing and media sources. I draw on and augment the findings of a co-
authored paper submitted to the journal Gender Place and Culture in tracing 
the constitution of Carraguard from the micro-terrain of women's bodies, to 
the macro-terrain of community, sub-national jurisdictions and nation-states; 
international, supranational and global networks (Burges Watson & Stratford 
forthcoming)63 . For this paper we applied a critical discourse analysis to an 
extensive survey of popular media representations of Carraguard, and to 
representations emanating from the United States Population Council and 
other microbicide advocacy organisations. The paper considered three 
questions related to prudentialism: first how are certain behaviours, 
identifies, interventions and means of surveillance enrolled in preventing 
HIV/ AIDS by Carraguard; second, to what extent are microbicides 
legitimated by their construction as a women's technology; and third, do 
technologies such as Carraguard enable risk to act at a distance as well as 
into the future? 
The particular geopolitics associated with microbicides and Carraguard 
unsettle the centrality of linkages among preventive technologies, neo-
liberalism and public health that have been developed elsewhere in this 
thesis. In the final sections, the network incorporating carrageenan and 
Carraguard is traced to recent developments in the US and the new found 
enthusiasm for microbicides demonstrated in the 2004 US President's 
63 This thesis incorporates the outcome of data analysis undertaken in collaboration with Dr Elaine 
Stratford as part of a research project under her supervision. The collaboration relates to research on 
media representations of microbicides and pertains to chapter 6 sections 6.2 to 6.4 of the thesis. The 
findings of that research have been reviewed as a paper for the journal Gender, Place and Culture and 
are in revision for resubmission. 
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Emergency . Plan for AIDS Relief (PEPFAR) (Global Campaign for 
Microbicides 2004; Office of the United States Global AIDS Coordinator 
2004). In the case of Carraguard, I ask whether concerns about public health 
and prevention are sufficient to account for policy on microbicides and 
HIV/AIDS emanating from the White House. With reference to the Bush 
Administration's neo-conservative values and Crina Archer's (2004) 
commentary on pre-emption and security, I examine how the new enthusiasm 
for Carraguard and microbicides may be viewed as consistent with an 
emergent neo-conservative pre-emptive politics of public health. In doing so I am 
flagging the need for future research and will consider whether pre-emption 
constitutes a new kind of space/time configuration in public health. 
The worth of Carraguard and other initiatives for the prevention of 
HIV/AIDS is not in question in this chapter. HIV/AIDS is a condition that 
threatens to kill millions of people and has far-reaching implications for the 
reproductive capabilities, economies and governance of entire nation states 
and supra-national regions (Bancroft 2001; De Waal 2003; Gayle 2003). 
Mitigating the suffering and death caused by HIV/ AIDS demands global 
attention. However, my purpose is to unsettle the tendency of technologies 
of remote control to embody (and employ) rationalities that are dubious, and 
whose socio/ technical congealments remain under-explored (Webster 2002). 
As the case of the McLean burger illustrates, IHTs can (and sometimes do) 
fail. Indeed, as Webster (2002: 447) observes, precisely because they are so 
complex 'contemporary health technology networks may be particularly 
difficult to build'. I conclude that the example of Carraguard demonstrates 
how the development of critical geographic and other social studies of health 
technologies help to reveal partial perspectives (Haraway 1988; Hyndman 
2004) and provide insight into broader, potentially destabilising, factors 
within health technology networks. 
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Carraguard as an actor/network 
The opening scene for a 21 'minute video about Carraguard (Pandamonium 
Productions 2003), developed for the Population Council to attract and 
inform recruits to the phase III clinical trials, exemplifies how different 
elements of the carrageenan actor-network are interwoven and drawn into 
the developing Carraguard actor-network (Box 6.1). 
Opening scene to Carraguard clinical trials promotional video: wide 
shot of an empty beach with pounding waves. In the distance a woman 
is walking towards the camera carrying a large handbag. The camera 
focuses on her. 
'Hi, I'm Lillian Dube, and I'm going to tell you more about this stuff, 
and it starts right hefe on the beach, let me show you why...' 
Lillian stops, bends down and picks up a piece Of seaweed from the 
sand 
'Look at this seaweed, it's a special plant that grows. It has all sorts of 
good things about it that most people don't know about, one of the good 
things that comes from it is carrageenan which has been used for 
hundreds of years in all sorts of ways.' 
Lillian puts the seaweed back on the sand, the Camera focuses briefly on 
the seaweed lying on the beach before panning up to see Lillian, 
reaching into her handbag, she draws out a bottle of lotion; 
'Look, my body lotion has carrageenan in it' 
She replaces the lotion and draws out a large container of infant formula 
'And it is used to make this baby formula thicker' 
Next she holds up a Carraguard applicator 
'And it's also been made into this, this is a new vaginal . gel called 
Carraguard'. 
Box 6.1 Content description for first scene of a promotional video for recruitment to 
clinical trials of Carraguard. Source: Pandemonium Productions 2003. 
Seaweed, tradition, carrageenan, baby formula, body lotion and a clean and 
(natural) beach scene contextualise Carraguard as benign; at least for the 
moment. In previous chapters I have highlighted some of the complexities of 
carrageenan actor-networks and the partial perspectives through which 
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carrageenan may be unsettled - in some instances rendered dangerous.. 
Carrageenan, degraded carrageenan, carcinogenicity, baby formula, Irish 
moss and so on become the territory, but not the map, upon which prudent 
consumers could draw inferences about Carraguard's risk. Carraguard may 
appear benign in the context of the video, however its representation as such 
is a dangerous strategy. As demonstrated throughout the thesis, prudent 
individuals are obliged to access, various sources of information that may 
suggest that carrageenan (and therefore Carraguard) is a risk, even though 
such information may be displaced and distant. Yet, there is already 
evidence that dangerous linkages have been made. For example, during a 
question and answer section of a public health seminar in International 
Relations at Yale University, Dr Helen Gayle, senior advisor to the Bill and 
Melinda Gates Foundation, one of the sponsors of clinical trials, was asked 
by a student in the audience: 'With respect to Carraguard's microbicidal gel, 
is it carcinogenic?' Dr Gayle replied 'I've never heard that. People will say 
almost anything is carcinogenic' (Kapoor, Maniam & Prelogar 2002). 
Furthermore, Carraguard is associated with other networks that have been 
mapped throughout this thesis. For example the carrageenan for Carraguard 
is being supplied to the Population Council exclusively by FMC Biopolymers 
(Population Council 2002). Carraguard is a formulation based on a lambda-
kappa carrageenan derived from certain (but not all) species of seaweed using 
particular technologies of refinement (chapter three), knowledge about 
which is held as proprietary information by the Population Council and FMC 
Biopolymers (Maguire, 2003, pers.comm., 15 January) 64. In other words, the 
material carrageenan for Carraguard is a specific type of carrageenan, rather 
than a generic product. Yet Carraguard's developers represent carrageenan 
as a boundary object (Bowker & Star 1999: 297) so reinforcing a politics of 
singularity about it. If the representation of carrageenan as ontologically 
stable can be contrasted to the actor-networks through which carrageenan is 
64 Robin A. Maguire is Program manager for microbicides at the Population Council's Centre for 
Biomedical Research. 
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minutely differentiated, and as demonstrated by the Yale seminar, 
Carraguard is vulnerable to destabilisation through associations with 
carrageenans - including so-called cancerous ones. 
Carraguard is deployed symbolically and as a material technology. In 
chapter two I described Carraguard as an emergent pharmaceutical, 
currently in developmental stage for use as an over-the-counter (OTC) 
prevention technology, for the mitigation of HIV/ AIDS and other sexually 
transmitted diseases. Users of Carraguard as an OTC product are necessarily 
prudent. In this regard, Carraguard is also being promoted as a technology 
controlled by women that has the added advantage of being cheap to 
produce (Bell, SE 2000; 2003; Fuqua 2002; Kaler 2001; Seale 2003). 
Unsurprisingly, it is regarded as a particularly good option in countries with 
populations suffering the effects of low incomes and/or high incidence of 
HIV/ AIDS, sub-Saharan Africa most prominent among them (Population 
Council 2002, 2004a). Carraguard folds into the diverse strategies of 
governing public health at a distance by working through and on prudent 
subjects. 
Carraguard has two particular champions. The first is the US Population 
Council, a non-profit research, development and advocacy organization 
established by John D Rockerfeller in 1957 to address the 'population 
problem' in developing countries (Population Council 2003). According to 
the Population Council the conditions of poverty in the developing nations 
were and remain symptomatic of the imbalance between over-population 
and resource availability. At first, fertility was the target of efforts to address 
poverty and suffering by reducing population pressures. Early on, the 
Population Council also supported the Eugenics Society of America in 
developing a range of reproductive technologies to control women's fertility. 
While the priorities of the Population Council have changed, the 
problematization of poverty in terms or resources and population remains 
central to its policy platform to optimise public health outcomes and work 
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within a traditional sustainable development framework in which human, 
economic and environmental domains are balanced (Population Council 
2003: no page). 
The other substantial sponsor of Carraguard is the Bill and Melinda Gates 
Foundation, established in January 2000 by the merger of the Gates Learning 
Foundation and the William H Gates Foundation; the first had focused on 
expanding access to technology through public libraries, the second on 
global health improvements. The merged foundation has an endowment of 
US$25 billion 'through the personal generosity of Bill and Melinda Gates' 
(Bill and Melinda Gates Foundation 2003: no page). Thus, the substantive 
financial and developmental support for Carraguard emanates from the US. 
Other initiatives for microbicide development that include Carraguard 
involve collaborations that aspire to a global reach. The World Health 
Organisation describes microbicides as the 'most feasible' method for 
primary prevention of HIV (alongside condoms) given the lack of progress 
on HIV vaccines, and recommends microbicide development by member 
states (World Health Organization 2003b: no page). Of the non-governmental 
communities involved in advocacy for microbicides that have emerged in 
recent years, and despite their 'diasaporic' existence via mediated spaces of 
the Internet, a substantial majority have their headquarters in the US. The 
most prominent are the Global Campaign for Microbicides (Washington D.C), 
Global Microbicide Project (Arlington, Virginia), International Partnership for 
Microbicides (Silver Spring, Maryland), and the (International) Alliance for 
Microbicide Development (Silver Spring, Maryland). As well, there are United 
Nations initiatives such as the International Working Group on Microbicides 
(IVVGM) and, since 2004, the Global Coalition on Women and AIDS 65 . Without 
questioning the intent of any of these organisations, the US focus of 
65 http://www.global-campaign.org/about.htrn (The Global Campaign has extensive networks with 
organizations in many different countries around the world); http://www.gmp.org/contact.htm (also 
has an office in Belgium) http://www.microbicide.orgh  IWGM was formed in 1993 at a WHO 
meeting in Geneva, Switzerland http://womenandaids.unaids.ore . 
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developers, and priorities of empowering women towards self-management 
of HIV/AIDS, match up with the new public health priorities in positioning 
a dominant mode of containing HIV/AIDS and other STDs in (neo-liberal) 
discourses emphasising personal responsibility (Pryce 2001). Like food 
consumption, the maintenance of sexual health is now cast as a lifestyle 
choice based upon principles of informed practice. Not only does such a 
strategy assume that choice is realistic for everyone, it also 'privileges the 
scientific truths of sex over the lived truths of erotic pleasure and sexual 
freedom' (Pryce 2001: 152). New public health discourse colonises the space 
of health and pleasure, and demands a particular kind of subjectivity, 
particularly found in recent debates concerning prudent and gendered 
subjects of risk. In summary, the geopolitics of Carraguard tie into 
heterogeneous networks that include carrageenan and its associated risky 
topologies; discourses of prudentialism; sexuality; natural/synthetic 
distinctions; particular places and publics; and central to the following 
discussion, gender concerns. 
Feminising HIV/AIDS and prevention 
Efforts towards the amelioration of HIV/AIDS take place not only in an 
international or global context, but also one in which gender relations are 
increasingly placed centre stage in the organisation of public health 
responses. Within global campaigns to curb HIV/AIDS, relations amongst 
gender, poverty and the virus that causes AIDS are widely understood to 
underscore and even fuel the epidemic (Annan 2002; Bancroft 2001; Bentley 
2004; Epstein et al. 2004; Geshekter 1995). Women are regarded as 
particularly vulnerable to HIV/AIDS and, in recent times, have become key 
targets for preventive interventions (Amaro & Raj 2000; Epstein et al. 2004; 
Harrison, Xaba & Kunene 2001; Ramdas 2003; Treichler 1999; UNIFEM 2003). 
Furthermore, the concern with women and HIV/AIDS has also been tied 
into broader debates about gender inequalities and women's empowerment 
(Bell, SE 2000, 2003; Kaler 2001; Ramdas 2003). 
165 
Since the 1980s the goal of strategically empowering women seems to have 
gained momentum in the discourses and practices of health and 
development. For some analysts, the 1994 Cairo Conference on Population 
and Development was a turning point in a new rhetoric of empowerment 
(Kaler 2001; Ramdas 2003). Certainly, the parties to the Conference 
positioned women as the centrepiece of their activities in relation to health 
promotion and prevention. Arguments supporting the new centrality of 
women included their systemic devaluation and discrimination; the 
disproportionate burden they bear in caring for the sick; and their biological 
and socio-cultural vulnerability to HIV/AIDS (Bill and Melinda Gates 
Foundation 2003: 12). Furthermore, empowering women in contexts of 
inequalities in gender relations has long been a focus of social movements. 
Thus discourses around HIV/AIDS and its mitigation have twin aims: first 
the promotion of health, and second the emancipation of women. 
Since the late 1980s, for example, Zena Stein has been among the most vocal 
advocates for microbicides, arguing that available prevention methods, such 
as the condom, fail because women are not always (and sometimes rarely or 
never) in a position to negotiate their use (Stein 1990, 1995). The deepening 
understanding of a relationship among power, gender and methods to 
prevent or limit HIV/ AIDS generated a snowballing interest in female-
controlled prevention- technologies. Stein's plea was for a technology to 
achieve what policies for social equality could not, namely a method that 
embodies new social relations between men and women that empowers 
women to act - in short, enabling prudent action without male knowledge or 
consent. 
The media, HIV/AIDS and Carraguard 
In the overlaps between US and global efforts to prevent HIV/ AIDS, gender 
concerns and the new public health, a problematic coalition emerges between 
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its western derived medico-morality and the bodies and lives that come 
under intense global health surveillance, and those (wealthy and/or 
heterosexual men) who do not (Geshekter 1995; Waldby 1996, 1999). 
However, Carraguard is a material technology that acts at a distance and, as 
the example of the McLean burger illustrated in the previous chapter, its 
translation in local contexts cannot be assumed to follow the expectations of 
its developers. Testing the 'effects, rather than imputed intentions, of the 
problematisation of HIV/AIDS in relation to a product not yet available on 
the open market, is far from straightforward. For this reason, I looked to 
mediated representations of Carraguard and my analysis rests on a number 
of observations about the important role of media as a source of data, and as 
reflecting and keynoting knowledges about the geopolitics of the new public 
health. 
Within critical geopolitics it is recognised that the media is also a source of 
raw data that can be quantitatively analysed to reveal common geopolitical 
tropes (Dalby 2003). Media representations of Carraguard fold into diverse 
governing strategies of HIV/ AIDS and part of the work that they perform is 
to map and remap the gendered and sexualised geopolitical domains of 
HIV/ AIDS (Abma 2002; Backstrom & Robins 1998; Brown, M & Gross 2002; 
Gillett 2003b, 2003a; Joffe 1999; Saywell & Pittam 1996; Seale 2003; Van Loon 
2003; Wilkinson 2001). Both the disease and its putative treatment are objects 
through which are perpetuated ongoing understandings of technology as 
society made durable (Latour 1991) and of risk as governable by such means. 
In April 2003, the term 'carraguard' was typed into the search engine 
LexisNexis66 . Secondary material was drawn from the detailed websites of 
microbicide advocacy groups and international organisations with 
LexisNexis is a searchable database of more than 5000 global media sources. 
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involvement in microbicide development, as well as the Population Council's 
own website of information on microbicide researth and development 67 
The survey returned 54 news items that specifically mention Carraguard, 
and that appeared between January 2000 and March 2003, a period when the 
Bill and Melinda Gates and Rockerfeller foundations were under the 
spotlight for providing substantial funds to microbicides research as part of 
larger campaigns against HIV/ AIDS. Certainly not the first scholarly attempt 
to examine the constitution of HIV/AIDS in the media 68 the analysis was 
nevertheless among the first to focus on Carrag-uard specifically, and 
microbicides more generally, within the mainstream press. 
As Wilkinson (2001) suggests, it is well accepted that the media help to 
structure initial debates around topics, however finding a suitable conceptual 
framework for how such information is reflective of existing social realities, 
or constructive of them is fraught with difficulty. Yet it is worth noting that 
media sources related to Carraguard are delimited to some extent because of 
the emergent or pre-market nature of the technology. As revealed by the 
sources identified in the 54 media articles on Carraguard, knowledge about 
Carraguard, emanates from the cloistered networks of the developer, 
manufacturing, advocacy and funding organisations. Whether the media 
reflect or construct social realities, media messages about Carraguard can be 
placed within discussions of western neo-liberalism and its extension to 
elsewhere through an examination of the (re)constitution of such western-
derived information. 
67 http://www.microbicide.org/ (Alliance for Microbicide Development), http://www.global-
campaign.org/(Global Campaign for Microbicides), http://www.gmp.org/(Global  Microbicides 
Project), http://www.microbicidesnow.org/.  
(Microbicides as an Alternative Solution), http://wwwipm-microbicides.orq/ (International Partnership for 
Microbicides (IPM), USA), http://www.natorq.uk/ (UK/Ireland Campaign for Microbicides/National AIDS 
Trust), http://www.populationcouncil.ora/ (US Population Council). 
68  See for example (Adkins 2001; Backstrom & Robins 1998; Bell, SE 2003; Browne & Barrett 2001; Davis 
2003; Fuqua 2002; Gillett 2003b, 2003a; Raimondo 2003; Saywell & Pittam 1996; Swain 2003; Treichler 
1999; Tulloch 1992; Watney 1987). 
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Further, other than those people specifically involved in medical trials of 
microbicides, the general public is unlikely to encounter microbicides 
through means other than media representations of them for some years to 
come. The media in this sense pre-emptively cultivates, or keynotes 
knowledges about Carraguard and microbicides, whilst contributing to 
discourses surrounding the risks and uncertainties of HIV and AIDS. 
In the genre of media, headlines and lead paragraphs often act to summarise 
articles, while 'satellite' paragraphs add detail (Fairclough 2003). Table 6.1 is 
a sample of headlines that illustrates the five main hooks that commonly 
appear in the reportage of Carraguard in the print media during the period 
under examination: these are HIV/ AIDS, the United States Population 
Council, the Gates Foundation, women and seaweed. 
Table 6.1 Sample Headlines on Carraguard and HIV/AIDS 
HI V/A IDS  
Anti HIV gel (2) 
Check up. HIV block 
New hope to stop Aids 
PanAfrica; gel for HIV/AIDS ready by 2007 
The US Population Council  
Grant helps Population Council advance HIV/AIDS prevention research 
NIH grant helps Population Council advance promising HIV/ AIDS prevention research 
Population Council to initiate microbicide trial 
Women 
Health: microbicides, a beacon of hope for women 
NIH grant helps Population Council advance promising HIV/ AIDS prevention research; support for 
'novel anti-HIV carrageenan-based rnicrobicides' research may result in more options for women to 
protect themselves from infections , 
Product to protect women from HIV is elusive 
Seaweed  
A weedy cure 
Ice-cream gel 'may protect against HIV' 
Kiss and gel 
Prospects better for seaweed firms 
Seaweed derivative could prevent HIV infection: researcher 
Seaweed HIV-block hope 
Seaweed may boost HIV war 
The Gates Foundation  
AIDS breakthrough finds charitable champions 
An AIDS breakthrough could go begging 
Bill Gates, Bono call on leaders at World Economic Forum to increase global health spending 
Disease prevention: Government launches trial of gel to protect women against HIV 
Gates Foundation to fund new AIDS-prevention study 
Gates Foundation to fund pilot anti-AIDS study using seaweed 
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The headlines keynote a number of issues of relevance to my themes of 
prudentialism, spatiality, visibility and futurity; and to the fortunes of 
carrageenan industries. Carraguard is a technology with which women can 
'protect themselves' through stealth (prudentialism/ visibility). The 
Population Council, NIH, Bill Gates and Bono help to produce and promote 
Carraguard for those, out there, that need it (spatiality/ geopolitics). As yet, 
Carraguard is not available and there has been some reluctance to support it 
(futurity). Finally, Carraguard is rendered novel, if not implausible, by its 
association with seaweed (natural/synthetic distinctions and the carrageenan 
industry). 
Carrageenan is constituted in media as more than just a material ingredient 
of Carraguard, as indicated by the 'carra' prefix, the incorporation is a 
deliberate strategy on the part of the Population Council that draws the 
carrageenan actor-network into the narrative about Carraguard. Within the 
Carraguard appears to be newsworthy because it is constituted as a 
novelty item; newsworthy because carrageenan's associations with ice cream, 
toothpaste, jell-o or chocolate milk render it somehow implausible as a 
serious medical technology; newsworthy because that novelty has 
entertainment value; newsworthy because of the risk of trusting something 
so benign in a battle against something as malignant as HIV/AIDS. 'A gel 
made from seaweed and used in ice cream and toothpaste could protect 
women against HIV, scientists suggest ... Trials are due to start this year on 
Carraguard, which is made from red seaweed that grows on the coasts of 
Nova Scotia and Chile. Scientists believe it binds to the HIV virus, coating it 
in a paint-like surface that prevents it from attacking the human body' (Barry 
2002: 24). Such associations locate Carraguard not only with places, but make 
durable ties with the carrageenan-bearing seaweed industry. 
On this matter, some articles suggest that the long-term prospects of the 
carrageenan industry appear 'brighter' as regulatory environments must 
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expand to accommodate the use of carrageenan for pharmaceutical uses 
(chapter two), 'tests are going on at Drugmaker, a company based in Metro 
Manila, for the retooling of its equipment to accommodate the use of 
carrageenan in the manufacture of capsules ... (Sino Cruz 2002: no page). 
Thus the Carraguard actor-network is extensive, opening up possibilities for 
many different associations that may span not only the sources from which 
the carrageenan is actually extracted, but across the length and breadth of the 
global carrageenan-bearing seaweed industry. Likewise public health 
priorities associated with Carraguard extend beyond the boundaries of the 
US, and into the realm of global public health. 'But what's truly 
groundbreaking is its potential for poor, AIDS-racked regions like Africa. 
Odorless and undetectable, the gel could be a lifesaver for women whose 
partners refuse to use protection--as long as it's sold for pennies'(Carmichael 
2002). Taking the global and extra-national context of Carraguard into 
account, and drawing on both media and other documents, I now turn to 
how Carraguard is geopolitically rendered as a woman's technology. 
Carraguard as a technology of women's empowerment 
A. United Nations report released last month shows that women now 
make up 50 percent of those infected with HIV worldwide — and in 
Africa that figure is now 58 percent. Today, AIDS has a woman's face 
(Arman 2002: no page). 
'I believe that one of the most powerful HIV vaccines available today is 
women's empowerment', Noleen Heyzer (UNIFEM 2003: no page). 
[Carraguard] may be the next great hope for millions of poor women 
seeking to protect themselves against the virus that •causes AIDS 
(Zimmerman 2002: 23). 
In placing women centre stage in the battle against HIV/ AIDS and in terms 
of women's empowerment, the media reportage of Carraguard is typical of 
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broader accounts of microbicides. For example, commemorating 
International Women's Day in March 2003, members of the Women's Global 
Health Imperative, a program in the AIDS Research Institute at the 
University of California, held a public briefing session on HIV/AIDS, 
preventive technologies and gender. Their title was AIDS has a Woman's Face: 
Gender and Power: New Strategies for HIV Prevention, which was modified from 
a New York Times article published in December 2002 and attributed to the 
United Nations Secretary General, Kofi Annan. Introducing the speakers for 
the session the program's Deputy Director, Suellen Miller, announced that 
'These women demonstrate that if AIDS has a woman's face then prevention 
also has a woman's face' (Miller, S 2003). 
If AIDS has a woman's face then prevention also has a woman's face. Does 
HIV/AIDS have a women's face? The answer must be no; rather, it is 
increasingly constituted as a disease beyond minority populations and one 
with the very real potential to shatter the reproductive and productive 
capacities of the peoples of entire nation-states and regions. How is one to 
read this conflation of HIV/AIDS and women and does such a tactic mean 
that Carraguard is being deployed as a technology of prudentialism in 
geopolitical networks of risk of HIV/AIDS in order to empower women. If 
so, to what effect? 
Studies concerning the efficacy of Carraguard and all other microbicides in 
development have thus far, been centred on vaginal uses (Global Campaign 
for Microbicides 2003). The most common argument used to justify delays in 
testing the effectiveness of rectal microbicides stems from a perceived gap in 
reproductive options for women in developing nations that scientists, 
philanthropists and members of women's organizations argue must be 
addressed. Then women will be able to control their sexual activities without 
necessarily negotiating male consent or understanding (Bell, SE 2000, 2003; 
Bitangaro 2002; Kaler 2001; Thrupp, Clift & Estes 1994). From such need, 
specific collaborative efforts emerged among a coalition of women's groups 
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known as the Women's Health Advocates on Microbicides (WHAM) and the 
Population Council to develop female controlled microbicides. Yet, in 
reporting on this affiance, Bell (2003) has observed that the members of 
women's groups hesitated in the 'halls of power' in the face of established 
feminist critiques of population and family planning practices, specifically 
because the Population Council's earlier development of Norplant and the 
IUD were seen to negatively affect the reproductive rights of women and 
particularly those from minority groups. However, a renegotiated 
relationship between WHAM and the Population Council that focused on 
microbicides did acknowledge the 'growing risk of contemporary AIDS 
prevention strategy in meeting women's needs [which has] created a 
scientific context for birth control and disease prevention groups of scientists 
to try to work together' (Bell, SE 2003: 204). In this view, the focus on 
prevention seemed to alleviate the risk of women losing control of their 
reproductive choices and practices. But does it, and how many women have 
such choice in the first place? 
By examining the effects rather than imputed intentions of media 
representations of Carraguard, it is possible to argue that networks of risk 
tend to favour a view of microbicides in which women's empowerment is 
increasingly subordinated to other risk priorities and geopolitical orderings. 
Success in stabilizing the networks in which Carraguard is implicated 
produces a gendered hierarchy of risk. As mere recipients of the new 
technology, women are valorized - alongside microbicides - as instrumental 
in creating equity: according to one reporter, this gel could do for women 
what condoms have done for men for years (Dobbs 2001). Academic 
• accounts of such concerns suggest that women are likely to be more sexually 
responsible than men, particularly as the latter are seen to fail to use the 
reliable technologies available to them (Lerner 2001). That men 'choose' not 
to use condoms and are in stronger position than women to make such 
decisions only serves to reinforce argument among those in microbicides 
research and development as well as the media that women need a 'stealth' 
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technology. Men's power relative to women also reinforces the current focus 
within the practices of global health on individual prevention and personal 
responsibility rather than structural and systemic change. Many women do 
not have the power in relationships to insist that men use existing HIV/ AIDS 
prevention methods (Lerner 2001). 
Many people also have only uneven and inadequate access to condoms and 
other reproductive technologies, and the social conditions governing their 
use in different locations are unfavourable for their widespread and 
continued use. As the 2003 annual report of the United Nations Population 
Fund on HIV/AIDS highlights, for both male and female condoms, 'the 
challenges are significant: massive shortfalls in supply compared to current 
needs, frequent stock-outs, and limited resources for programming to instil 
safer sexual behaviours. Pervasive myths, misperceptions and fears about 
condoms also inhibit their use' (UNFPA 2003: 7). Given these dilemmas, it is 
noteworthy that violence is rarely referred to in media accounts of 
Carraguard and HIV/ AIDS, with only one report among over 50 declaring 
that 'Violence — or the threat of violence — against women increases their 
vulnerability to HIV and reduces their ability to protect themselves against 
infection' (Macan-Markar 2000: no page). 
The adoption of the idea that women's empowerment coexists with female 
controlled microbicides is apparent in the promotional tools used to justify 
their development - but in ways that render women mere instruments of risk 
mitigation. For instance, one media source suggests 'Women's empowerment 
is ... very important ... because if you had a product that a woman could use 
without her partner knowing it, it would be a way to slow down the progress 
of this epidemic globally' (Mayer in (Jacoby 2001: 1D). In this view, there 
appears to be no consideration that stealth might be difficult to achieve or 
maintain. Carraguard is an odourless gel, but this must not be confused with 
invisibility; technologies of application, education, distribution as well as 
mediated knowledges 'reveal' it to men; deceit - no matter that it may be 
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enacted for self-protection - exposes women to manifold physical and social . 
risks. 
In her study of impediments to the uptake of another preventive technology, 
the female condom, Amy Kaler (2001) suggests that not least among the 
barriers to prevention technologies gaining widespread use among certain 
populations in parts of Cape Town, Nairobi and rural western Kenya, is a 
deep-seated suspicion among the men of these populations that the female 
condom captures sperm. They fear that female sexual partners may later take 
this sperm to the 'witch doctor' for use against them, or that the loss of their 
sperm in such fashion will erode their virility. Kaler's research suggests that, 
given these reactions, women using the female condom (and this number is 
limited for various reasons) do so by resorting to stealth in attempts to 
empower themselves. Drawing on a typology developed in 1985 by 
anthropologist Maxine Molyneux, Kaler argues that empowerment meets 
both strategic and practical gender interests, but advances a third idea of 
empowerment as a zero-sum game in which men are necessarily 
disempowered; the stealthy use of preventive technologies is one example of 
that, delaying men's responsibilities in sexual relations. Stealth has been 
lauded as a possibly empowering approach for women in the use of various 
preventive technologies (including Carrag-uard) and there is a functionality 
to it that bridges all three categories of empowerment to which Kaler refers. 
Stealth is strategic because its necessity highlights the deeply entrenched 
regimes of practice that serve to oppress women and disempower them 
institutionally and organizationally relative to men. It is practical insofar as 
its use is a rational (if not reasonable) means by which to meet crucial needs 
for safety and the mitigation of terrible risks. It is a zero-sum game insofar as, 
by their own admission, men will seek to reclaim power, typically using 
violence, if they discover the act of stealth. Its capture as a marketing tool in 
the sale of pharmaceutical products such as Carraguard is highly 
contentious. 
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The rhetoric of empowerment is not outside the exercise of power or existing 
gender relations; either in relation to women's participation in the 'halls of 
power' or to the use of Carraguard. In the first case, the development of 
Carraguard has not been entirely a product of a western neo-liberal view, 
and indeed, its developers claim legitimacy for the new technology through 
the participation of women in developing countries. On the one hand this 
may be viewed as an initiative of women in developing countries. However, 
it is also possible to view their participation, and the participation of other 
activist organisations as a transformation of those at risk into active, prudent 
citizens through technologies of agency (Dean, M 1999b; Rose 1999). 
On the other hand, discourses of empowerment can create sometimes 
illusory ideas of choice amongst subjects that, as demonstrated in relation the 
McLean burger, may be unrealistic in the context of situated social identities 
and can promote a sense of failure and invoke a culture of blame or even 
violence. Discourses that promote women's empowerment and choice must 
navigate between addressing social and material inequalities in gender 
relations. As Epstein et al. (2004: 4) comment, while there may be short term 
benefits of interventions that promise to empower women, 'such benefits are 
often short-lived and cannot survive the intrusion of material differences in 
power, access to money and so on'. Further, gender related violence, 
especially rape, not only contributes to spreading the virus that causes AIDS, 
but contributes to the maintenance of gender relations. Thus placing 
HIV/AIDS in the context of gender debates creates both possibilities and 
expectations about women's empowerment, and runs the risk of deflecting 
attention away from, or even contributing to, conditions of gender inequality 
and violence against women. 
In summarising Carraguard's constitution as a women's technology in 
media, as elsewhere, I wish to emphasise the consistency with which 
discourses of new public health map on to, and (re)produce women as self-
regulating and prudent subjects of and at risk of disease. Such discourses 
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produce a gendered hierarchy of risk in which inequalities in gender 
relations are subordinated to other geopolitical orderings. To some extent, 
microbicides are legitimised within public debate through their constitution 
as 'empowering' technologies, but at the same time women (and not men) 
become the key targets of prevention in which there is an obligation to 
respond but not necessarily the capacity to do so. 
The epidemiological framing of HIV/ AIDS in at-risk populations and 
lifestyle behaviours can skew the perception of disease such that the social 
context of risk and lifestyle is under-explored. 
For Sub-Saharan Africa in particular, the number of clients seen by 
prostitutes, the country of origin of those clients, and the degree of 
condom use in sexual transactions seem more important in many 
studies than are the reasons why women enter commercial sex work, 
men visit prostitutes, or refuse to use condoms (Craddock 2000). 
As Brown (2000) remarks, it is in the construction of deviance from the norm 
or of 'at risk' groupings through which social governance is enabled. It is not 
that boundary-marking practices in the governance of HIV/ AIDS are 
unnecessary, but that reflection on the effects of such practices in disciplining 
particular bodies at particular times rarely considers how such boundary 
markings seem so often to co-exist with bodies/groups/nations that are 
already stigmatised. Indeed, HIV/ AIDS has been described as a disease of 
signification (Treichler 1999) serving to marginalise those already 
marginalised, infecting with anxiety those remote from the experience of the 
virus that causes AIDS, and inscribing bodies, places and spaces with 
calculations of risk and modes of organising them (Brown, T 2000; Waldby 
1996, 1999; Watney 1987). Carraguard too, serves to reinforce the boundaries 
around marginal women in marginal places. 
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Extending 'freedom': HIV/AIDS and microbicides in the White 
House 
As the title of the 'Office of the US Global AIDS Co-ordinator' suggests, the 
blurring of national and global responsibilities and efforts towards the 
prevention of HIV/AIDS positions public health well beyond the boundaries 
of nationhood. O'Tuathail defined the study of geopolitics as the study 'of 
the spatialization of international politics by core powers and hegemonic 
states' (0 Tuathail 1996: 60). The suggestion that hegemonic states play an 
important role in constituting spaces of governance seems, in the current 
politics of terror, to remain apposite as well as proving an important counter 
to the ambivalence of ANT to questions of human exemptionalism (Murdoch 
2001). 
As the human immunodeficiency virus (HIV) pandemic surely should 
have taught us, in the context of infectious diseases, there is nowhere in 
the world from which we are remote and no one from whom we are 
disconnected. Consequently, some infectious diseases that now affect 
people in other parts of the world represent potential threats to the 
United States because of global interdependence, modern 
transportation, trade and changing social and cultural patterns 
(Lederberg, Shope & Stanley C. Oaks 1992: v). 
The tactics of governing risk may be internal to and/or extend beyond the 
boundaries of states, particularly where, as Lederberg et al. suggest, risk is 
perceived or constructed as a threat to the security of the body politic. 
HIV/AIDS is constructed in geopolitical discourse as one such threat to 
security (King 2002). In the post-colonial treatment of HIV/ AIDS, 'mitigation 
occurs anew through deterritorialised networks of technologies, information 
and management. Nowhere is this truer than in actions against what 
Lederberg and the US administration refer to as the pandemic of HIV/AIDS 
(Office of the United States Global AIDS Coordinator 2004). The geographic 
imaginary of HIV/ AIDS as a pandemic renders the disease simultaneously 
everywhere and (not) here - threatening because global flows and 
interconnections mean that HIV/AIDS is less easily confined within 
territorial space, but not here because threats are in the external origin of 
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HIV/AIDS. Rather than a pandemic, HIV/ AIDS like obesity or cancer, 
cholera, or typhoid, exists in places woven together as a pandemic through 
networks of associations and the geopolitical scripting of illness, bodies and 
of spaces of risk (Dalby 2003; Hyndman 2004; O Tuathail 1996, 1999). In the 
contemporary context of microbicide development, the US has taken a 
leading role. 
The Administration unveiled their [sic] implementing program pursuant 
to the passage of this Act in February 2004. After years of work to 
increase federal recognition of the importance of microbicides research, 
US advocates were pleased to see 'Microbicide Development' as a topic 
heading in the new President's Emergency Plan for AIDS Relief 
(PEPFAR) ... We were particularly encouraged to see a decisive 
statement supporting the concept of microbicides, which was articulated 
more affirmatively than might have been expected in the current 
political climate (Global Campaign for Microbicides 2004: no page). 
Than might have been expected. On the 16th December, 2004 the Senate 
Appropriations Committee passed the Foreign Operations Bill for the 2005 
financial year with a $10 million increase in support for microbicide 
development, bringing the total annual support to $32 million. Alongside the 
commitments expressed in the PEPFAR document, the 'surprise' of advocacy 
groups was understandable given the apparent lack of support for 
microbicides that preceded the Bill, and the growing ambivalence (if not 
contempt) of the US government to women's empowerment. Prior to the 
incorporation of microbicides into the five-year President's Emergency Plan 
for AIDS, released in February 2004, microbicides advocates struggled to 
obtain support from the US government. The 2004 plan however, commits 
the Department of Health and Human Services and USAID to support 
research and testing of microbicides and the expansion of prevention trials of 
microbicides (Office of the United States Global AIDS Coordinator 2004: 90- 
91). Lori Heise, the Director of the Global Campaign for Microbicides 
suggested the increased funding was a 'victory for citizen advocates' and an 
important step forward for the world's women' (Larkin 2004: no page). I am 
more cautious in reading the new found enthusiasm and economic 
commitment given to microbicides in such terms, particularly with respect to 
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how this relates to the world's women because the context of HIV/AIDS 
debates and gender in US has moved increasingly towards neo-conservative 
values. 
Under the George W. Bush Administration, many of the hard won victories 
extending women's reproductive rights have been under assault. An 
editorial published in the New York Times in January 2003, for example, 
described the Bush Administration's various reproductive reforms 69 as a 
'war against women' in both domestic and foreign affairs; "Mot Americans 
would be shocked at the lengths American representatives are going to in 
their international war against women's rights to control their bodies" (2003). 
The conflation of neo-conservative values in relation to reproductive health, 
and the US support for technologies that promote individual responsibility 
and women's empowerment seems contradictory. How can the new 
commitment to microbicides be understood? 
In the preface to this thesis I remarked that the war in Iraq marks out a new 
enthusiasm for preventive interventions on the part of the US Government. 
Notwithstanding that Carraguard is being developed by a philanthropic 
organisation, the change of heart support for microbicides leav. es open 
questions about Carraguard's association with, and/or assimilation into, the 
diverse strategies of colonising space that may be associated with a new kind 
of American imperialism (Pieterse 2004; Roberts, Secor & Sparke 2003; 
Soederberg 2004). The idea of the American empire etches another and 
equally complex context in which issues of security and international 
commerce have been enrolled in the quest for new global health priorities 
that rework the international and gendered geopolitics of the HIV/AIDS 
debate. 
69 In particular the editorial points to Bush policy on abortion and the various attempts to undermine 
the 'free-choice' enshrined by the Roe Vs Wade decision; the reinstatement of a global 'gag' order 
preventing American health professionals from offering advice or assistance in relation to abortion; the 
ban on late-term abortions; and decreased financial support for global health initiatives for 
reproductive health within the World Health Organisation and United Nations Population Fund. 
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A feature of the US empire of liberty is the politicisation of privatisation such 
that 'the politics of neoliberalism treats politics as a business 
proposition'(Pieterse 2004: 124). The 'business' approach to HIV/ AIDS is 
best represented by George W. Bush appointment of a former business CEO, 
Randall L. Tobias to the position of US Global AIDS Co-ordinator (Office of 
the Press Secretary 2003). Bush expressed little concern about his lack of a 
public health or medical background but rather emphasised his business 
credentials, stating that: 
Randy is one of America's most talented and respected executives. He 
was Vice Chairman of AT&T International and Chairman of ATT 
International, guiding the firm through immense organizational 
challenges. He went to head Eli Lilly and Company, one of our nation's 
largest and most innovative pharmaceutical companies (Office of the 
Press Secretary 2003: no page). 
If the appointment of a CEO without any expertise in health was an issue of 
concern raised by global advocates of microbicides, the more troubling issue 
for many was his association with the pharmaceutical giant Eli Lilly. 
HIV/ AIDS advocacy groups have been outspoken about the reduced 
support to the multilateral Global Fund, increased support for prevention 
programs focused on abstinence, and lack of demonstrable commitment to 
generic anti-retroviral drugs. Reluctance to fund anti-retroviral drugs has 
been a noted feature of all western donor programmes, attributed by some as 
a post-colonial contempt for African bodies (Jones 2004). Some theorists have 
pointed to the increased profile of technological solutions promoted by 
pharmaceutical and medical technology interests accompanied by the more 
general shift away from public health as a problem of provision and social 
management. 
Neoliberal empire is a marriage of convenience with neoliberalism 
indicated by inconsistent use of neoliberal policies, and an attempt to 
merge the America whose business is business with the America whose 
business is war, at a time when business is not doing so well (Pieterse 
2004: 123) 
For Pieterse, the problem facing the US is that it is severely over-stretched 
financially but also aiming towards greater involvement in affairs of empire. 
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In such a context, the economic rationale for a prevention technology such as 
Carraguard that is low cost option but still enables direct interventions 
makes sense. 
Further, while the globalisation of neo-liberal values can be seen to have 
accompanied free-markets and economic globalisation, the American empire 
is underpinned by the sense that American values are universal and 
expressed not by economic might but by what Pieterse has termed an 
'empire of liberty' (Pieterse 2004: 120). In his view, the promotion of ideals of 
freedom underpin the US military campaigns, a view that I consider relevant 
to the export of technologies such as 'Carraguard for .the prevention of 
HIV/ AIDS, and under which freedom is on strict terms. 
This week, I will speak in New York to the United Nations General 
Assembly, and I will talk about the great possibilities of our time to 
improve health, expand prosperity and extend freedom in our world. 
America and many nations are taking a bold stand in the fight against 
HIV/ AIDS. My emergency plan for AIDS relief will provide an 
unprecedented $15 billion over five years to support the fight against the 
AIDS pandemic throughout the world, with the focus on the most 
afflicted countries in Africa, the Caribbean, and Asia (Bush 2004: no 
page). 
Extending freedom through commitments to fund HIV/ AIDS campaigns 
elsewhere comes with caveats. The PEPFAR, consistent with domestic policy, 
promotes particular kinds of interventions and funds certain activities. 
Freedom is granted so long as the activities conform, in general, to the ideal 
of ABC (Abstinence, Monogamy and use a Condom as a last resort), and are 
implemented through faith-based and community based groups. This sense 
of freedom is not only circumscribed, but imposes neo-conservative values. 
Despite two decades of focused attention on prevention, however, we 
have yet to achieve widespread success. Inappropriate and inconsistent 
prevention messages, stigma, gender inequality, poor knowledge of HIV 
status, limited testing strategies, medical transmission of HIV through 
unsafe injections and blood supply, and HIV transmission from mother 
to child continue to fuel the spread of HIV. President Bush's Emergency 
Plan is specifically designed to address these challenges by using 
evidence-based prevention programs such as the "ABC" approach of 
Abstinence, Be faithful, and as appropriate, the correct and consistent 
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use of Condoms (Office of the United States Global AIDS Coordinator 
2004: 10). 
Extending neo-conservative regulated freedoms has become a .condition of 
health assistance to developing countries. In the war against HIV/ AIDS this 
new form of arrogance now underlies policies that aggressively promote 
freedom, with strong conservative and moral views about what freedom is. 
Contextualised within a new public health geopolitics of American empire, 
the support for microbicides may be less surprising than the advocates of the 
Global Campaign suggest, and associated with a new kind of fusion between 
neo-liberal economics and neo-conservative values; ones that justify pre-
emptive actions against risk. 
Breaking new ground: microbicides in a pre-emptive politics? 
In a recent conference paper assessing the revised National Defense Strategy of 
the Bush administration, Crina Archer (2004) argues that the notion of 'pre-
emptive' intervention differs markedly from ideas of prevention and is 
deeply troubling for democratic politics. She suggests that where prevention 
has a focus on evidence and the accuracy of evidence, pre-emption operates a 
different set of understandings that impute a sense of 'future dangerousness'; 
does this suggest a return to Castel's (1991) sense of dangerousness or 
something else? 
Citing the example of the increased state based adoption of 'Sexually Violent 
Predator Laws', Archer demonstrates that pre-emptive logic is not altogether 
new - for the past 15 years under such laws sex offenders may be confined to 
psychiatric institutions 'after the completion of their jail terms, on the basis of 
the possibility of a repeat offense' (Archer 2004: no page). She suggests such 
actions are explicitly pre-emptive because there is no punitive or deterrent 
reason for offenders' incarceration. Rather, such actions are premised on the 
rationale of stopping sexual crimes before they happen. In her view, the 
danger of such pre-emptive arguments is that there is no acknowledgement 
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that risk .calculations involve some degree of political judgement where the 
future is concerned. Moreover, without the acknowledgement of judgement, 
actions are constructed as 'common-sense' responses to inevitable outcomes. 
Such inevitable outcomes are calculations - but more troubling still is that 
they may be invisible to us. 
Other rationales for action may be hidden and she cites such examples as 
regime change, promotion of Christian moral values and promotion of 
corporate interests. On this point there are obvious overlaps with the US 
commitment to HIV/ AIDS and notions of American Empire. If the logic of 
pre-emption is guiding US policy towards microbicides, then the support for 
prevention of HIV/ AIDS is subordinated to an excessive optimism that 
western science can predict where HIV/AIDS will go, and also how it should 
be treated. Microbicides are then the answer for women who will get 
HIV/ AIDS - as if it has already occurred. Unlike prevention, such calculations 
do not take into account the question of probabilities, but assume certain 
outcomes. In this scenario, political judgement and reasonable uncertainty 
gives way to an 'optimism about OUT ability to calculate future 
dangerousness' (Archer 2004: no page). 
Moreover, the example demonstrates how Carraguard's deployment as a 
technology and its effects depends in no small measure, to who deploys it. 
The (re)formulation of microbicides as US technologies of pre-emption may 
not have been anticipated by the developers. There is always a danger that 
technologies come to embody more than is expected. 
Concluding remarks 
In this chapter I have considered how Carraguard embodies ideas of choice 
and responsibility, and if such so-called choice constitutes freedom or 
constraint. My concern was to ask how (and if) Carraguard reconfigures and 
constructs biopolitics elsewhere; how (and if) it enables prudent subjects, and 
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risk, at a distance. I built on insights developed in earlier chapters to propose 
that through its association with its US developers and advocates based 
predominantly in the neo-liberal west, Carraguard is a technology of 
prevention that is shaped by and shapes prudentialism. Further, I suggested 
Carraguard acts as a gendered technology within networks of concern about 
HIV/ AIDS, security, morality and gender. 
The example of Carraguard supports an argument that prudentialism 
exposes individuals to technologies that shape subjectivities across scales and 
locations. The scales that emerge from Carraguard as a complex actor-
network are various and implicate the illness,* carrageenan, technologies, 
developers and recipients. Carraguard is global in reach through its 
association with priorities in post-colonial health as well as intimate and 
personal in the lives of women, including also those enrolled for the most 
recent trials in South Africa". 
In this chapter I have demonstrated that microbicides and Carraguard 
(already) exist as complex actor-networks associated with various goals and 
priorities in particular visions of public health, and of central concern in this 
chapter, in focusing on prevention, women and ideas of empowerment. I 
have demonstrated that technologies of remote control may constitute an 
unproblematic neo-liberal and gendered subject of, and at risk of, the disease; 
the brutalizing effects of such a tendency serving to reinscribe various 
geopolitical boundaries whose effects on the pursuit of social and spatial 
justice are questionable. Carraguard is a gendered technology that permits 
the government of risk at a distance. Through Carraguard, HIV/ AIDS may 
be created anew as a disease of marginal women in marginal places. 
More troubling though, is the translation and incorporation of Carraguard . 
into the diverse strategies of an emergent American empire, which fuses neo- 
70  Large scale efficacy trials for Carraguard began in three locations in South Africa in March 2004 
(Population Council 2004b) 
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liberal economic strategies with neo-conservative values. I have only begun 
to explore these linkages here, and more work needs to be done to assess if 
this example is a portent for a more extensive re- figuring of public health. 
Conclusion: risking 
prudentialism 
Carrageenan is a seemingly irmocuous extract of seaweed that has grown in 
importance in how food and pharmaceutical industries respond to demands 
for prudentialism in the new public health. To facilitate a fuller 
understanding of how carrageenan functions in public health practice, in 
chapter one I combined two theoretical approaches in an analysis of it as an 
item of everyday consumption. The first was a critical geographic approach, 
combining post-structuralist scholarship that is attentive to the mentalities 
that make particular ways of thinking about public health possible, 
particularly Foucauldian inspired research on governmentality and risk. I 
also drew on geographic scholarship (both within and outside the formal 
discipline) that emphasises the importance of how space and place are 
affected by and affect public health. The second approach drew from actor-
network theory and provided a method to map out heterogeneity in relation 
to carrageenan. Emerging from these approaches were my three themes of 
visibility, futurity and spatiality which explicitily and implicity underscored 
my examination of prudentialism and carrageenan in the new public health. 
In applying a critical geographic/network approach, and the three themes, I 
was able to trace out a complex and expansive network of connections across 
various scalar concerns - from the remote workings of public health and 
their proximities to individuals through material technologies such as food 
labels, food products and pharmaceuticals, to less formalised and even 
virtual spaces of health information resources including the Internet and 
popular media. The significance of this approach has been the partial 
perspectives it revealed. Such partial perspectives contribute to what Donna 
Haraway (1988) has identified as 'objective' enquiry. 
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My adoption of a critical geographic/network approach allowed me, in 
short, to reveal topologies and topographies of seaweed and carrageenan 
that have hitherto remained under-explored, and that reveal the workings of 
discourses of the new public health in affecting new realities for the 
carrageenan industry as well as for individuals within activities related to 
prevention, promotion and provision in public health. I was able to trace out 
how carrageenan is refigured and refigures what public health is and who it 
affects, and to reveal, in stark material form, an underbelly to choice, 
freedom and practices associated with health prevention. The dissertation 
made visible the ways in which relations of power/knowledge congeal in 
material and non-material networks. Through the three themes of visibility, 
futurity and spatiality I extended the significance of such networks beyond 
the immediacy of the places in which I encountered and documented them. 
Chapter two explored the proximity of public health to prudent individuals 
through the materiality of food labels. Such technologies of public health are 
more than simple statements about what is in food; rather they orient 
individuals toward prudent behaviour(s), aligning them with particular 
regimes of governing health at a distance. For a number of reasons I 
problematised the prudent subject. First, while carrageenan appears on labels 
as safe, it is virtually impossible for individuals to navigate the complex 
informational quagmire to make assessments about it. Carrageenan 
describes a complex network, but is reduced to singularity in the regulatory 
environment, and as a boundary object amongst industry players. 
Carrageenan is visible yet not, exposing individuals and communities to 
discourses that promote the future (care) of self, and the spatial qualities of 
such remote yet proximate interconnections with the new public health. Yet 
as I documented in chapter three, carrageenan is minutely differentiated and 
complex across a vast field of different knowledges and situated social 
framings. As the complexity of knowledge about carrageenan expands 
within and across epistemic communities, its visibility to prudent subjects 
becomes increasingly displaced and distant. Moreover, what counts as a risk 
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in relation to carrageenan is not consistent across different contexts or 
different representations. For example, carrageenan that is considered 
'generally recognised as safe' or GRAS is associated with risks that are 
different from carrageenan that is regulated as safe, but not classified as 
GRAS. There are consequences for prudent subjects in the different risk 
calculi and their (visible) representation, as material environments are 
modified and transformed. There are also consequences as carrageenan 
industries must respond to the increasingly (and seemingly• unending) 
durable relationships 'established between risk and carrageenan in some 
contexts. Risks become virtually immutable and the carrageenan industry is 
obliged to respond - and inadvertently propagate that immutability. 
In chapter four the extent of the informational environment, beyond the 
'official' discourses of public health or singularity of carrageenan-on-labels, 
was considered in a discussion of carrageenan and carcinogenicity. The 
example showed the partial perspectives of different epistemic knowledges, 
and the partial perspectives that are contrived through various media. It 
would not take much effort for a prudent consumer of health to download 
information from the Internet and discover 'risks' of cancer or .ulcerations 
arising from carrageenan consumption. Individuals are placed in a role of 
perpetual conflict with the trust-in-authority that is implied by a politics of 
singularity within regulatory environments, and the obligation to be prudent 
and validate what is or is not safe to consume. Complicating entities, such as 
degraded carrageenan/poligeenan, become risks in part because they create 
boundaries around what are much more complex actor-networks, and ones 
that may be based on future calculations of risk. Maintaining carrageenan's 
ontological stability becomes increasingly difficult as techno-scientific 
fractions of risk multiply across spatial and temporal locales. Risking 
carrageenan depends on partial perspectives, but most views are based on 
singular perspectives that are often in competition with others. 
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Furthermore, one complication that arose from delimitations of risk and 
carrageenan was unexpected material and non-material changes in what 
constitute such things as food products in the present. Refering to the US 
Nutrition Labeling and Education Act, I demonstrated how the food industry 
responded to prudent reading of labels in part by modifying food content to 
meet these expectations and, in chapter five, also showed that it is not always 
clear who benefits from such changes. Food modification for alleged public 
health goals has become rhore widespread, and has loosened some of the 
regulatory barriers that previously prohibited the use of products, such as 
carrageenan in meat, for the purposes of food modification. While 
manufacturers have increased the use of food additives to modify health-
related properties, this does not necessarily signal that food has become 
either more healthy, or more risky, but it does represent a significant shift not 
only in what food is, but what it represents. The development of food 
products such as the McLean is representative of the (re)medicalisation of 
food and new centrality of issues of health in decision-making about the 
production, manufacture and (supposedly) consumption of food. The 
futurity of risk calculation has effects in the present. Moreover, 
prudentialism is no longer cast as choice but as a matter of course. Despite 
that, there are many 'rational' reasons to explain why individuals may 
choose, or not, so-called healthy options that are silenced in the matrix of the 
new public health. Because elements such as the aesthetic/expressive 
dimensions of choice are rarely considered in developing prevention 
technologies one consequence, demonstrated by the media analysis of 
articles about the McLean's failure, is blame of self and others under the 
terms of the new public health. 
In a similar vein, the calculative rationality underscoring carrageenan as a 
risk in relation to carcinogeneity or ulcerations also applies to the 
development of the McLean and Carraguard as responses to risks associated 
with obesity and HIV/ AIDS. These technologies have not been designed for 
people who suffer from obesity or HIV/ AIDS, but focus on the future health 
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of already healthy populations and environments cast as at risk. I do not 
mean to suggest that obesity, cancer or HIV/AIDS are not pressing issues, 
but when the technologies of the McLean or Carraguard are resituated 
amongst partial perspectives, I have shown that they affect subjectivities of 
individuals and collectives within healthy populations in the present. Health 
technologies are not benign even when they are designed for prevention 
amongst the healthy. 
In chapter six, I traced the geopolitics of one carrageenan actor-network 
through the global scales of health provision in relation to HIV/ AIDS and to 
one possible 'futurity' - pre-emption. Microbicides articulate prudentialism 
for particular publics, marginal women in marginal places. Exemplified also 
by the McLean, the discourse of prudentialism is premised on a subject 
decontextualised from socio-cultural and material factors that disable 
subjects. For example, I highlighted how the economic geography of food 
choice, or violence against women is obscured when the ideal of the prudent 
subject is invoked. The calculation of health risk and production of prudent 
subjects belies the complexity of the context in which decision-making 
occurs. Moreover the deployment of prudent or even 'empowering' 
technologies of prevention such as microbicides may be undergoing a 
significant realignment. It may be that the development of Carraguard forms 
part of the underlying neo-liberal and neo-conservative political mentalities 
of the new public health and their extension into spaces and places beyond 
neo-liberal polities. However, further research is warranted to assess how 
neo-conservative values are affecting new mentalities in public health. 
In tracing out various carrageenan actor-networks associated with 
prevention in public health, I made transparent how underlying mentalities 
of governance, and the calculations of risk, are implicit in where and how 
carrageenan is deployed. Carrageenan modifies the material qualities of 
food, is used to constitute pharmaceutical products, and different risk calculi 
affect different uses. Moreover, the deployment of carrageenan for different 
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uses affects how health is defined, understood and acted upon. For the 
carrageenan industry such developments have created both opportunities 
and threats. The McLean was a technology that had potential to increase the 
production of carrageenan-bearing seaweed industries, but it did not. 
Microbicides may yet revolutionise (parts) of the industry. However labels 
and alleged risks may turn consumers away, particularly if the network 
connections concerning carcinogenicity lengthen and disperse. 
In more general terms, one reason I have given for many of transformations 
that have taken place in public health practice is the increased salience of risk 
in underscoring calculations, constructions and visibility of what become 
issues of concern and action. Risk is, to some extent, a catch-all phrase for 
many different governmental rationalities, although it is not, as I found with 
uncertainty and its relation to entrepreneurship in chapter two, the only 
rationality underlying public health activity. Moreover its construction 
structures debates about whether carrageenan is safe or not to consume, and 
multiplies and expands alleged-risks. Risk is self-propagating but risk does 
not necessarily bear equivalence to a corresponding danger. Indeed it appears 
that risks associated with carrageenan and carcinogenicity were deduced and 
emboldened from a fusion of risk calculations decontextualised from the 
significance of their accumulation. I do not wish to imply that carrageenan 
should be pronounced safe or unsafe, or that carrageenan should not be 
tested. Rather, by resituating safety concerns about carrageenan within such 
partial perspectives, it is possible to see how risks are invigorated. Such 
partial perspectives offer one possible avenue for reducing the angst that has 
characterised discussions about carrageenan as a safe or unsafe additive. 
At the same time, one question that this study raised for me was how 
prudentialism has become and is maintained as central to the new public 
health. I have questioned the foundation of prudentialism and in particular 
the incitement to notions of choice. •T'he power of prudentialism amongst 
many publics derives from its appeal and packaging as choice or freedom. 
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Laudable though this package may seem, choice and freedom do not exist 
outside the exercise of power. For various reasons choices are limited and in 
some situations, such as the provision of HIV/AIDS prevention technologies 
designed for 'stealth', such expectations of prudentialism may , not give 
women greater control and may place them in physical or other forms of 
danger. The example given in chapter six of microbicide developments for 
Sub-Saharan Africa perhaps best demonstrate how such discourses of choice 
can be appropriated in ways that have little to do with emancipation. In the 
case of Carraguard, recent developments in the US concerning microbicides 
suggest that neo-conservative values and 'anti-choice' agendas are 
increasingly and visibly colonising the various domains of public health - 
and the future. 
Prudentialism is sold through the promise of emancipation and appeals to 
ideals of freedom, but in some contexts gives effect to the opposite: spaces 
that were once less under the surveillance of public institutions, like 
sexuality and the simple (yet complex) enjoyment of food, are bought to 
public account through the discourse of prudent individualism. One effect of 
the new public health is that foods and pharmaceuticals are modified to 
respond to these new ways of thinking about public health. As one among 
other consequences, industries like the carrageenan industry react to new 
public health discourse and modify applications for carrageenan accordingly. 
Food labels, Carraguard and the McLean are technologies that are both 
developed for, and oblige prudent individualism. People may reject the 
McLean without any great consequence, but the 'freedom' to use Carraguard 
against HIV/AIDS may have costs - particularly for women. Women who 
may be exposed to physical danger, and/or are unable, for various other 
reasons, to use such technologies, may be blamed by publics for failing 
public health. Despite the philosophical commitment to autonomous healthy 
individualism, neither the provision for that, nor its execution is guaranteed 
to produce the effects that are expected. There are risks associated with 
prudentialism: from what constitutes choice, to the obligations such choice 
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demands, to the concealment of the limits of choice, and to the potential for 
blame. 
A further conclusion that can be drawn from this research concerns the 
tendency of scientific and expert accounts to focus on how prudent subjects 
are enabled (or not) by information about safety. In my view there is much 
scope for the examination of how they are also disabled by the lack of social 
studies such as this that contextualise such debates. If prudentialism remains 
central to how public health happens, the provision of partial perspectives as 
advocated by Haraway (1991) would enable what she describes as more 
'objective' decision-making about prevention-focused technologies. 
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APPENDIX 
Appendix 2.1 
[Code of Federal Regulations] 
[Title 21, Volume 3] 
[Revised as of April 1, 2003] 
From the U.S. Government Printing Office via GPO Access 
[CITE: 21CFR182.7255] 
[Page 467] 
TITLE 21--FOOD AND DRUGS 
CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND 
HUMAN 
SERVICES (CONTINUED) 
PART 182--SUBSTANCES GENERALLY RECOGNIZED AS SAFE--Table of Contents 
,Subpart H--Stabilizers 
Sec. 182.7255 Chondrus extract. 
(a) Product. Chondrus extract (carrageenin). 
(b) Conditions of use. This substance is generally recognized as 
safe when used in accordance with good manufacturing practice. 
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Appendix 2.2 
[Code of Federal Regulations] 
[Title 21, Volume 3] 
[Revised as of April 1, 2003] 
From the U.S. Government Printing Office via GPO Access 
[CITE: 21CFR172.620] 
[Page 67-681 
TITLE 21--FOOD AND DRUGS 
CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND 
. HUMAN 
SERVICES (CONTINUED) 
PART 172--FOOD ADDITIVES PERMITTED FOR DIRECT ADDITION TO FOOD FOR 
HUMAN CONSUMPTION--Table of Contents 
Subpart G--Gums, Chewing Gum Bases and Related Substances 
Sec. 172.620 Carrageenan. 
The food additive carrageenan may be safely used in food in 
accordance with the following prescribed conditions: 
(a) The food additive is the refined hydrocolloid prepared by 
aqueous extraction from the following members of 
[[Page 68]] 
the families Gigartinaceae and Solieriaceae of the class Rodophyceae 
(red seaweed): 
Chondrus crispus. 
Chondrus ocellatus. 
Eucheuma cottonii. 
Eucheuma spinosum. 
Gigartina acicularis. 
Gigartina pistillata. 
Gigartina radula. 
Gigartina stellate. 
(b) The food additive conforms to the following conditions: 
(1) It is a sulfated polysaccharide the dominant hexose units of 
which are galactose and anhydrogalactose. 
(2) Range of sulfate content: 20 percent to 40 percent on a dry-
weight basis. 
(c) The food additive is used or intended for use in the amount 
necessary for an emulsifier, stabilizer, or thickener in foods, 
except 
for those standardized foods that do not provide for such use. 
(d) To assure safe use of the additive, the label and labeling 
of 
the additive shall bear the name of the additive, carrageenan. 
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Appendix 2.3 - Extract 
[Code of Federal Regulations] 
[Title 21 Volume 5] 
[Revised as of April 1, 2003] 
From the U.S. Government Printing Office via GPO Access 
[CITE: 21CFR310.545] 
[Page 38-47] 
TITLE 21--FOOD AND DRUGS 
CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND 
HUMAN 
SERVICES (CONTINUED) 
PART 310--NEW DRUGS--Table of Contents 
Subpart E--Requirements for Specific New Drugs or Devices 
Sec. 310.545 Drug products containing certain active ingredients 
offered over-the-counter (OTC) for certain uses. 
(a) A number of active ingredients have been present in OTC drug 
products for various uses, as described below. However, based on 
evidence currently available, there are inadequate data to establish 
general recognition of the safety and effectiveness of these 
ingredients 
for the specified uses: 
(12) Laxative drug products--(i) Bulk laxatives. 
Agar 
Carrageenan (degraded) 
Carrageenan (native) 
Guar gun 
(20) Weight control drug products. 
Alcohol 
Alfalfa 
Alginic acid 
Anise oil 
Carboxymethylcellulose sodium 
Carrageenan 
Cholecalcierol 
Choline 
Chondrus 
Citric acid 
Cnicus benedictus 
Copper 
Copper gluconate 
Corn oil 
Corn syrup 
Corn silk, potassium extract 
